Aass N, 256, 273–287
Abad L, 52–59
Abbey A, 41–57, 144–154, 155, 172–192, 217–233, 234, 235, 430–438, 461–475
Abbott AF, 240–256
Abdalla HI, 308–317, 510–518
Abel PD, 5–18, 38–56
Abraham N, 219–234
Abraham S, 99–112, 113, 446–457
Abrahams N, 40–57, 70–71, 115, 172–192
Abrams BF, 446–457
Abshoff K, 417–426
Abt M, 203–210
Abyholm T, 53, 59
ACT Health, 528–541
Acton W, 215
Adair A, 308–317
Adam R, 72–82
Adams J, 197–209
Adams ML, 190–194
Adams PB, 106–115
Adamson D, 464–475
Addis A, 104–114
Adinma JB, 71–81
Adler A, 157
Affleck G, 93–96, 144–154, 430
Affonso D, 444–456
Agarwal A, 48–58
Agazzi L, 173–193
Aggleton P, 70–81
Aghanwa HS, 70–71
Aghassa MM, 74–82
Ahn H, 121
Ahsan SK, 70–74
Ahuja KK, 319–337, 510–518, 519
Ainsworth M, 486–492
Aitkin M, 261–286
Ajmera RL, 205–211
Alagappan RK, 238–256
Alcolea R, 240–256
Alcott WA, 215
Alesi R, 331–338
Alexander BB, 415–426
Alexander CM, 65–80, 81
Alexander F, 133, 170
Alexander-Roberts, C, 400–410
Alhadeff JM, 292–303
Ali ME, 205–211
Allard M, 143–154
Allen C, 269–287
Allen JSF, 280–288
Alper M, 55
Alstein H, 400
Althaus M, 392–409
Althof SE, 225–234
Altmark D, 101–113
Altshuler LL, 104–114, 115, 445
Amer SA, 52–59
American Academy of Pediatrics Committee on Drugs, 104–114
American Board of Genetic Counseling, 261–286
American Board of Obstetrics and Gynecology, 23–35
American College of Obstetricians and Gynecologists, 271–287, 288
American College of Obstetrics and Gynecology Committee Opinion, 271
American College of Obstetrics and Gynecology Practice Bulletin, 447–457
American Counseling Association, 65
American Psychiatric Association, 98–112, 297–304
American Psychological Association, 61, 65, 87–95, 118–127, 527–541
American Psychological Association Practice Directorate and Interdivisional Healthcare Committee, 502–503, 505–507
American Society for Reproductive Medicine, 5–18, 20–35, 36, 84–95, 189–194, 256, 271–287, 289, 306–316, 318, 329–338, 357, 358–369, 376–386, 481–491, 513–519, 526–541, 542, 545–556
American Urological Association, 27–36
Americans with Disabilities Act, 531–542
Amos J, 239–256
Amsterdam JD, 105–115
Amuzu B, 307–316
Andayani S, 69–80
Anderson A, 479–491
Anderson DJ, 240–256
Anderson J, 246–257, 331–338
Anderson KM, 46–58, 231–235
Anderson N, 199–209, 321–337, 340–354
Anderson R, 67–80
Andersson L, 39–56, 362–369
Andersson SA, 202–209
Andrews FM, 41–57, 144–154, 155, 172–192, 217–233, 234, 235, 430–438, 461–475
Anemone R, 457
Angelsioo L, 445–457
Annas GJ, 243–256, 512–519
Annon J, 228–235
Anonymous v. Anonymous, 535–542
Ansorge MS, 105–115
Anthony S, 479–491
Anton HL, 423–427
Apfelbaum B, 227–235
Appel S, 197–208
Applegarth LD, 130–141, 322–337, 338, 339–354, 355, 359–368, 369, 470–476, 498–507, 515–520
Appleton TC, 83, 85–95, 356–368, 527–541
Apter A, 105–115
Aral SO, 216–233
Araoye MO, 42–57, 81, 219–234
Araoz D, 223–234
Archer RP, 134–142
Ardenti R, 173–193
Argaval A, 205–210
Arian-Schad, M, 319–337
Arici A, 52–53, 58–59
Aristotle, 213
Armare NA, 319–337, 510–519
Arnold ES, 93–95
Arntz A, 297
Aronson M, 206–211
Arthur NJ, 158–167, 168
Artificial Conception Act, 525–540
Arya R, 216–233
Asay TP, 118, 120–127
Asch RH, 343–354
Asher T, 310–318, 326–338
Asimakopoulos B, 313–318
Asmar P, 41–57, 130–141
Aso T, 202–209
Assisted Reproductive Technology Bill, 547–556
The Assisted Human Reproduction Act, 146–155, 524–540, 544–556
Astbury J, 430–438
Aston J, 539–543
Athayde N, 279–288
Atkinson DR, 65–80
Atwood JD, 153–155
Augustus, 412
Aurrell R, 276
Austin C, 430–438
Australia & New Zealand Infertility Counsellors Association, 529–541
Avery O,
Avidan D, 351–355
Aviram-Goldring, AL, 269–287
Aviv A, 217–218, 234, 432–438
Axelsen A, 204–210
Aylward M, 100–113
Azam F, 217–234
Baccetti B, 203–210
Bachman GA, 224–234, 235
Backlund v. University of Washington, 530–541
Backstrom T, 101–113
Baetens P, 83, 85–95, 314–318, 319–337, 341, 527–541
Bahadur G, 510–519
Bahce A, 105–115
Bailey JW, 104–114
Bain J, 228–235
Bakelants E, 144–154, 158–168
Baker AB, 245–257
Baker DB, 120
Baker HWG, 430–438, 442–456
Baker JB, 120
Baker V, 464–475
Bakketeig LS, 269–287
Balasch J, 52–59
Baldo TD, 495–507
Balen A, 311–318
Balercia G, 205–211
Balls Organista, P, 62–79, 411–425
Balmaceda J, 343–354
Baltzer FR, 514–520
Baluch B, 67–80, 82
Banchi P, 202–209
Bancroft J, 136–142
Bandura A, 134–142, 199–209
Bangrazi A, 202–209
Bankier A, 276–288
Banks JM, 294–304
Baqui AH, 70–74
Baram D, 84–95, 98–112, 152–155
Baran A, 307, 391–409
Baras M, 414–426
Barglow P, 171–192
Bar-Hava, M, 217–234
Barlow SH, 157–167
Barnes J, 463–475
Barnes PM, 197–208
Barnett RC, 43–58
Baron J, 527–541
Barreda-Hanson, MC, 462–475, 482–492
Barrett J, 242–256
Barron JW, 417–426
Barrow RG, 511–519, 556
Bartels DM, 260–286
Bartholet E, 399–409, 410
Bartlam B, 119
Bartlett H, 145–155, 182–194
Bartlett JA, 324–337, 344–355
Bartlik B, 223–234
Barton M, 305
Bartoov B, 39–56, 203–210
Baruch GK, 43–58
Bary JD, 280–288
Bashford RA, 345–355
Basseri, 66
Bassin D, 131–141
Basson F, 218–234
Basson R, 222–234
Bastra L, 170–192
Bateman S, 284–289
Bateson CD, 346–355
Bateson G, 135
Bateson W, 259
Battaglia C, 204–210
Batzer FR, 515–520
Bauer M, 101–113
Baum JD, 291–303
Baumeister L, 282–289
Beary JF, 171–192
Beauchamp TL, 512–519
Beaurepaire J, 38–56, 93–95, 106–115, 173–193
Beck A, 134
Becker G, 39–56, 58, 84–95, 132–141, 149–151, 153–155, 217–234, 308–317, 359–369, 434–438
Bee v. Greaves, 530–542
Beeney LJ, 53–59
Beerendonk CC, 53–59
Beeson D, 267–286
Begum L, 70–74
Belar CD, 170–192
Bellissimo A, 175–193
Belluck P, 360–369
Belonoschkin B, 7–19, 216–233
Benagiano G, 510–519
Bendvold E, 307–316
Benedek T, 6–19, 112, 130–141, 216–233, 442–456, 494–506
Benedi A, 105–115
Benedict R, 61
Benezon N, 145–155, 470–476
Benfield DG, 292–303
Benjamin LT, 120
Bennet HA, 445
Bennet JA, 106–115
Bennet MJ, 271–287
Bennett D, 204–210
Bennett JM, 360–369
Bennett RL, 282–289
Benoff S, 239–256
Benoit J, 53–54, 59
Ben-Rafael, Z, 292–303
Bensch RL, 93–95
Bensen P, 391–409
Benshushan A, 510–519
Benson HR, 53–54, 59, 103–114, 120, 124, 158–167, 168, 171, 184–194, 419–426, 429–438
Benson K, 121
Bentley G, 415–426
Benward J, 536–542
Benyamini Y, 42–57, 172–192
Beran MD, 86–95
Berenson AB, 102–114
Berg BJ, 6–19, 38–56, 135, 145–154, 155, 179–193, 217–234, 419–426, 430–438, 477–491
Berg G, 445–457
Berga JL, 203–210
Berga SL, 184–194, 244–257
Bergart A, 158–167
Bergeeron S, 224–234
Berger DM, 39–56, 494
Berger MD, 307–316
Berger P, 50–59
Bergh C, 430–438, 479–491
Bergh D, 441, 456
Bergh T, 39–56, 479–491
Bergin AE, 63–79
Bergman P, 307–316
Bergman S, 44–58
Berkkanoglu M, 68–80
Berkowitz L, 346–355
Berman J, 222–234
Bernal G, 62–79
Bernardini M, 242–256
Bernstein J, 2–17, 98–112, 442–456, 457, 470–475, 476
Berretta MC, 107–115
Berriot-Salvadore, E, 320–337
Berry JW, 62, 64–79, 80
Berryman JC, 451–458
Bertalanffy L, 309–317
Bertrand E, 510–519
Bertrand-Servais, M, 449–458, 470–476
Beski S, 51–59
Betteridge K, 477–491
Beutel M, 99–112
Beutler LE, 126
Bevc V, 361–369
Beyler SA, 359–369
Bharadwaj A, 388–408
Bhasin S, 273–287
Bhatti LI, 416–426
Biagiotti G, 205–210
Bianchi P, 510–519
Bibring G, 141
Biebl W, 446–457
Biener L, 43–58
Biesecker BB, 261–286
Bigner JJ, 514–520
Bill C-6, 310–318
Bingham C, 106–115
Binik YM, 222–234
Bish A, 308–317, 463–475
Bissonette F, 53–54, 59
Bitzer J, 83, 85–95, 264–286, 495–507, 527–541
Black BP, 442–456, 465–475
Black L, 391–409
Blackwell RE, 218–234
Blanchard A, 388–408
Blaney F, 119–127, 158–167, 246
Blankenstein J, 343–354
Bledsoe CH, 412–425
Blehar MC, 486–492
Blenner JL, 11, 66, 144–154, 430, 431–438
Blondel B, 467–475
Blood D, 510–519
Blood J, 310–318
Bloom BL, 138–141
Blumberg B, 281–288
Blyth E, 306–316, 317, 339–354, 372–386, 524–540, 544–555, 557, 561
Bochard E, 323–337
Boggio A, 306–316, 321–337, 340–354
Boivin JA, 4–18, 39–56, 58, 75–82, 83, 85–95, 96, 98–112, 117–127, 128, 143–154, 155, 157–167, 173–192, 193, 194, 217–234, 310–318, 362–369, 419–426, 429–438, 439, 494–507, 527–541, 565–568
Bombard A, 271–287
Bonacich P, 360–369
Bonadonna G, 241–256
Bonanno GA, 163
Bonduelle M, 272–287, 479–491
Bonnickson A, 285–289
Bonte L, 106, 174–193
Bontis J, 40–57, 73–82
Boonmongkon P, 414–425
Boostanfar R, 51–59, 333–338
Borders L, 391–409
Borduin CM, 134–142
Borg G, 430–438
Bork MA, 22–35
Bornstein J, 361–369
Borochowitz ZU, 281–288
Borrero C, 363–369
Boscaro M, 205–211
Bosch E, 300–304
Bosch X, 50–59
Boss P, 327–338
Bostwick JM, 158–167, 168
Bourne S, 291–303
Boveri T, 259
Bowen M, 486–492
Bowen-Simpkins P, 510–518, 519
Bower B, 390–409
Bower C, 269–286, 480–491
Bowlby J, 293, 326–338, 393–409, 486–492
Boxer AS, 39–56, 84–95, 98–112, 232–235, 430–438, 494–506
Boydell KM, 119–128, 165–168
Bozzo M, 240, 256
Braat DDM, 53–54, 59, 106–115, 117–127, 430–438, 456, 479–491
Bracken MB, 191–195
Bradbury TN, 143–154
Bradley S, 468–476
Bradshaw J, 309–317
Bradstreet A, 411
Bradt JO, 461–474
Brähler E, 306–316
Brand HJ, 54–59
Brandon J, 309–317
Brandt KR, 457
Brandt U, 122, 136–142, 144–154
Brannon L, 43–58
Brater DC, 503–507
Braude P, 524–540
Braverman AM, 335, 338, 342–354, 355, 372–386, 429–438, 449–458, 468–476, 494–507, 514–519
Bray JH, 503–507
Brazier M, 510–519
Breheny SA, 359–369
Brender W, 98–112, 119, 124, 145–154, 173–193, 217–234, 419–426
Brenner JL, 100–113
Brensinger C, 299–304
Bresnick E, 4–18, 493–506
Bretherick KL, 275–287
Brew T, 432–438
Brewaeys A, 307–308, 309–316, 317, 463–475, 483–492, 553–557
Brey K, 248–257
Brezinka C, 446–457
Brier N, 300–304
Brigham S, 300–304
Brill M, 344–355
Brinsden P, 324–337
British Infertility Counselling Association, 528–541, 553–557
Britt DW, 301–304
Brobst K, 65–80
Broca PP, 259
Brochu J, 104–114
Brockington I, 106–115
Broderick P, 172–192
Brodzinsky DM, 310–318, 390–408, 409
Brokaw v. Mercer County, 531–542
Bronzo M, 105–115
Broome A, 41–57, 98–112
Broverman DM, 100–113
Brown C, 311–318
Brown D, 388–408
Brown L, 4, 477, 489, 522
Brown SE, 93–95, 98–112
Bruce NW, 174–193
Bruhat MA, 5–18
Bruinse HW, 456, 479–491
Brumbach B, 107–116
Bryan EM, 301–304, 468–476
Bryant LT, 242–256
Bryson CA, 430–438
Buck PS, 388
Buitendijk S, 479–491
Bulik CM, 99–112
Bundren JC, 101–113, 114
Bunge RG, 341–354
Burgos C, 324–337
Burke WF, 137–142
Burlew AK, 62–79
Burlingame GM, 157–167
Burn IP, 341–354, 355
Burnett A, 222–234
Burns LH, 4–17, 18, 19, 22–35, 39–56, 58, 64–79, 80, 88–95, 105–115, 125, 164–168, 169–192, 194, 212–233, 234, 235, 258–285, 297–304, 310–318, 319–337, 338, 425, 440–455, 458, 459–474, 475, 486–492, 505–507, 527–541, 552–556
Burrow AL, 392–409
Burrows T, 157
Burry K, 531–542
Burston A, 469–476
Bush V, 83
Buss KA, 41–57, 71–81
Buster J, 356–368
Butcher JN, 134–141, 142
Butler A, 359–369
Butler P, 2–17
Butow PN, 53–59
Buzaglo JS, 53–54, 58–59
Byrn F, 307–316
Byrnes AL, 282–289
Cadman J, 481–491
Cahill DJ, 204–210
Cai X, 202–209
Cain M, 421–427
Caldwell JC, 415–426
Caldwell P, 415–426
Calef V, 461–474
Calis KA, 42–53, 58–59, 67–80
Callahan CM, 503–507
Callahan EJ, 444
Callahan MM, 118–127
Callahan TL, 448–457
Callan VJ, 55–60, 184–194, 430–438
Callaway LK, 333–338
Campari C, 173–193
Campbell A, 510–519
Campbell MJ, 205–210
Campbell NA, 259–285, 286, 292–303
Campbell SB, 441–445, 456, 457
Campbell SM, 177–193
Camus M, 319–337, 431–438, 449–458, 479–491
Canadian Counseling Association, 528–541
Cannon WB, 171
Cantrell W, 45–58
Capitulo KL, 294–304
Caplan AL, 260–286, 335, 338, 509–518, 519, 520
Caplan G, 136–142
Capparelli S, 205–211
Cardone VS, 52–59
Carey MP, 220–234
Carlsson SA, 52–59
Carnpana A, 130–141
Carol MP, 171–192
Carrell DT, 283–289
Carrera L, 300–304
Carr-Saunders AM, 259–286
Carruthers ME, 119–127
Carson SA, 510–519
Carter B, 416–426
Carter JW, 153–155, 421–427
Carter MD, 36, 153–155, 421–427
Carter RT, 65–80
Cartmill D, 283–289
Casas JM, 65–80, 81
Cashman FE, 101–113
Casini ML, 204–210
Casper RC, 100–113, 114
Casper RF, 93–95, 98–112
Caspi A, 467–475
Castonguay LG, 122, 126
Cates W, Jr, 216–233
Caudill OB, 533–542
Cavillini G, 205–210
Cedars M, 26–36
Cedenho AP, 203–210
Cella DF, 245–257
Cerritelli B, 246–257
Cervamtes M, 343–354
Cervantes Miguel de, 117
Chabon M, 37
Chally PS, 511–519
Chambers CD, 104–114, 445
Chan L, 50–58
Chan PJ, 205–210
Chan R, 486–492
Chan WW, 202–209
Chandley AC, 273–287
Chang LJ, 336–338
Chang RJ, 20–35
Chang SS, 100–113
Chapnick EM, 7–19
Chase GA, 267–286
Chase J, 343–355
Chatterton R, 299–304
Chaudron LH, 101–113
Che Y, 71
Check JH, 197–209
Chen A, 202–209
Chen D, 202–209
Chen HF, 336–338
Chen SU, 336–338
Chen T, 99–112
Chen X, 202–209
Chenier NM, 5–18, 376–386
Chevret E, 273–287
Chevret M, 307–316
Chibber R, 333–338
Chicz-Demet, A, 442–456
Chikovore J, 219–234
Child LM, 305
Child Welfare League of America, 390–408
Childress JF, 512–519
Childs B, 267–286
Chinnaswamy P, 191–195
Chir B, 308–317
Chodorow NJ, 325–338
Choe JK, 197–209
Cholst I, 322–337, 470–476
Choo P, 69–81
Chretien MF, 269–287
Christensen A, 150–155
Christensen M, 390–409
Christensen U, 179–193, 194
Christiansen OB, 300–304
Christianson C, 158–168
Christie GL, 84–95, 159–168
Christophe AB, 106–115
Chu E, 173–193
Chu TY, 70–81, 415–426
Chukchee, 66
Chun KM, 62–79, 411–425
Church AT, 68–80
Churchill W, 196
Chyu L, 197–208
Ciccarelli J, 372–386
Civil Rights Act, 531–542
Clapp D, 54–59, 66–80, 119–120, 124, 127, 131–141, 158–168, 185–194, 467–475
Clark AL, 246, 444–456
Clark AM, 119–127, 158–167, 189–194
Clarke RN, 190–195
Clayton CE, 307–316
Cleland J, 71
Clifford E, 462–475
Cline FW, 392–409
Coeffin-Driol C, 217–233
Cogswell ME, 189–194
Cohen D, 152–155, 222–234
Cohen HR, 216–233
Cohen J, 276–287, 376–386, 509
Cohen LS, 104–114, 115, 445
Cohen M, 495–506
Cohrs WA, 119–128, 165–168
Colburn D, 430–438
Cole JO, 105–115
Coleman P, 197–208
Colla M, 106–115
Collins JA, 20–35, 39–56, 174–193, 430–438
Collins RL, 307–316, 342–354
Colman AD, 444–456
Colman LL, 444–456
Colpin H, 466–475, 483–492
Colton CC, 521
Conlon C, 300–304
Connidis IA, 418–426
Connolly HV, 42–57
Connolly KJ, 7–19, 38–56, 145–155, 172–192, 194, 419–426
Connor E, 243–256
Conrad R, 40–57
Constabile L, 204–210
Cook R, 308–317, 463–475, 476, 483–492
Cooke HG, 273–287
Cooke ID, 38–56, 145–155, 184–194
Coon HM, 68–80
Cooper G, 239–256
Cooper JF, 133–141
Cooper PE, 414–425
Cooper PJ, 454–458
Cooper SL, 468–476, 509–518
Cooper TG, 205–211
Cooper-Hilbert B, 12, 144–154
Cooperman AB, 331–338
Cordray B, 308–317
Corrie S, 118–127
Corrigan E, 146–155, 527–541
Corson SL, 372–386, 449–458
Cortigight B, 66–80
Costabile L, 204–210
Costabile R, 239–256
Costei AM, 104–114
Costello C, 52–53, 59
Cosyns P, 106–115
Cote-Arsenault, D, 300–304
Cott NF, 215–233
Coulson C, 198–209
Courtar DA, 430–438
Cousineau TM, 182–194
Cousins N, 53–54, 59
Covens A, 242–256
Covington SN, 4–17, 18, 36, 39–53, 56, 58, 59, 64–80, 130, 146–155, 164–167, 168, 196–208, 237–256, 257, 290–303, 304, 305–316, 318, 338, 434–439, 440–455, 459–474, 493–506, 507, 509–518, 519, 527–541, 552–556
Cowan CP, 326–338
Cowan PA, 326–338
Cowley DS, 457
Cowling-Guyer S, 310–318
Cox H, 199–209
Cox JL, 454–458
Cox LW, 321–337, 340–354, 358–369
Cox S, 473–476
Coyl D, 390–409
Coyle A, 308–317
Cozze J, 273–287
Craft IL, 51–59, 74–82
Cram DS, 273–287
Crane MM, 189–194, 244–257
Crawford EC, 336–338
Crawshaw M, 132–141
Crenshaw DA, 137–142
Crha I, 190, 204–210
Crick F, 258, 260
Cridennda DK, 197–209
Crockin S, 537–542, 543
Crone K, 324–337, 338
Crosby RD, 106–115
Crow S, 22–35, 105–115
Csemiczky G, 174–193
Cudmore L, 119
Cuisinier MC, 292–303, 304, 442–456
Culasso F, 205
Culberg J, 102–114
Cullari S, 117–127
Cullenberg J, 292–303
Cumming CE, 39–56
Cumming DC, 39–56, 431–438
Cunningham ML, 104–114
Curavett AP, 205–210
Curry CJR, 281–288
Curson R, 308–317, 344–355, 484–492
Czybo JC, 307–316
Daar A, 2–17, 413–425
Dagg PKB, 292–303
Dahoun S, 281–288
Dailey JV, 281–288, 292–303
Dale PO, 53, 59
Daling JR, 191–195, 242–256
Dalla Corte, R, 320
Dally A, 413–425, 460–474
Dalphonse S, 423–427
Dalton M, 319–337, 510–519
Daly KJ, 10–19
Damber JF, 101–113
El-Danasouri L, 197–210
El-Danasouri I, 22–35
D’Andrea M, 65–80
Daniel A, 279–288
Daniels D, 309–317
Daniels J, 65–80
Daniels KR, 165, 306–316, 317, 318, 335, 341–354, 355, 484–492, 494–506, 527–541
Daniels TL, 185–194
Daniluk JC, 38–56, 57, 122, 145–155, 172–192, 430–438, 441
Dare FO, 70–71
Darwiche J, 86–95, 527–541
Data Protection Act, 533
Date J, 202–209
Datner E, 299–304
Datta B, 2–18
Davanloo H, 133
David A, 351–355
David H, 45–58
David M, 72–82
Davidson MK, 203–210, 345–355
Davis DC, 172–192
Davis O, 442–456
Davis RB, 197–208, 211
Davis RI, 104–114
Davis S, 323–337
Davis v. Davis, 522–540, 542
Dawson EB, 205–211
Dawson K, 510–519
Daya S, 52–59, 300–304
de Beaufort, ID, 470–476
de Boer, EJ, 190–195
de Bruyn, JK, 553–557
De Ceballos, ML, 105–115
de Graaf, 320
de Graauw C, 295–304, 442–456
de Graauw KP, 292–303
de Groot RH, 107–115
de Jars M, 508
de Lacey S, 10–19, 359–369
de Liz TM, 118–127, 158–167
De Nuccio L, 205–210
De Shazer S, 152
De Swiet M, 514–519
De Vriese SR, 107–115
de Watteville H, 216–233
de Wert G, 376–386
Dean W, 481–491
Deane L, 219–234
Dear JF, 345–355
Dear MJ, 359–369
Deardorff WW, 170–192
Dearman CN, 172–192
DeBattista A, 104–114
DeBattista C, 105–115
DeBaun MR, 481–491
Debay A, 215
DeBlock G, 239–256
DeCherney AH, 20–35, 84–95, 98–112, 143–154, 292–303, 419–426, 477–491, 494–506, 509–518
deCrespigny L, 278–288
deDie-Smulders CE, 276–287
Déhault, 305
Deketelaere V, 479–491
Del Rio J, 105–115
Del’Aune W, 84–95
Delbanco TL, 206–211
DeLisi A, 430–438
Della Serra A, 239–256
DeLuca RS, 41–57
Demylle D, 22–35
Demyttenaere K, 106, 144–154, 158–168, 174–193
den Tonkelaar I, 41–57, 99–112
Denber HCB, 7–19
Denekens J, 214–233
Dennerstein L, 85–95
Department of Health and Social Security, 544–556
Derde M, 479–491
DeRyke M, 481–491
Descartes R, 170
Desiderato L, 444
Desnyder R, 106–115
DeSouza S, 481–491
Deuschle M, 106–115
Deutsch H, 130–141, 442–456
Devellis BM, 267–286
Deveraux LL, 12
Devizzi L, 239–256
Devoto L, 22–35
Devroey P, 22–35, 239–256, 319–337, 376–386, 431–438, 479–491
Dhaliwal LK, 70, 172–192
Dhar V, 101–113
Dhillon R, 39–56
D’Hooghe T, 158–168
Di Pierro I, 50–58
Di Pietro J, 483–492
Di Renzo GC, 204–210
Diakogiannis I, 40–57, 73–82
Diamant A, 156–167
Diamond MP, 98–112, 292–303
Diamond R, 11–19, 50–58, 144–154, 155, 309–317
Diane L Johnson et al., v. California Cryobank Ind., et al., 522–540
Dick LM, 104, 445
Dickens C, 143
Dicker D, 292–303
Didzus A, 42–57
Diehl DJ, 101–113
Diener E, 70, 78
Dietz WH, 189–194
Diez-Domingo, J, 300–304
Ding J, 356
DiPietro JA, 463–475
Directive 2004/23 EC, 321–337, 340–354
Dittus RS, 503–507
Djurdjinovic L, 258–285
Dmowski WP, 356
Dobkin S, 153–155
Doherty RW, 69–81
Doherty WJ, 495–507
Doka KJ, 420–426
Dokras A, 467
Dolbin M, 77–82
Dolmans MM, 22–35
Domar AD, 41–54, 57, 58–59, 66–80, 98–112, 114, 119–120, 124, 127, 131–141, 158–167, 168, 178–193, 194, 245–257, 419–426, 432–438
Domar AH, 552–556
Donat R, 50–58
Dong G, 202–209
Donnez J, 22–35
Donor Conception Network, 306–316
Donor Conception Support Group, 306–316
Doornbos v. Doornbos, 535–542
Dor J, 102–114
Dor Y, 102–114
Dorrepaal C, 479–491
Dovidio JF, 62–79
Dow KH, 245–257
Dowling-Guyer S, 418–426
Downey J, 84–95, 98–112, 130–141, 301–304, 446–457
Dredge R, 278–288
Dreher H, 46–58
Drevon C, 107–116
Driekurs R, 157
Driscoll DA, 279–288
Drotar D, 445–457
Duchesne C, 53–54, 59, 145–154, 172–192, 434–438
Ducot B, 37–56
Dufour S, 307–317
Duka WE, 477–491, 509–518
Duncan W, 398–409
Dunington R, 461–474
Dunkel-Schletter C, 7–19, 41–57, 171–192, 193, 442–456
Dunn SM, 53–59
Dunstan JA, 107–116
Duque L, 22–35
Duqueno L, 323–337
Dusek JA, 54–59, 67–80, 119–127
Dyer SJ, 40–57, 70–71, 172–192, 219–234
Eagle MN, 417–426
Easthope G, 197–209
Eberhard M, 152–155
Eckardt v. Charter Hosp., 532–542
Edelmann RJ, 7–19, 38–56, 98–112, 145–155, 172–192, 194, 196–208, 212–217, 233, 234, 419–426
Edmonds DK, 271–287
Edwards EG, 510–519
Edwards M, 106–115
Edwards RG, 4, 22, 478–491, 509, 510–518
Egan G, 11
Eggert J, 191–195
Eidelman AI, 468–476
Einarson A, 104–114, 445
Einarson TR, 104–114, 444–456
Einhorn LH, 239–256
Eisenberg DM, 197–208, 211
Eisenstadt v. Baird, 522–540
Eisner BB, 216–233
Elefant E, 104–114
Elias S, 512–519
Elizur A, 173–193
Ellis A, 134
Ellison MA, 468–476
Elsenbruch S, 55–60
Eltes F, 203–210
Emanuele MA, 191–195
Emanuele NV, 191–195
Emerson RW, 369, 370
Emery J, 173
Emery M, 86–95
Emiliano AB, 115
Emmerson G, 510–519
Ender-Spelling, C, 48–58
Endo T, 204–210
Engel GL, 175–193
Engelhard IM, 297–304
Engels GL, 309–317
Engelsmann F, 291–303
Engfeldt P, 191–195
Englert Y, 510–518, 519
Enzlin P, 144–154, 158–168
Epstein YM, 159–168, 324–337
Erb K, 479–491
Erickson E, 131–141, 417–426
Erickson M, 135
Ericson A, 104–114, 479–491
Ericsson HL, 341–354, 355
Erikson EH, 309–317
Ernest E, 197
Erwin PG, 65–80
Eskenazi B, 191–195
Esses VM, 62–79
Etgen A, 100–113
Ethics Committee of the American Society for Reproductive Medicine, 146–155, 240–256, 257, 434–439, 459–474, 485–492, 509–518, 519, 520, 531–542, 545–556
Ettner SL, 448–457
Eugster A, 53–54, 59, 117–127, 184–194
Eunpu DL, 261–286
European Society of Human Genetics, 276–287
European Society of Human Reproduction & Embryology, 146–155, 509–518, 522–540, 548–556
European Society of Human Reproduction & Embryology Capri Workshop, 448–457
European Society of Human Reproduction & Embryology Task Force on Ethics and Law, 5–18, 276–287, 289, 322–337, 341–354, 357–369
European Union Tissue and Cells Directive, 357–369
Evan B, 388–408, 409
Evans CD, 292–303
Evans DR, 64–80
Evans K, 388–408
Evers AW, 173–193
Evers JLH, 430–438
Ezugwu F, 388–408
Fabres C, 74–82, 324–337
Facchinetti F, 158, 168, 173–193, 194, 204–210
Fainman D, 292–303
Fair A, 246–257
Fair CC, 359–369
Falbo T, 467–475
Falcone T, 269–287, 288
Fallone A, 67–80
Family Relationships Amendment Act, 525–540
Fan X, 390–409
Fang L, 202–209
Fantini D, 283–289
Faraone SV, 104–114
Farhi J, 292–303
Farquharson R, 300–304
Farrand A, 555–557
Farrant B, 246–257
Farrow A, 47–58
Fasano v. Nash, 538–543
Fasouliotis SJ, 442–456
Fasuba OB, 42–57
Fathalla MF, 63, 419–426
Fauser BCJM, 470–476
Fayad M, 100–113
Fear JL, 99–112
Feast J, 309–318
Feder L, 392–409
Federal Privacy Act, 533–542
Fedorcsak P, 53, 59
Fehr E, 346–355
Feichtinger W, 277–288, 289
Feil R, 481–491
Feinberg AP, 481–491
Felbergaum R, 321–337, 340–354
Feldberg D, 173–193
Feldkamp M, 104–114
Feldman PR, 468–476, 496–507
Felicia R L, 330
Fenton LF, 292–303
Ferguson v. McKiernan, 535–542
Ferial ML, 37–56
Fernandez H, 242–256
Ferre C, 479–491
Fertility Clinic Success Rate and Certification Act, 522–540
Feuer GS
FG v. McDonnell, 529–541
Fiala J, 190, 204–210
Fiamanya W, 319–337, 510–519
Fidler A, 2–17
Fido A, 42–57, 70, 74, 99–112, 419–426
Fiegl J, 119–127
Fielding D, 323–337
Figlerski L, 505–507
Figley CR, 498–507
Figueiredo-Torres v. Nichols, 529–541
Fikree FF, 416–426
Findlay J, 342–354
Fine BA, 263–286
Finkler K, 310–318
Finley GE, 392–409
Fins JJ, 515–520
Fiore S, 240–256
Firth L, 485–492
Fischbacher U, 346–355
Fischer IC, 7–19, 216–233, 494–506
Fish J, 373
Fisher JR, 442–456
Fitzgerald CE, 104–114
Fitzgerald EM, 245–257
Fitzgerald FS, 544
Fitzgerald L, 276–288
Fitzgerald OR, 42–53, 58–59, 67–80
FitzSimmons SC, 271–287
FIVNAT, 479–491
Flam F, 292–303
Flamigni C, 204–210
Fleisher BE, 104–114
Fletcher JC, 263–286, 510–519, 520
Florin I, 49–58, 119–128, 131–141, 144–154, 185–194
Fluker MR, 275–287
Fogel CI, 212, 213–233
Foley V, 486–492
Foli KJ, 473–476
Folkman S, 136–142, 176–193, 429–438
Folkvord S, 219–234
Fonagy P, 292–303
Foote RH, 3–18
Ford ESC, 494–506
Ford WC, 47–58
Forman I, 494–506
Forrest GC, 291–303
Forst C, 42–57
Forthofer MS, 172–192
Fortier C, 430–438
Fossa SC, 256, 273–287
Foster GD, 190–194
Fottler MD, 360–369
Fouad NA, 65–80
Foudila T, 359, 369
Fox J, 86–95
Fox R, 204–210
Fraga ED, 65–80
Fraley JK, 107–115
Frances-Fischer JE, 462–475
Francis MM, 51–59, 333–338
Frank RG, 503–507
Franke K, 204–210
Frankel SA, 451–458, 467–475
Franklin R,
Franklin S, 310–318
Franks D, 372–386
Franz L, 538–543
Franzini LR, 414–425
Fraser CF, 267–286
Frazier S, 269–287
Freckleton I, 5–18
Frederpckx V, 239–256
Freeark K, 361–369
Freed SC, 170–192
Freeman EW, 39–56, 57, 84–95, 98–112, 132–141, 145–154, 430–438, 494–506
Freeman MP, 107–116
Freizinger M, 54, 58–59, 119–120, 124, 127, 131–141, 158–168
French N, 482–492
Frets P, 267–286
Freud A, 373–386
Freud S, 157, 293
Friden B, 430–438
Friedlander ML, 241–256, 392–409
Friedman H, 77–82
Friedman R, 41–54, 55, 57, 59, 98–112, 158–167, 178–193, 194, 245–257
Friese C, 359–369
Friez MJ, 336–338
Fritz MA, 359–369
Frumovitz M, 510–518
Frydman N, 277–288, 289
Frydman R, 242–256, 277–288, 289, 342–354, 470–476
Fu Z, 202–209
Fudge JL, 115
Fuentes A, 22–35
Fuentes C, 37
Fuertes JN, 65–80
Fugate KA, 216–233
Furhiman A, 157–167
Furniss KK, 42–57
Fyer AJ, 99–112
Gabler F, 22–35
Gacinski L, 72–82
Gagin RM, 495–507
Galinsky E, 465–475
Galletly C, 119–127, 158–167, 189–194, 246
Gallinelli A, 171–192
Gallois C, 55–60, 184–194
Gallops MS, 99–112
Galst JP, 199–209
Galton F, 259
Galusk DA, 190
Galvin H, 48–58
Gamache G, 387–408
Gambescia N, 225–234
Gamble VN, 509–518
Gambotto M, 333–338
Gandini L, 205–210
Gannon K, 5–18, 38–56
Garbis HM, 104–114
Garcia CR, 41–57
Garcia-Espana, F, 105–115
Garcia-Velasco, JA, 22–35
Gardner R, 282–289
Garel M, 467–475
Garfinkel E, 203–210
Garner CH, 93–95, 442–456
Garza J, 283–289
Gatkin TB, 77–82
Gaub, 169
Gavriilidou D, 40–57, 73–82
Gaylor E, 104–114
Geerinck-Vercammen, CR, 302–304
Gelber R, 243–256
Gelenberg A, 107–116
Geller G, 344–355
Geller PA, 300–304
Gendrin A, 3
Genovesi G, 205–210
George AM, 279–288
Geraedts JP, 276–287
Gerard JL, 359–369
Gergen K, 309–317
Gerhard I, 5–18, 93–95, 119–128, 144–154, 189–194, 202–209, 210
Gerli S, 204–210
German EK, 331–338
Gerrits T, 71, 74–81, 413–425
Gershon S, 101–113
Gerstel GA, 43–58
Gervaize PA, 300–304
Gheldof M, 106, 174–193
Giamorol L, 205–210
Gianaroli L, 321–337, 340–354
Gianmi A,
Giavazzi MT, 307–317, 464–475, 483–492
Gibran K, 459
Gibson FL, 462–475, 482–492
Giddens A, 309–317
Gilbert BR, 47–58
Giles DE, 185–194
Giles G, 242–256
Gilio B, 205–210
Gilles A, 104–114
Gillet WR, 307–316
Gillison G, 3–18
Gingrich JA, 105–115
Giodana J, 77–82
Girard Y, 53–54, 59
Gise LH, 444
Gissler M, 479–491
Gitlin M, 105–115
Gittelsohn J, 343–355
Giuavazzi M, 483–492
Giwa-Osagie, O, 413–425, 432–438
Gladu R, 537
Gladu v. Boston, 537–542
Glaser BG, 442–456
Glasier AF, 100–113
Glass RH, 83–95, 100–113
Glavac I, 123, 148–155, 179–193
Glazebrook C, 473–476
Glazer ES, 245–257, 361–369, 444–456, 465–475, 476
Glazer G, 119, 158–168, 461–474
Glenn T, 101–113
Glover L, 5–18, 38–56
Glynn LM, 442–456
Goates MK, 118, 120–127
Goebel P, 307–316
Goffman E, 10–19, 44–58, 248–257, 310–318, 325–338, 418–426
Golbus M, 281–288
Goldberg J, 223–234
Goldberg NC, 322–337, 470–476
Goldbloom DS, 99–112, 446–457
Goldbus M, 267–286
Golden KA, 105–115
Goldfarb J, 430–438
Goldfried MR, 122, 126
Golding J, 47–58
Goldman JA, 205–211
Goldman JC, 450–458
Goldschmidt S, 306–316
Goldschmitt I, 390–409
Goldstein DJ, 104–114
Golombok S, 98–112, 307–317, 324–337, 373–386, 463–475, 476, 483–492, 510–519, 553–557
Gon, 66
Gonzales LO, 414–426
Gonzalez LO, 10, 39–56
Gonzalez RR, 22–35
Goodheart CD, 253–257
Goodman D, 105
Goodman E, 463–475
Goodman K, 158, 249–257
Goodman M, 415–426
Goodwin J, 214–233, 412–425
Goossens E, 239–256
Gopalan S, 70, 172–192
Gordon AG, 462–475
Gordon EG, 556
Gordon ER, 455, 466–475, 511–519, 546–556
Gordt S, 99–113
Gorgy A, 51–59
Gorman KS, 336–338
Gorrill M, 531–542
Gosden R, 477–491
Gosden RG, 336–338
Gotlieb L, 182–194
Gottlieb BH, 151–155
Gottlieb C, 308–317, 485–492, 553–557
Gottman JM, 150–155
Gozlan M, 42–57, 172–192
Graham C, 136–142
Graham JR, 93–95
Graham MC, 156
Grambsch PL, 22–35, 105–115
Grandall CS, 310–318
Grant TV, 159–168
Graunaug A, 482–492
Gravitz MA, 184–194, 203–210
Gray DL, 280–288, 391–409
Greb A, 264–286
Green D, 48–58
Green JM, 276–288, 342–354
Green K, 241–256
Green M, 292–303
Greenberg LS, 151–155
Greenfeld DA, 88–95, 98–112, 113, 125, 130–141, 173–193, 292–303, 304, 307–316, 322–337, 338, 362–369, 419–426, 442–456, 457, 458, 462–475, 476, 477–491, 492, 494–506, 518
Greenfeld DG, 323–337, 462–475
Gregersen AT, 118, 120–127
Gregoire AT, 305–315
Gregorian RS, 105–115
Gregory RJ, 414–425
Greil AL, 2–18, 131–141, 145–154, 170–192, 418–426, 431–438, 460–474
Grencavage LM, 121
Gresham E, 292–303
Grieco SFM, 215–233
Griesinger G, 204–210
Griez C, 100–113
Griffin D, 2–17
Griffin PD, 38–56, 63
Griffith CS, 29–36
Griffiths K, 246–257
Grill E, 324–337, 338, 442–456
Grill J, 228–235
Grimes DA, 29–36
Grimmig RE, 423–427
Grinstead DM, 359–369
Grisso JA, 299–304
Gritz ER, 245–257
Groff AA, 42–53, 58–59, 250–257, 435–439
Grosse v. Purvis, 533–542
Grotevant H, 390–409, 410
Growe G, 171–192
Guerra-Diaz, D, 99–112, 307–317, 483–492, 527–541
Guillen A, 22–35
Gunby J, 52–59
Gunn A, 292–303
Guo XL, 336–338
Gupta KR, 70, 172–192
Gurman AS, 143–154
Gurmankin AD, 146–155, 335, 338, 343–355, 514–519
Gutmann JN, 196–208
Haagen EC, 182–194
Haan G, 184–194
Haarmann BS, 41–57, 130–141
Haase J, 320–337, 339–354, 524–540, 544–555
Haasz P, 99–112
Hacksaw AK, 279–288
Haddad NG, 216–233
Haddow JE, 271–287
Hahn CS, 463–475, 483–492
Hahn S, 55–60
Hahnemann S, 203
Haidl G, 40–57, 217–234
Haimes E, 309–318
Haley J, 135
Haley WE, 503–507
Hall JE, 448–457, 468–476
Halman JL, 144–154, 217–233, 234, 235
Halman LJ, 41–57, 172–192, 430–438, 442–456, 461–475
Halverson LR, 42–53, 58–59, 250–257, 435–439
Ham GC, 216–233
Hamamy HA, 281–288
Hamazaki K, 106–115
Hamazaki T, 106–115
Hamberger L, 441, 456, 479–491
Hamer R, 217–218, 234, 432–438
Hamilton JA, 101–113
Hammar M, 527–541
Hammarbachk S, 101–113
Hammarberg K, 430–438
Hammerman AJ, 12
Hammond KR, 218–234
Hanafin H, 372–386
Handelsman DJ, 50–58
Handley S, 323–337
Handyside AH, 275–287
Hansell PL, 179–193
Hansen M, 269–286, 480–491
Hanson K, 281–288
Harden L, 333–338
Hardy E, 38–56
Hardy KV, 77–82, 275–287
Hardy RI, 86–95
Har-Even, D, 390–409
Harlow CR, 204–210
Harman J, 342–354
Harper JC, 277–288
Harper PS, 265–286
Harris BG, 266–286, 288, 442–456, 458, 465–475
Harris D, 71–81
Harris JR, 245–257, 342–354
Harris R, 261–286
Harris WA, 205–211
Harrison N, 100–113
Harrison RF, 119–127, 203–210
Hart VA, 78–82, 139–142
Hartikainen A, 479–491
Hartley JA, 205–210
Hartman J, 150–155
Hartoma R, 205–211
Harvey JH, 9–19
Hasan MY, 416–426
Haseltine FP, 173–193, 419–426, 494–506
Hassan MAM, 189–194
Hastings DW, 414–425
Hata H, 204–210
Hata M, 202–209
Hatcher J, 198–209
Hatfield E, 69–81
Hatzissabas I, 313–318
Hawkes WC, 205–211
Hay DA, 301–304
Hayakawa K, 202–209
Hayes SC, 124, 125
Haynes D, 104–114
Haynes RB, 122, 125
Hays PA, 65–80
Hayward MD, 419–426
Healy D, 242–256
Heape W, 477
Heard I, 240–256
Hearn HB, 242–256
Hearn MT, 84–95, 98–112, 145–154, 184–193, 419–426, 431–438, 461–474
Heavy C, 150–155
Hecht v. Superior Court of County of Los Angeles, 539–543
Heckscher E, 106–115
Heil D, 100–113
Heiman JR, 224–234
Heine SJ, 69–80
Heineman E, 335–338
Heineman-Kuschinsky, E, 323–337
Heinmiller v. Department of Health, 529–541
Heinonen K, 204–210
Heird WO, 107–115
Helding C, 392–409
Heldring M, 503–507
Helfand BT, 448–457
Helland I, 107–116
Helmerhorst FM, 553–557
Hemenway N, 159–168
Hemminki E, 479–491
Hen R, 105–115
Henderson LS, 158–167, 199–209, 246–257
Hendrick V, 104–114, 115
Hendrickx K, 214–233
Hendrie HC, 503–507
Hendriks J, 182–194
Henig RM, 390–409
Henmi H, 204–210
Hennessy TF, 430–438
Henning K, 37–56, 138–142
Henrion-Geant, E, 240–256
Henry IV (King), 341
Henry S, 310–318
Henry VII (King), 1
Henzl MR, 101–113
Hepp U, 144–154, 430–438
Hepworth J, 503–507
Herbert M, 5–18, 376–386
Herbison G, 307–316
Herman JL, 108–116
Hermann H, 307–316
Hermann M, 50–59
Hermanns JMA, 123
Hersherberg P, 322–337
Hervey TV, 510–519
Herz E, 291–303
Heuer MA, 206–211
Heuser I, 106–115
Hibbeln J, 106–115, 116
Hickman TN, 158–168
Higdon HL, 189–194, 244–257
Hil J, 77–82
Hill C, 307–316
Hill R, 107–116
Hillensjo T, 479–491
Hillis SD, 52–53, 59
Himmel W, 138–142
Hindle PA, 511–519
Hippocrates, 20, 170
Hird MJ, 417–426
Hirsch AM, 431–438
Hirsch SM, 431–438
Hjelmstedt A, 39–56, 362–369
Hjern A, 392–409
Ho T, 104–114
Hobbs M, 134–142
Hobdy J, 446–457
Hoffman DI, 219–234, 359–369
Hoffman DJ, 245–257
Hoffman J, 330–338
Hoffman LW, 70–81, 461–474
Hoffman M, 70–71, 461–474
Hofstede C, 69–81
Hogge WA, 282–289
Hoksbergen R, 392–409
Holahan CJ, 178–193
Holden JM, 454–458
Holditch-Davis D, 266–286, 288, 442–456, 458
Holland JS, 247–257
Hollander MB, 36
Hollifield J, 446–457
Hollmann M, 189–194
Holm S, 509–518
Holmes FF, 245–257
Holmes GE, 245–257
Holstein BE, 179–193, 194, 435–439
Holzle C, 122, 136–142, 144–154
Homburg R, 52–59
Honig D, 72–82
Honig S, 238–256
Hoogduin KA, 292–303
Hooghe TD, 144–154
Hook EB, 271–287
Hooper R, 454–458
Hopper E, 292–303
Hopton JL, 41–57, 131–141
Horesh N, 38–56
Horne B, 48–58
Horney K, 43, 97, 324–338
Hornstein MD, 22–35, 190–195
Hornstra G, 107–115
Horrobin D, 106–115
Horsey K, 526–541
Horskamp B, 101–113
Horton S, 197–209
Hosaka T, 41–57, 70–81, 99–112, 159–168, 172–192
Hotamisligil S, 468–476
Houghton D, 310–318
Houghton P, 310–318
Houle M, 131–141, 145–154, 182–193, 419–426, 461–474
House of Commons Science and Technology Committee, 553–556, 557
Houseknecht SK, 419–426
Hovatta O, 321–337, 340–354
Howard C, 388–408
Howard S, 539–543
Hoyme HE, 104–114
Hruba D, 190, 204–210
Hsu MT, 294–304
Hsu YL, 172–192
Hu P, 190–193
Huan M, 106–115
Huang G, 203–210
Huang K, 84–95, 98–112
Huang V, 28–36
Hubbard E, 429
Huber G, 442–455
Hubert J, 42
Hubner MK, 245–257
Hudson-O’Hanlon W, 150–155
Huff RM, 64–80
Huffman L, 390–408
Hughes P, 292–303
Huhner M, 21
Hui PW, 276–288
Hui SL, 503–507
Hull MGR, 47–58, 146–155
Human Assisted Reproduction Technology Act, 306–316, 547–556
Human Fertilisation and Embryology Act, 311–318, 522–540, 544–556, 557
Human Fertilisation and Embryology Authority, 5–18, 85–95, 146–155, 306–316, 321–337, 340–354, 357–369, 510–518, 523–540, 546–556
Human Reproductive Technology Act, 525–540, 547–556
Humphrey M, 212–233, 390–409
Hunfeld JAM, 470–476
Hungerford v. Jones, 529–541
Hunt J, 49–58, 552–556
Hunter, 305
Hunter J, 477
Hunter M, 10–19
Huo LL, 294–304
Hurley I, 239–256
Hurley K, 53–54, 58–59
Hurwitz JM, 514–520
Husang TT, 356
Huter O, 446–457
Huxley A, 455, 506
Hwang S, 104–114
Hynes GJ, 55–60, 184–194
Hynie M, 62–79, 81
Iancu J, 105–115
Ickovics JR, 433–438
Idoyaga Molina A, 213–233
Ifugao, 66
Igarashi M, 204–210
Ikechebelu JI, 71–81
Ikegwuonu SO, 71–81
Iliescu A, 320
Imber-Black E, 309–317, 327–338
Infertility Network, 306–316
Infertility Treatment Act, 525–540, 544–556
Infertility Treatment Authority, 5–18, 547–556
Inglis M, 119
Ingram KM, 55–60
Inhorn MC, 2–18, 19, 37–56, 57, 71–81, 219–234, 411–425
Inoue T, 101–113
International Infertility Counselors Organization, 544–556
Ippoliti F, 202–209
Iredell J, 292–303
Ireland MS, 324–337, 418–426
Ironside W, 467–475
Irvine DS, 46–58, 231–235
Irvine SCE, 39–56
Isasi RM, 262–286
Ishigami J, 205–211
Ishikawa H, 202–209
Isikoglu M, 68–80
Israel A, 529–541
Ito S, 104–114
Itomura M, 106–115
Ittner E, 138–142
Ivey AE, 65–80
Iwasa GY, 65–80
Izumi S, 41–57, 70–81, 159–168, 172–192
Jackson ML, 70–81
Jacob HS, 189–194
Jacob MC, 335–338, 487–492
Jacob MS, 470–476
Jacobsen G, 269–287
Jacobson C, 522
Jacobson L, 132–141, 145–154
Jacobson NS, 143–154, 155
Jacobsson B, 450–458
Jacobsson L, 53–59
Jadoul P, 22–35
Jadva V, 307–317, 464–475, 484–492, 553–557
Jain JK, 51–59, 333–338
Jain T, 22–35
Jaiser F, 423–427
James CA, 55–60, 451–458
Jamieson DJ, 52–53, 59
Jamison PH, 414–425
Janata JW, 343–355, 359–369
Jannini EA, 226–235
Jansen V, 283–289
Janson PO, 202–209
Janssen HJ, 292–303, 304, 442–456
Janssen OE, 55–60
Jarow J, 238–256
Jarvi K, 238–256
Javda V, 372–386
Jeanty A, 279–288
Jefferson F, 373–386
Jeffries DJ, 342–354
Jeker L, 84–95, 130–141
Jelinkova L, 203–210
Jeng G, 479–491
Jenkins GL, 412–425
Jenkins J, 198–209, 308–317
Jenkinson C, 247–257
Jennings E, 1, 212
Jensen CL, 107–115, 347–348, 355
Jensen M, 65–80
Jensvold MF, 102–114
Jerath BK, 444
Jerman J, 361–369
Jevning R, 203–210
Jeyendran RS, 239–256
Joffe MM, 299–304
Johannes CK, 65–80
Johannsen W, 259
Johanson A, 479–491
Johanssson O, 52–59
Johnson KA, 104, 445
Johnson L, 531–542
Johnson M, 243–256, 273–287
Johnson SB, 151–155, 503–507
Johnson SH, 447–457
Johnson SM, 514–519
Johnson v. Calvert, 522–540
Johnson VE, 218–234
Johnston DR, 3–18
Johnston M, 93–96
Jones G, 247–257
Jones KP, 93–95, 283–289
Jones M, 38–56, 93–95, 106–115, 173–193
Jones SL, 283–289
Jonsen AR, 508–518
Jordan C, 54, 59
Joris H, 272–287
Joris V, 86–95
Josefsson A, 445–457
Josephs LS, 324–337, 338
Joyce AS, 163–168
Joyce JN, 100–113
Jozefowicz-Sembini D, 361–369
Juana (Queen), 341
Juang K, 99–112
Juffer F, 392–409
Jung BJ, 173–193
Kaali SG, 204–210
Kader NS, 508–520
Kaempfer SH, 245–257
Kahlo F, 37
Kaij L, 100–113
Kainz RM, 495–507
Kakizaki K, 202–209
Kalfoglou AL, 343–355, 372–386
Kalish LA, 245–257
Kallela K, 204–210
Kallen B, 104–114, 479–491
Kaltman S, 163
Kan AKS, 510–518
Kaneko S, 202–209
Kang W, 106–115
Kanhai HH, 302–304
Kanoti G, 343–354
Kaplan AH, 7–19
Kaplan HS, 218–234
Kaplan RM, 414–425
Kaptchuk TJ, 197–208
Karahasanoglu A, 171–192
Karasawa M, 78–82
Karkanias GB, 100–113
Karnis MF, 275–287, 449–458
Karow AM, 245–257
Karpel MA, 309–317
Kase NG, 83–95, 100–113
Kashima Y, 430–438
Kaslow NJ, 120
Katz DL, 190–194
Katz MG, 276–288
Kaufman SC, 52–53, 59
Kauppila A, 100–113
Kavi S, 322–337
Kazarian SS, 64–80
Kazdin AE, 120, 123, 124
Kazer R, 105–115, 478–491
Keck PE, 106–115
Kedem P, 39–56
Kee BS, 99–112, 173–193
Keh A, 320
Keijnen J, 120
Keiley MK, 77–82
Keita GP, 43–58
Keith-Spiegel, P, 533–542
Kellner KR, 291–303, 304
Kellner R, 442–456
Kelly AL, 165–168, 552–556
Kelly M, 93–95
Kemer P, 217–234
Kemeter P, 119–127
Kemmann E, 98–112, 430–438, 448–457, 468–476
Kemmelmeier M, 68–80
Kendell RE, 106–115
Kenen R, 262–286
Kennan E, 145–154
Kennard A, 279–288
Kennedy S, 247–257
Kennell JH, 291–303
Kentenich H, 4–18, 72–82, 83, 101–113, 138–142, 204–210, 307–317, 318, 320–337, 435–439, 494–507, 527–541
Kent-First MG, 273–287
Keppler-Noreuil KM, 269–286
Kerin JF, 100–113, 147–155
Kerper P, 269–287
Kerr J, 311–318
Kerr SM, 515–520, 539–543
Kertz B, 107–115
Kessel B, 54–59, 119–120, 124, 127, 131–141, 158–168
Kessler RC, 197–208
Kessler S, 264–286
Kessopoulou E, 205–211
Keye WR, Jr, 20–35, 51–59, 93–95, 216–233, 537
Kezur D, 11–19, 50–58, 144–154, 155
Khalife S, 222–234
Khalsa HK, 205–211
Khan A, 416–426
Khan KS, 120
Khataya GM, 416–426
Khorram NM, 197–209
Khosla S, 481–491
Khoury MJ, 280–288
Khylchevskaya RI, 100–113
Kielin WG, 120
Kikendall KA, 9
Kikuyu, 66
Killick SR, 189–194
Kim H, 107–115
Kim U, 64–80
Kim WJ, 389–408
Kimmel I, 308–317
Kinast C, 204–210
Kind KL, 482–491
King A, 205–210
King CR, 206–211, 224–234, 242–256
King’s Fund Centre Counseling Committee, 5–18, 365–369
Kingsberg SA, 50–59, 330–338, 339–354, 355, 359–369, 467–475
Kinzl J, 446–457
Kirchengast S, 42
Kirchmeyer P, 99–112
Kirk HD, 390–408
Kirkley-Best, E, 291–303
Kirkman M, 5–18
Kirkpatrick P, 319–337
Kirkwood R, 390–409
Kirsch I, 200–209
Kirsch N, 41–57
Kisekka MN, 71–81
Kitajima Y, 204–210
Kitayama S, 69–81
Kittredge C, 3
Kitzinger C, 42, 57
Kjellberg S, 463–475
Klaiber EL, 100–113
Klaus M, 291–303
Klein DF, 100–113
Klein M, 418–426
Klein SD, 346–355, 373–386
Klempner L, 131–141
Klier CM, 300–304
Kliewer W, 55–60
Kline J, 292–303, 445–457
Kline MV, 64–80
Klock SC, 5–18, 83–95, 96, 105–115, 299–304, 307–316, 317, 322–337, 338, 343–354, 355, 358–369, 442–456, 469–476, 477–491, 492, 494–506, 552–556
Klompenhauwer JL, 106–115
Klonoff-Cohen H, 117–127, 190–195, 442–445, 456
Kloske B, 430–438
K.M. v. E.G., 536–542
Knapp RJ, 292–303, 304
Knoppers BM, 262–286
Kobayashi R, 197–209
Kobayashi Y, 100–113
Kodaman PH, 52–53, 58–59
Koehler WF, 360–369
Koenig HG, 254–257
Kofman-Alfara S, 261–286
Kohut H, 43, 44, 108–116
Koivurova S, 479–491
Kokia E, 42–57, 172–192
Kolata G, 79, 82, 330–338
Kollantai J, 301–304
Kolonoff-Cohen H, 173–193
Kondo A, 41–57, 70–81
Kontogianni EH, 275–287, 288
Koonce DA, 65–80
Kopitzke EJ, 172–192, 193
Koppelman MCS, 101–113
Koran L, 107–116
Korea L, 510–518
Koren G, 104–114, 115, 444–456
Korenman S, 105–115
Kornblith AB, 246–257
Koropatnick S, 172–192
Kosasa TS, 356
Koss MP, 134–141, 142
Kostaras X, 104–114
Koster-Okekan W, 71–81
Kottler JA, 138–142
Kotzeva T, 418–426
Koudstaal J, 456, 479–491
Kouides RW, 283–289
Kouznetsova N, 69–80
Kovacs CT, 307–316
Kovacs GT, 359–369
Kowalsky D, 55–60
Kozer E, 104–114
Kraaimaat FW, 173–193
Kraisarin T, 447–457
Krakaue S, 77–82
Krappmann L, 309–317
Krause NM, 360–369
Krause W, 40–57, 58, 119–128, 131–141, 142, 144–154, 172–192, 194, 306–316
Kraut DA, 447–457
Kremer JAM, 53–54, 59, 124, 173–193, 430–438
Kretzer PA, 218–234
Krey LC, 100–113, 332–338
Kristeller JL, 66–80
Kristoffersen I, 463–475
Kroger WS, 170–192
Krokoff LJ, 150–155
Krupp D, 69–80
Kuang W, 48–58
Kubler-Ross E, 11
Kubo H, 277–288
Kubota S, 202–209
Kubu CS, 102–114
Kuchenhoff J, 8–19
Kudo R, 204–210
Kuhse H, 516–520
Kui YR, 336–338
Kuihne’s, 172–192
Kulhara P, 70, 172–192
Kulin N, 104–114
Kulin S, 204–210
Kulkarni V, 202–209
Kumamoto Y, 205–211
Kumi-Diaka J, 205–210
Kump L, 332–338
Kuo BJ, 172–192
Kupfer J, 99–112, 306–316
Kurinczuk J, 269–286, 480–491
Kurogawa M, 197–209
Kurzban R, 310–318, 325–338
Kushner H, 53–54
Kuti O, 42–57
Kutzelnigg A, 204–210
Laborie F, 4–18
Lacan J, 418–426
Lacey JH, 446–457
Lafayette L, 419–426
Laffont I, 98–112, 217, 234
Lafors L, 450–458
LaFramboise T, 65–80
Lagos S, 40–57, 73–82
Lalak A, 50–58
Lalinec-Michaud M, 291–303
Lalonde RN, 69–81
Lalos A, 52–59, 132–141, 145–154
Lalos O, 52–59, 132–141, 145–154, 308–317, 485–492, 553–557
Lalwani SI, 55, 275–287, 449–458
Lamb MA, 245–257
Lamb ME, 486–492
Lambert MJ, 118, 120–127
Lampman C, 310–318, 418–426
Lampropoulos GK, 122, 126
Lanasa MC, 282–289
Lancaster PA, 448–457
Lancastle DS, 117–127
Land JA, 430–438
Landau R, 306–316, 339–354, 525–540, 553–557
Lande R, 216
Landgren BM, 174–193
Landsberg L, 206–211
Lane MK, 98–112, 145–154
Lang M, 100–113
Lang SS, 414–425
Langenbuch M, 40–57
Lansac J, 37–56
Lansing MH, 253–257
Lapane KL, 105–115
Lapido OA, 446–447, 457
Laraia MT, 445–457
Larget-Piet L, 269–287
Larner G, 118–127
Larney LC, 393–409
LaRoche C, 291–303
Laros RK, 446–457
Larsen U, 71–81
La-Sala, GB, 173–193
Lashwood A, 277–288
Lasker JN, 292–303, 304
Laskowitz v. Ciba Vision Corp., 530–541
Laszoloffy TA, 77–82
Latarche E, 510–518
Latham PM, 237
Laungani P, 64–80
Laurino MY, 282–289
Lauver D, 212, 213–233
Lavery SA, 276
Lavigne SV, 104–114
Lavon H, 205–211
Law on Artificial Insemination, 306–316
Lawler EJ, 360–369
Lawson S, 106–115
Laxoca R, 307–316
Layne C, 150–155
Lazarou S, 219–234
Lazarre J, 319
Lazarus RS, 136–142, 176–193, 429–438
Lazell E, 157
Le X, 202–209
Leader A, 145–155
Leary MR, 310–318, 325–338
Leathem AJ, 205–210
Lechtin A, 248–257
Lecours A, 143–154
Lederberg MS, 161–168
Lederman H, 203–210
Lederman R, 442–456
Ledger WL, 52–59, 119–127, 189–194
Leduc C, 474
Lee CW, 242–256
Lee FR, 341–354
Lee H, 468–476
Lee J, 359–369
Lee RG, 72–82
Lees, 415–426
Lee SH, 99–112, 132–141, 173–193, 306–316, 318
Lee TY, 40–57, 70–81, 415–426
Lee-Ancaias, JC, 104–114
Leeds Teaching Hospital NHS v. A., 538–543
Leeton J, 320–337, 342–354, 478–491
Lehman AK, 134–142
Leiblum SR, 37–56, 98–112, 130–141, 145–154, 217–218, 223–234, 235, 430–438, 448–457, 468–476
Leichhardt NSW, 5–18
Leitko TA, 132–141, 145–154
Lemmens GMD, 144–154, 158–168
Lenahan KM, 336–338
Lentner E, 119, 158–168
Lenton E, 145–155
Lenzi A, 205–210, 226–235
Leon IG, 9–19, 130–141, 142, 267–286, 291–303, 304
Leonard CO, 267–286
Leong FTL, 61–79
LeRoy BS, 260–286
Lesaca T, 105–115
Leslie GI, 462–475
Lessor R, 343–354
Lester EP, 131–141, 443–456, 458
Letizia KA, 190–194
Letur-Konirsch H, 321–337, 340–354, 449–458
Levin S, 344–355
Levine DJ, 336–338
Levinson DJ, 43–58
Levi-Setti P, 240, 256
Levron J, 269–287
Levy DM, 461–474
Levy-Schiff R, 38–56, 390–409
Lewicka S, 106–115
Lewin A, 205–211
Lewis E, 291–303
Lewis GM, 344–355
Lewis J, 442–456
Lewis V, 283–289
Leyland Z, 478
Li D, 202–209
Li TC, 52–59
Li TC, 300–304
Li XH, 336–338
Liang J, 360–369
Licciardi F, 283–289, 332–338
Lie RT, 269–287
Lieb SA, 292–303
Liebaers I, 22–35, 276–288, 479–491
Liebars I, 481–491
Lieberman BA, 173
Liebowitz L, 142
Liedtke R, 40–57
Lien YR, 336–338
Lifches v. Hartigan, 537–543
Lifshiz LV, 515–520
Lifton BJ, 392–409
Lightsey OR, 462–475
Liguori A, 202–209
Lin JH, 202–209
Lindblad F, 308–317, 392–409, 485–492, 553–557
Lindblad R, 308–317
Lindemann E, 293
Lindheim SR, 322–337, 343–355, 359–369, 510–518
Lindner K, 479–491
Linehan MM, 73–82, 108–116
Lintsen AM, 190–195
Lippman-Hand A, 267–286
Lipschultz LI, 36
Lipshultz LI, 238–256
Lira A, 105–115
Lisbona H, 430–438
Liss J, 197–209
Lissens W, 269–287
Liswood MP, 119–128
Litt MD, 93–96
Littam G, 205–211
Liu H, 106–115
Liu JH, 100–113
Liu L, 387–408
Liu SH, 202–209
Llabre MM, 132–141
Llewellyn-Jones D, 99–113, 446–457
Llorente AM, 107–115
Lobardo F, 226–235
Lobel M, 41–57, 171–192
Lobo RA, 51–59, 342–354, 478–491
Locke HJ, 147–155
Lodewijckx E, 214–233
Loft A, 276–287
Loi Fédérale sur la Procreation Médicalement Assistée, 549–556
Lombard CJ, 172–192
Lombardo F, 205–210, 226–235
Lonner WJ, 68–80
Lopes P, 37–56
Lopez E, 52–59
LoPiccolo J, 220–234
LoPiccolo L, 220–234
Lord SE, 182–194
Loret de Mola R, 430–438
Loriz L, 511–519
Loucks TL, 185–194, 244–257
Louwe LA, 553–557
Lovell-Smith HD, 203–210
Lu EG, 503–507
Lu F, 203–210
Lu G, 41–57
Lu Y, 41–57
Lübke F, 307–316
Luborsky M, 415–426
Ludwig M, 442–455, 457
Luine VN, 100–113
Lukse MP, 8–19, 158–167, 186–194
Lumley J, 242–256
Lummen G, 48–58
Luna F, 526–541
Lundeberg T, 197–209
Lundin K, 276–287, 479–491
Lundstedt G, 202–209
Lundstrom-Lindstedt V, 292–303
Luolon Z, 202–209
Lusskin SI, 445
Lust K, 333–338
Luthra M, 64–80
Lutjen P, 320–337, 342–354, 478–491
Lutkenhaus R, 122, 136–142, 144–154
Lycett E, 307–317, 373–386, 464–475, 484–492, 553–557
Lydiard RB, 445–457
Lyngstadaas A, 269–287
Lyons AS, 1–17
Ma K, 273–287
Mabasa LF, 40–57, 70–81
Macauley J, 346–355
MacCallum F, 307–317, 373–386, 463–475, 483–492, 553–557
MacCormack C, 3–18
Macdonald JA, 515–520
MacDougall K, 359–369
Macduff S, 98–112
Macek M, 264–286
Maciocia G, 202–209
Mack S, 129, 131–141
Mackenzie KR, 163–168
Mackenzie TB, 457
Macklin R, 455
MacMahon C, 482–492
Macnamee C, 481–491
Macomber D, 22
MacPherson A, 205–211
Maddock JW, 221–234
Madgar I, 269–287
Madge S, 243–256, 273–287
Madsen KM, 271–287
Maes M, 106–115
Magarelli PC, 197–209
Magna A, 67–80
Magnusson C, 292–303
Mahlstedt PP, 43, 45–58, 84–95, 98–112, 132–141, 144–154, 307–316, 338, 344–355, 362–369, 450–458, 469–476, 477–491, 494–506
Mahoney MJ, 134–142
Mai FM, 141
Maier DA, 5–18, 48–54, 58–59, 84–95, 237–256, 307–316, 335–338, 343–354, 469–476, 487–492, 494–506
Maier LU, 48–54, 58–59, 237–256
Maio GR, 64
Majewski M, 100–113
Mak V, 238–256
Makino T, 41–57, 70–81, 159–168
Makuch MY, 38–56
Malan D, 133
Malcolm CE, 431–438
Malinge MC, 269–287
Mallon GP, 514–520
Malmquist Larsson A, 100–113
Malone FD, 450–458
Mamiso J, 510–519
Manase K, 204–210
Mancino A, 205–211
Mandala R, 144–154
Mandelbrot L, 240–256
Manese JE, 65–80
Mangan CE, 53–54, 58–59
Mann J, 133
Mann K, 55–60
Mannion PT, 216–233
Mannuzza S, 99–112
Manovich R, 38–56
Mantalenakis S, 40–57, 73–82
Mantegazza I, 341
Mantero F, 205–211
Manus GI, 143–154
Manyande A, 74–82
Marangell L, 107–115
Marcellini L, 205–210
Marchand S, 37–56
Marchbanks PA, 52–53, 59
Marcus MD, 185–194, 244–257
Margara R, 308–317
Marin G, 62–79, 411–425
Marina F, 240–256
Marina S, 240–256
Marks I, 152–155
Marks JH, 261–286
Markus H, 69–81
Marlatt GA, 66–80
Marosek KR, 495–507
Marrs R, 190–195
Marsch EM, 493–506
Marsella T, 204–210
Marsh C, 157
Marsh M, 2, 4–18, 460–474
Marshall LA, 514–519
Marshall R, 300–304
Marteau TM, 261–286
Martikainen H, 100–113
Martin C, 173–193
Martin E, 44
Martin MS, 495–507
Martinez J, 107–115
Maruta H, 205–211
Mascie-Taylor CG, 415–426
Mason L, 322–337
Mason MC, 132–141, 310–318
Massey JB, 285–289
Massey JK, 297–304
Masters WH, 218–234
Mastroiacova P, 104–114
Mastroianni L, 39–56
Matarazzo JC, 169–192
Mathur NK, 205–211
Matsubayashi HT, 41–57, 70–81, 99–112, 159–168, 172–192
Matsui D, 104–114
Matsumoto D, 69–80
Matt GE, 121
Matteo ML, 171–192
Matthews AM, 10–19, 144–154, 390–409, 417–426
Matthews R, 10–19, 144–154, 390–409, 417–426
Mattox JH, 442–456
Maxia N, 204–210
May ET, 460–474
Mayer JF, 359–369
Mayer KH, 240–256
Mayer RC, 305–315
Mayes G, 365–369
May-Panloup P, 269–287
Mazor M, 225–234
Mazure CM, 84–95, 99–113, 173–193, 323–337, 419–426, 477–491, 494–506
Mbizvo MT, 219–234
McBride J, 448–457
McCallum F, 359–369
McCallum M, 163–168
McCarthy BW, 226–235
McCarthy K, 119–128, 165–168, 243–256, 273–287
McCluskey MM, 216–233
McConkle-Rosell A, 267–286
McConvil J, 535–542
McCook JG, 42–57
McCubbin HI, 10–19
McCusick BA, 260–286
McDaniel SH, 503–507
McDermid A, 359–369
McDonald OL, 446–457
McDonald v. McDonald, 536–542
McElhatton PR, 104–114
McElroy SL, 106–115
McEwen BS, 100–113
McFadden J, 64–80
McFann K, 197–208
McGauley GA, 292–303
McGee G, 510–519
McGill DW, 77–82
McGinley P, 37
McGoldrick M, 77–82, 416–426
McGrade JJ, 40–57
McGrath E, 43–58
McGrath PJ, 9, 248–257
McGue M, 391–409
McGuire A, 279–288
McIntyre HD, 333–338
McKinney M, 84–95, 98–112, 301–304, 449–457
McLeod J, 119
MCLS, 529–541
McMahon CA, 442–456, 462–475
McMullin JA, 418–426
McNamee PI, 356
McNaughton-Cassill ME, 158–167, 168
McNeil TF, 100–113
McNutt RA, 264–286
McQueeney DA, 119–127, 158–167
McRoy R, 391–409, 410
McWhinnie AM, 309–318, 469–476, 527–541
Meade RD, 70–81
Meadows L, 315–318
Meana M, 222–234
Meijer J, 100–113
Meikle S, 479–491
Meller WH, 22–35, 105–115
Melli M, 400
Meltzer H, 106–115
Mendel G, 259
Mendola R, 430
Menezo YJR, 277–288, 289
Menge AC, 249–257
Menkveld R, 205–211
Menning BE, 7–19, 98–112, 117–127, 129–141, 144–154, 156, 252–257, 494–506
Mental Health Professional Group of American Society for Reproductive Medicine, 545–556
Merali Z, 2–17, 413–425
Merari D, 173–193
Merarim D, 67–80
Merkus HMWM, 205–211
Merkus JMWM, 189–194
Meschini P, 205–211
Mesquita B, 78–82
Messer L, 239–256
Mester R, 102–114
Mettler L, 144–154, 430–438
Metz ME, 226–235
Meyer WR, 345–355, 359–369
Meyers M, 11–19, 50–58, 144–154, 155
Miall CE, 10–19, 39–44, 56, 58, 80, 308–317
Michiels A, 22–35
Michova Z, 463–475
Micioni G, 84–95, 130–141
Mickle J, 239–256
Mignosa M, 204–210
Mikesell SG, 184–194
Mikulincer M, 38–56, 217–234
Milad MP, 299–304
Miller B, 390–409, 514–520
Miller D, 342–354
Miller JB, 44–58, 325–338
Miller LJ, 107–116, 443–456, 457
Miller SM, 41–54, 57, 58–59
Miller WR, 62–79, 80, 188–194
Mills E, 535–542
Milsom I, 450–458
Milson I, 307–316
Milunsky A, 239–256
Mindes EJ, 55–60
Mindes J, 292–303, 449–457
Ministerial Committee on Assisted Reproductive Technology, 5–18
Minuchin S, 327–338
Mira M, 99–113, 446–457
Mischel W, 53–54, 58–59
Misri S, 104–114
Mitchell E, 98–112, 494–506
Mitchell GD, 306–316
Mitchell J, 430–438
Miura J, 101–113
Mo X, 202–209
Mochen MM, 138–142
Mocroft A, 243–256, 273–287
Moe N, 307–316
Moffitt TE, 467–475
Mohr L, 478–491
Mokoena NE, 40–57, 172–192
Moleiro C, 126
Molock SD, 64–80
Monach JH, 49–58, 494–506, 552–556
Mondin GW, 121
Monleon Sancho J, 300–304
Monro JM, 467–475
Montanana V, 300–304
Montavanie A, 483–492
Moody M, 121
Mooney SB, 204–210
Moore CA, 280–288
Moore DE, 191–195, 242–256
Moos RH, 178–193
Mor E, 51–59, 333–338
Moreno L, 22–35
Morgan A, 159–168
Morgan D, 72–82
Morgan TH, 259
Morley FH, 204–210
Morris, 101–114
Morris M, 467–475
Morrow A, 100–113
Morrow KA, 93–96
Morse C, 85–95
Morton C, 356
Mosca F, 205–211
Moses S, 299–304
Mosher WD, 20–35
Moss H, 488–492
Moss R, 488–492
Mostyn BJ, 510–518
Motohashi T, 202–209
Mousset-Simeon N, 269–287
Moynihan CJ, 461
Muechler E, 84–95, 98–112
Mueller BA, 191–195
Mueller KA, 418–426
Muhammed S, 524–540
Mukerjee T, 331–338
Mulatu MS, 64–80
Mulciner M, 39–56
Mulhauser LC, 280–288
Muller MJ, 217–234
Mumford SE, 146–155
Munday RN, 141
Munkelwitz R, 47–58
Munne S, 276–287
Murata M, 202–209
Murphy GE, 101–113, 119–127
Murray C, 307–317, 324–337, 373–386, 464–475, 484–492, 553–557
Murray L, 454–458
Mushin DN, 462–475
Mushkin DN, 482–492
Muthusami KR, 191–195
Myers M, 152–155
Naaktgeboren N, 479–491
Nachtigall RD, 10–19, 39–56, 58, 84–95, 132–141, 149–151, 155, 172–192, 217–234, 266–286, 308–317, 335, 359–369, 434–438, 469–476
Nadelson CC, 448–457
Nagui AR, 100–113
Nagy J, 99–112
Nahin RL, 197–208
Nahoul K, 205–211
Najavits L, 245–257
Najmabadi H, 28–36
Nardo LG, 52–59
Nasseri M, 40–57, 70
Natarajan L, 173–193, 195, 442–456
Nathanson DL, 44–58
Nathanson YE, 39–56, 217–234
National Ethics Committee on Assisted Human Reproduction, 358–369
National Health Insurance Law, 525–541
National Institute of Clinical Excellence, 118, 127
Navarro AM, 121
Nave O, 72–82
Nawaz H, 190–194
Neal GS, 158–167, 168
Neel JV, 259–286
Neirmeiher M, 267–286
Nelson DB, 299–304
Nelson LM, 36, 42–53, 58–59, 241–256
Nemeroff CB, 454–458
El-Nemr, A, 190–195
Nestoros JN, 122, 126
Neter F, 281–288
Netter A, 205–211
Nettles E, 7–19
Neuberg SL, 310–318, 326–338
Neugebauer R, 292–303, 304, 445–457
Neumann-Kunhelt B, 204–210
New York Public Health Law, 539–543
New York State Task Force on Life and the Law, 5–18
New Zealand Ministry of Social Development, 528–541
Newfoundland Welfare of the Child Act, Part II, 524–540
Newson AJ, 315–318
Newton CR, 84–95, 98–112, 114, 123, 131–141, 145–154, 155, 172–192, 193, 359–369, 419–426, 431–438, 461–474
Newton D, 448–457
Neziroglu F, 457
Ng KK, 50–58
Nicholl JP, 197–208
Nichols JE, 189–194, 244–257
Nicol MT, 292–303
Niederberger C, 10–19
Nielsen B, 67–80
Niemitz EL, 481–491
Nieschlag E, 205–211
Nieuwenhuyse H, 41–57
Nikolettos N, 313–318
Nilsson L, 479–491
Ningel K, 85–95, 117–127, 138–142
Nippert I, 263–286
Nishimura T, 202–209
Nixon J, 120
Noble E, 468–476
Nonacs RM, 104–114, 115
Norcross JC, 121
Nordoff V, 190–195
Norman RJ, 119–127
Norre J, 99–113
Norris S, 5–18, 376–386
North K, 47–58
Noss U, 203–210
Notarius CI, 150–155
Notman MR, 443–456
Notman MT, 131–141, 445–457
Novaes SB, 343–354
Noyes RW, 7–19
Nulman I, 104–114, 115
NYCRR, 539–543
Nygren K, 479–491
Oakley CE, 243–256
Oakley D, 442–456
Oates MG, 473–476
Oates RD, 239–256
Ober C, 239–256
Oberlander TF, 104–114
Obermeyer CM, 215–233
Obi S, 388–408
O’Brien JH, 219–234
O’Connor E, 514–519
O’Connor N, 343–354
Oddens BJ, 41–57, 99–112
Odebiyi A, 71–81
Odegaard OA, 219–234
Odell M, 77–82
Offerman-Zuckerberg J, 293–303
Offner AH, 55–60
Ogle R, 279–288
Ogrodniczuk JS, 163–168
Ogunniyi SO, 70–71
Ogunyemi BO, 510–518
O’Hanlon WH, 135, 152–155
O’Hanlon-Hudson P, 150–155
O’Hara MS, 103–107, 114, 473–476
O’Hara MW, 441–445, 457
Ohashi M, 202–209
Ohl DA, 249–257
Oishi S, 70, 78
Okonofua FE, 2–18, 71–81
Oktay K, 22–35, 241–256
Olaitan A, 243–256, 273–287
Olivius C, 430–438
Olney RS, 280–288
Olsen A, 5–18
Olsen J, 20–35
Olsen S, 107–116
Olshansky EF, 5–18, 43–58, 442–456, 461–462, 474
Olson CK, 269–286
Olson JH, 245–257
Olson JM, 64
O’Moore AM, 119–127, 203–210
O’Moore RR, 119–127, 203–210
Onah H, 388–408
Onah N, 71–81
Ondrizek RR, 205–210
Oppozzi L, 86–95
Orav J, 54, 58–59, 120, 131–141, 158–168
Orenstein P, 305–316
Orie EF, 71–81
Orji EO, 42–57
Ormond KE, 279–288
Orshan SA, 42–57
Orstavid KH, 269–287
Ort SI, 462–475
Orubuloye IO, 415–426
Osata FG, 321–337
Osborne D, 331–338
Osman LM, 246–257
Osmanagaoglu K, 431–438
Otto S, 107–115
Otto T, 48–58
Ouden A, 479–491
Ovsenk M, 361–369
Ovsenk R, 361–369
Ovum Donor Task Force of the Psychological Special Interest Group of the American Fertility Society, 494–507
Owens DJ, 212–233
Oyserman D, 68–80
Pace-Asciak, P, 105–115
Pacheco A, 22–35
Pacheco IM, 74–82, 324–337
Pados G, 333–338, 449–458
Page A, 291–303
Pajares, 199–209
Pal L, 42–57
Palmer R, 21
Palmer S, 64–80
Palomaki GE, 271–287
Palomino WA, 22–35
Pander HC, 3
Pannor R, 307, 391–409
Pannu M, 69–81
Paoli D, 205–210
Paolini P, 205–210
Papago, 66
Papiligoura Z, 482–492
Papp P, 309–317
Papreen N, 70–74
Parekattil SJ, 48–58
Paret IH, 11–19, 388–408
Park CL, 433–438
Park J, 249–257
Parker JC, 182–193
Parker JP, 372–386
Parker PJ, 449–458
Parkes CM, 293
Parrilla JJ, 52–59
Parry BL, 101–113
Parry T, 482–492
Pashigan MJ, 5–18, 413–425
Pashigian MJ, 70–81
Pasker de Jong PC, 190–195
Pasley B, 391–409
Pasquale S, 430–438
Passchier J, 470–476
Pastuszak A, 104–114
Paszkowski T, 190–195
Paton J, 391–409
Patraglia F, 204–210
Patrick M, 345–355
Patrizio P, 238–256
Patterson CJ, 486–492, 514–519
Pattinson HA, 172–192
Patton NC, 205–210
Patton P, 531–542
Paul B, 67–80
Paul S, 100–113
Pauling L,
Paulson JD, 41–57, 130–141
Paulson RJ, 51–59, 333–338, 342–354, 478–491, 494–506
Paulus EW, 197–210
Paulus WE, 22–35, 202–209, 210
Paxson H, 72–82
Paz G, 525–541
Peake TH, 134–142
Pearce J, 77–82
Pearsall-Jones JG, 301–304
Pearson CL, 387
Pedersen FA, 291–303
Pederson PB, 61–79
Peet M, 106–115
Pei J, 203–210
Pekarik G, 138–142
Pellegrini DS, 150–155
Peller JE, 135–142
Pellicer A, 22–35
Penchaszadeh VB, 261–286
Pengelly P, 119
Pennebaker JW, 46–58
Penney GC, 41–57, 131–141
Penney LL, 93–96
Pennings G, 147–155, 330–338, 341–354, 376–386, 485–492, 510–519
Penzias A, 55, 67–80
People v. Shreve, 535–542
Pepe M, 205–210
Peplau LA, 177–193
Peppers LG, 292–303, 304
Perel JM, 104–114
Peritz E, 414–426
Perotti L, 239–256
Perry B, 469–476
Perry C, 108–116
Perry GS, 189–194
Perry JC, 108–116
Perry Y, 391–409
Perry-Rogers v. Fasano, 538–543
Perry-Rogers v. Obasaju, 538–543
Personal Information and Electronic Documents Act, 533–542
Peskin B, 430–438
Peters J, 262–286
Petersen K, 5–18
Peterson BD, 145, 172–192
Peterson HB, 2–10, 17, 52–53, 59, 479–491
Peterson P, 4, 66–80, 387–408, 411–425
Petok WD, 56, 214–233
Petrocelli RJ, 8
Petti F, 202–209
Pfrunder D, 423–427
Pfuhl EH, 310–318
Phillipou G, 100–113
Phillips G, 121
Phillips LH, 103–107, 114, 445
Phillips RS, 197–208
Phinney JS, 62–79
Phipps S, 442–456
Pi WP, 202–209
Pies RW, 101–113
Pike S, 145–155
Pilu P, 279–288
Pinching AJ, 342–354
Pineda JA, 336–338
Pinter J, 99–112
Piomboni P, 203–210
Piper WE, 163–168
Pitcher L, 58, 335
Pitts M, 216
Plachot M, 358–369
Planned Parenthood of SE PA v. Casey, 534–542
Plath S, 37
Platteau P, 22–35
Platz-Christensen JJ, 52–59
Pleck JH, 486–492
Plomin R, 348–355
Plunkett KS, 268–286
Podd J, 201–209
Polan ML, 204–210
Polin G, 515–520
Politch JA, 240–256
Pollock C, 442–456
Polo M, 440
Polonsky D, 226–235
Ponjaert I, 307–317
Ponjaert-Kristofferson I, 309–317
Ponterotto JG, 65–80, 81
Pook M, 40–57, 58, 119–128, 131–141, 144–154, 172–192, 194
Popay J, 120
Pope KS, 533–542
Porreco RP, 333–338
Porter KL, 132–141, 145–154
Portner J, 4, 66–80, 387–408, 411–425
Posner NA, 454–458
Postman N, 477
Postneek F, 202–209
Potts M, 213–233
Potuznikova P, 264–286
Powell S, 445–457
Powell-Griner E, 197–208
Powes HJ, 205–211
Practice Committee of the American Society for Reproductive Medicine, 22–35, 36, 190–195, 249–257, 276–287, 340–354, 523–540, 543
Pratt E, 345
Pratt JH, 156
Prem AR, 202–209
Prentice-Dunn S, 179–193
The President’s Council on Bioethics, 22–35
Previn LA, 228–235
Price WA, 100–113
Primomo J, 247–257
Pritts EA, 52–59
Probasco KA, 344–355
Proverbs, 493
Pry M, 356
Pryor JL, 226–235
Pu Y, 202–209
Pugh TF, 444
Puryear L, 107–115
Qui Y, 48–58
Quick EK, 135–142
Quigley MM, 343–354
Quintero R, 203–210
Quiroga SS, 10–19, 58, 172–192, 266–286, 469–476
Quresh A, 68–80
R v. HFEA ex parte Diane Blood, 524–540
Raboy B, 486–492
Rachman S, 152–155
Raghavan D, 256, 273–287
Ragin A, 448–457
Ragni G, 239–256
Ragson N, 101–113
Raimy VC, 120
Raina R,
Ramalho AS, 261–286
Rana N, 356
Rand CS, 297–304
Randall JM, 100–113
Ranga GA, 190–195
Ranga GM,
Rankin WE, 205–211
Raoul-Duval A, 342–354, 449–458, 470–476
Raphael B, 132–141
Raphael-Leff J, 125, 443–456
Rapoport L, 136–142
Ratoye B, 104–114
Rattray A, 46–58, 231–235
Ratzoni G, 105–115
Rausch DT, 343–355
Rawson D, 64–80
Re: Baby M, 538–543
Re: C.K.G., 536–542
Re: Evelyn, 525–540
Re: Guardianship of I.H., 535–542
Re M, 205–210
Re: Marriage of Bazzanca, 538–543
Re: Sullivan, 535–542
Read J, 11–19
Reading AE, 90–95, 147–155, 222–234
Reale G, 202–209
Reame NE, 42–57, 285–289, 372–386, 450–458
Reamy KJ, 453–458
Reardon W, 269–287
Rebar RW, 20–35, 36, 42–53, 57, 59, 241–256
Rector JM, 63–79
Red Latino American de Reproduccion Asistida, 526–541
Redlinger-Grosse, K, 258–285
Redmond C, 119–128, 165–168
Reece JB, 259–285, 286
Reed GM, 503–507
Reed SC, 261–286
Rege NN, 202–209
Regier DA, 99–112
Regnani G, 204–210
Rehavi M, 102–114
Rehm LP, 441–445, 456, 457
Reichman B, 241–256
Reid W, 243–256, 273–287
Reijo R, 48–58, 238–256, 273–287
Reik W, 481–491
Rein MS, 86–95
Reindollar RH, 55
Reis F, 204–210
Reis J, 343–354
Reissman CK, 5–18, 70–81
Reitz M, 400–409
Remennick L, 70–81, 414–425
Reminick AM, 104–114
Renne KS, 415–426
Renou P, 342–354
Renshaw DC, 100–113
Repping S, 216–233
Reproductive Technology Act, 525–540, 547–556
Requena A, 22–35
Resch M, 99–112
Resnick R, 372–386
RESOLVE, The National Infertility Association, 351–355, 357–369, 423–427
Revak-Lutz R, 297–304
Revel M, 261–286
Revenson TA, 54, 59
Rhodes EA, 245–257
Ricciardo-Lamonica G, 205–211
Rice PL, 294–304
Rice v. Flynn, 536–542
Richards PS, 63–79
Richards S, 307–316
Richardson WS, 122, 125
Rich-Edwards, JW, 468–476
Riches S, 292–303
Richie JP, 239–256
Richter ML, 261–286
Rickels K, 39–56, 57, 84–95, 98–112, 132–141, 145–154, 494–506
Riddick DH, 212–233
Riedinger S, 204–210
Rieker PP, 48–58, 245–257
Riessman CK, 419–426
Riet G, 120
Riggs W, 104–114
Riley D, 391–409
Rilke RM, 290
Rindfleisch W, 21
Riordan M, 309–317, 485–492
Ripatti U-R, 359, 369
Ritsher JB, 300–304
Rives N, 269–287
Rizk DE, 416–426
Robbins FP, 216–233
Robert B v. Susan B, 538–543
Roberts C, 482–491
Robertson JA, 249–257, 534–542
Robertson LH, 106–115
Robertson S, 482–491
Robins LN, 99–112
Robinson C, 228–235
Robinson GE, 99–112, 446–457
Robinson J, 482–491
Robinson RD, 158–167, 168
Robinson WP, 275–287
Robson J, 184–194
Roca CA, 106
Rodeck C, 279–288
Rodesch C, 510–519
Rodgers D, 292–303
Rodolfa ER, 120
Roe v. Wade, 522–540
Rogers C, 263
Rogstad KE, 39–56
Rohr R, 330–338
Rohrle B, 40–57, 58
Rojanksy N, 251–257
Rojewski J, 387–408
Rolf C, 190–195, 205–211
Rolfs RT, Jr, 216–233
Rollnick S, 188–194
Romero R, 279–288
Romitti PA, 269–286
Roncaglia R, 171–192
Ronnberg L, 100–113
Ronner W, 2, 4–18, 460–474
Roscon AS, 206–211
Roseff SJ, 205–210
Rosen A, 138–142, 497–507
Rosen J, 138–142, 497–507
Rosen KH, 145, 172–192
Rosen R, 232
Rosenbaum JF, 106–115, 445
Rosenbaum R, 135–142
Rosenberg EL, 361–369
Rosenberg HS, 159–168, 324–337
Rosenberg W, 122, 125
Rosenblatt M, 281–288, 292–303
Rosenblatt PA, 451–458
Rosenblatt PC, 4, 66–80, 387–408, 411–425
Rosenblatt PG, 297–304
Rosenfeld DL, 98–112, 494–506
Rosenthal JL, 511–519
Rosenthal MB, 50–59, 467–475
Rosenwaks Z, 442–456, 515–520
Rossing MA, 242–256
Roth AJ, 256, 273–287
Rothman BK, 158, 278–288, 440–455, 460–474
Rothman D, 7–19
Rothmann SA, 342–354
Rovet J, 104–114, 115
Rowe PJ, 2–10, 17, 38–56, 63
Rowson L, 478–491
Roy C, 245–257
Royal Commission on New Reproductive and Genetic Technologies, 544–556
Royal Commission on New Reproductive Technologies, 5–18
Roy-Byrne, RP, 457
Ruangsri RA, 447–457
Rubben H, 48–58
Rubenstein BB, 216–233, 493, 494
Rubin B, 341–354
Rubin I, 21
Rubin S, 309–317, 485–492
Rubin TI, 415–426
Rubinow DR, 106
Rubinstein BB, 7–19
Rubinstein RL, 415–426
Rumball A, 308–317
Rump EE, 141
Rumpold H, 50–59
Runganga AO, 70–81
Runnebaum B, 189–194
Ruokonen A, 100–113
Rurak D, 104–114
Ruspa M, 130–141
Russell ST, 514–519
Russo NF, 43–58
Rust J, 307–317, 483–492
Rutherford RN, 216–233
Ryan GL, 467
Saadat P, 51–59, 333–338
Saarem K, 107–116
Sabatini L, 190–195
Sabin K, 70–74
Sabourin S, 53–54, 59, 145–154, 155, 172–192, 430–438, 470–476
Sachs P, 319–337
Sachse K, 191–195
Sackett D, 122, 125
Sage S, 104–114
Sagovsky R, 454–458
Sahakian V, 197–209
Sahbar MA, 261–286
Said TM, 190–195
Sajaniemi N, 323–337
Salacone P, 205–210, 226–235
Saleh RA,
Salerno RL, 41–57, 130–141
Saller DN, 283–289, 292–303
Saloniemi H, 204–210
Salovey P, 134–142
Salvati G, 205–210
Salvatori M, 204–210
Salzer LP, 150–155, 387–410
Sandelowski M, 10–19, 266–286, 288, 442–456, 458, 465–475
Sanders K, 174–193
Sanders MR, 22
Sanderson C, 73–82
Sanderson MO, 221–234
Sanderson WC, 118–127
Sandler B, 130–141, 171–192
Sandman CA, 442–456
Sanger WG, 245–257
Sanigorski A, 106–115
Santiago-Rivera AL, 61–79
Santori A, 239–256
Santoro A, 241–256
Santoro N, 42–57
Santulli M, 205–210
Sarafino EP, 188–194
Saraiy KS, 282–289
Sarkar M, 104–114
Sarrel PM, 143–154, 494
Satir V, 486–492
Sauer MV, 51–59, 322–337, 342–354, 355, 359–369, 478–491, 494–506, 510–518
Saugstad O, 107–116
Saunders D, 38–56, 482–492
Savage OMN, 42–57
Sawyer SM, 246–257
Sayres Van Neil, M, 138–142
Scanlan LC, 75–82, 86–95, 310–318, 435–439
Schachter A, 205–211
Schaefer JA, 176, 178
Schaffer J, 309–317
Schaible A, 307–316
Scharf CN, 50–58, 144–154, 155
Scharf ES, 206–211
Schatzberg AF, 105–115
Schechter MD, 390–409
Schechtman KB, 280–288
Schedlowski M, 55–60
Schegel PN, 515–520
Schei B, 5–18
Scheib JE, 309–317, 485–492
Scheidlinger S, 157–167
Schenker JG, 67–80, 82, 251–257, 351–355, 510–519
Scher HI, 256, 273–287
Scherer KR, 77–82
Scherg H, 93–95, 119–128
Schick-Boschetto, B, 104–114
Schieve LA, 189–194, 479–491
Schiff I, 86–95
Schilling G, 40–57, 217–234, 306–316, 317
Schmiady H, 204–210
Schmid J, 42
Schmidt L, 117–127, 174–193, 194, 435–439
Schmidt WM, 444
Schneider DM, 310–318
Schneider MG, 172–192
Schofield PE, 53–59
Schoonveld C, 258–285
Schoreder CM, 53–54, 58–59
Schover LR, 220–234, 245–257, 269–287, 288, 307–316, 342–354, 355, 449–458
Schreiber P, 53–54, 58–59
Schreiner R, 292–303
Schreiner-Engel, P, 292–303, 449–457
Schroeder SA, 190–194
Schuiling GA, 170–192
Schuler L, 104–114
Schumacher T, 307–316
Schwartz GE, 169–192
Schwartz R, 100–113
Scibona M, 205–211
Scott E, 440
Scott R, 205–211
Scottish Intercollegiate Guidelines Network, 442–456
Sears S, 41–57
Seaton A, 319–337, 510–519
Seaward G, 242–256
Secher N, 107–116
Seelig AS, 449–457
Seeman MV, 100–113
Seibel MM, 41–54, 57, 59, 103–114, 120, 124, 130–141, 158–167, 168, 206–211, 419–426, 442–456
Seibring AR, 182–194
Selby PI, 243–256
Sele B, 273–287
Self SG, 242–256
Seli E, 52–53, 58–59
Selman P, 388–408
Selye H, 170–192
Semke I, 305–315
Semprini AE, 240, 256
Senol Y, 68–80
Serdula MK, 190
Sermon K, 276–288
Servy EJ, 245–257
Sewall G, 322–337, 425
Sewpaul V,
Sexton TL, 121, 125, 126
Seyle H, 170
Sha JL, 3–18
Shaaraway M, 100–113
Shadish WR, 121
Shaikh BT, 198–209
Shalev J, 38–56
Shamma FN, 20–35
Shapiro CH, 132–141, 258–285, 297–304, 420–427, 452–458
Shapiro DM, 285–289
Shapiro H, 333–338
Shapiro JR, 11–19, 388–408
Shapiro SS, 307–316
Shapiro VB, 11–19, 388–408
Sharma A, 70–74, 391–409
Sharma KK, 205–211
Sharp S, 319–337
Sharpe M, 46–58, 231–235
Shatford LA, 93–95
Shaw L, 299–304
Shaw P, 93–96
Shaw R, 93–96
al-Shawaf T, 74–82, 190–195
Shay J, 106–115
Sheard C, 473–476
Sheffield LJ, 261–286
Sheinin S, 105–115, 478–491
Shelling G, 77–82
Shenfield F, 343–355, 376–386, 510–518
Sherman JK, 245–257, 341–354
Sherrard WS, 125–126, 148–155, 179–193
Sherwin BB, 102–114
Shettles LB, 341–354
Shields P, 216
Shields S, 414–425
Shilkret v. Annapolis Emergency Hosp., 529–541
Shiloh S, 258–285
Shipley WU, 239–256
Shirai Y, 67–80
Shoog-Svanberg A, 39–56
Short R, 213–233
Shrout P, 292–303, 445–457
Shuhaiber S, 105–115
Shushan A, 67–80
Shusler JJ, 206–211
Sibbritt DW, 197–209
Sichel DA, 106–115
Siebel MM, 103–114
Sieber W, 173–193
Siedntopf F, 101–113
Siegel-Itzkovich J, 336–338
Siegel-Itzkovich L, 525–541
Sierens J, 205–210
Sifneos P, 133
Sigal M, 101–113
Sigmon S, 119–127, 158–167
Silber SJ, 38–56, 336–338
Silbert L, 269–287
Silman R, 501–507
de Paiva e Silva RB, 261–286
Silver L, 477–491
Silver RC, 144–154
Silver RK, 448–457
Silvertz K, 104–114
Simkin P, 441–455
Simmons RG, 346–355, 373–386
Simmons RI, 373–386
Simmons RL, 346–355
Simon AE, 275–287
Simon GE, 104–114
Simon R, 400
Simons EG, 319–337, 510–518, 519
Simons HF, 467–475
Simpson JL, 268–286, 287, 510–519
Sims J M, 21
Sinclair AJ, 106–115
Singer D, 10–19
Singer E, 391–409
Singh L, 70–81
Sireling L, 152–155
Siterman S, 203–210
Sitland-Marken PA, 101–113
Sjro P, 205–210
Skau M, 393–409
Skinner v. Oklahoma, 521, 534–542
Skirton H, 264–286
Skjaeraasen J, 307–316
Skoog-Svanberg A, 362–369
Slade P, 173
Slater CC, 51–59, 333–338
Slawsby EA, 54–59, 66–80, 119–120, 124, 127, 131–141, 158–168, 185–194
Slayden S, 285–289
Slota D, 102–114
Slyter H, 291–303
Smajdor AC, 315–318
Smeenk JMJ, 53–59, 106–115, 117–127, 171–192, 193
Smiley J, 37
Smith ACM, 266–286
Smith AL, 345–355
Smith GC, 446–457, 467–475
Smith H, 63–79
Smith LM, 104–114, 116
Smith R, 106–115
Smith SM, 310–318, 326–338
Snarey J, 172–192, 423–427
Snowdon C, 276–288
Snowdon EM, 306–316
Snowdon R, 306–316
Snyder DK, 147–155
Soderstom-Antilla V, 321–337, 340–354, 359, 369
Sodowsky GR, 77–82
Soenen S, 483–492
Solnit JA, 280–288
Son L, 172–192
Sonmezer M, 22–35, 241–256
Soranus, 20
Sorensen J, 107–116
Sorocco KH, 65–80
Sorosky AD, 391–409, 469–476
Soule DJ, 292–303
Soules MR, 20–35, 285–289
Soules R, 20–35
Soussis I, 277–288
Souter VL, 41–57, 131–141
Sovio U, 479–491
Spallanzani L, 3, 21, 477
Spandorfer SD, 442–456
Spanier GB, 147–155
Spar D, 529–541
Sparks AF, 359–369
Sparrow MK, 533–542
Spector IP, 220–234
Speidel H, 42–57
Spensley JC, 462–475, 482–492
Sperling H, 48–58
Sperling R, 243–256
Speroff L, 83–95, 100–113
Speyer E, 546–556
Spira A, 37–56
Spivey G, 104–114
Srougi M, 203–210
St. Augustine, 412
St. James, 320
St. Paul Fire and Marine Insurance Co. v. Cecil B Jabson, Jr, 522
Stack JM, 291–303
Stading G, 144–154
Staeding G, 430–438
Staessen C, 22–35
Stahl S, 105–115
Stammer H, 5–18, 50–58, 93–95, 119–128, 138–142, 144–154, 548–556
Standis E, 291–303
Stangor C, 310–318
Stanton AL, 7–19, 41–57, 119–127, 144–154, 158–167, 176–193, 194, 430
Stanworth M, 414–426
Stark JH, 280–288
Status of Children (Amendment) Act, 525–540
Steegers-Theunissen RPM, 205–211
Steif G, 204–210
Steiger C, 391–409
Steinbock B, 340–354
Steirteghem A, 479–491
Stener-Victorin, E, 197–209
Stephens LE, 104–114
Stephenson P, 4–18
Steptoe P, 4, 22, 478–491
Sterky K, 400–410
Sterling EW, 361–369
Stern MJ, 150–155, 157–167
Sterzik K, 22–35, 197–209, 210
Stevens DC, 292–303
Steward AE, 120
Stewart DE, 99–112, 114, 115, 119–128, 165–168, 446–457
Stewart S, 430–438
Stewart-Williams S, 200–209
Stich F, 121
Stief G, 101–113
Stiles WB, 122, 126
Stolwijk AM, 53–54, 59, 124, 430–438
Storeng R, 53, 59
Storey LB, 143–154
Stotland NL, 446–457, 494–506
Stoudemire A, 99–112
Stouffs K, 269–287
Stout JE, 345–355
Stowe ZN, 104–114, 115, 454–458
Strathern M, 3–18, 310–318
Straus SE, 122, 125
Strauss AL, 442–456
Strauss B, 5–18, 37–56, 57, 85–95, 117–127, 138–142, 144–154, 415–426, 430–438, 527–541
Strehler E, 22–35, 197–209, 210
Strickland BR, 43–58
Strickler RC, 20–35
Strobino B, 282–289
Strong C, 264–286
Stuart EM, 184–194
Stuart W, 538–543
Substitute Parent Agreement Act, 525–540
Sue DW, 65–80
Sugishita C, 198–209
Sugiyama Y, 159–168
Suh E, 70, 78
Suleiman SA, 205–211
Sullivan PF, 99–112
Sun GH, 40–57, 70–81
Sun Q, 41–57
Sun Y, 106–115
Sundby JS, 5–18, 70–81, 219–234, 430–438
Sureau C, 510–519
Suri R, 104–114
Surrogate Contracts Act, 525–540
Surrogate Parenthood Act, 525–540
Sutcliffe AG, 463–475, 481–491
Sutherland G, 282–289
Sutton WS, 259
Suzbak P, 100–113
Suzuki LA, 65–80, 81
Suzuki T, 41–57, 70–81
Swain ME, 531–540, 542
Swan JE, 360–369
Swank N, 300–304
Swanson KM, 292–303, 304
Swanson PB, 301–304
Sweet V, 245–257
Swerdly S, 165–168
Swerdlyk S, 119–128
Sydsjö, A, 463–475
Sydsjö, G, 463–475
Sykes DH, 430–438
Syme GJ, 292–303
Synesiou K, 371–386
Syrop C, 102–114
Syz HC, 157
Szasz T, 20
Szendei G, 99–112
Szkupinski Quigora, S, 308–317
Szoke H, 5–18, 306–316
Szuba MP, 104–114, 445
Tabachnick BG, 533–542
Tabaste JM, 37–56
Tachann JM, 335
Taddio A, 444–456
Taffe RC, 77–82
Tagatz GE, 106–115
Tagnfors U, 202–209
Takefman JE, 93–96, 98–112, 119, 124, 145–154, 155, 173–193, 217–234, 320–337, 339–354, 419–426, 429–438
Takeshita N, 277–288
Takeuchi S, 69–80
Talebi H, 126
Tallec A, 37–56
Tanbo T, 53, 59, 269–287
Tang M, 336–338
Tansey MJ, 137–142
Tarabusi M, 158, 168, 173–193, 194
Tarasoff v. Regents of the Univ. Cal., 532–542
Tarlatzis BC, 40–57, 73–82, 333–338, 376–386
Tarlatzis I, 40–57, 73–82
Tash JA, 515–520
Taska L, 448–457, 468–476
Tatla S, 69–81
Tattersall MH, 53–59
Tausig J, 132–141, 145–154
Taylor H, 47–58
Taylor K, 306–316
Taylor PJ, 20–35, 145–155
Taylor RN, 52–59
Taylor SE, 68–80, 431–438
Taymor ML, 4–18, 130–141, 175–193, 493–506
te Velde, ER, 50–59, 308–317
Teeter MA, 245–257
Tekpetey F, 359–369
Templeton AA, 41–57, 100–113
Tennant C, 38–56, 442–456, 462–475, 482–492
Tennen H, 93–96, 144–154, 430
ter Kuile, MM, 158–167
ter Laak, J, 392–409
Teresawa K, 106–115
Terry DJ, 55–60, 184–194
Tessler R, 387–408
Thatcher SS, 42–57
Thebaud F, 215–233
Theiring P, 173–193
Theobald H, 191–195
Theut SK, 291–303
Thewes B, 241–256
Thiering P, 38–56, 93–95, 106–115
Thomas AJ, 48–58, 269–287, 288
Thomas CMG, 189–194, 205–211
Thomas KJ, 197–208
Thomas L, 258
Thomas M, 105–115
Thomas v. Rubin, 535–542
Thomasset C, 214–233
Thompson EA, 10–19
Thompson JF, 53–59
Thompson JG, 482–491
Thompson JR, 473–476
Thompson K, 69–81
Thong J, 173–193
Thonneau P, 37–56
Thoreson CE, 62–79
Thorn BE, 179–193
Thorn P, 165, 305–318, 336–338, 527–541
Thornbill AR, 276–287
Thornley B, 190–194
Throsby K, 122, 430–438
Tieman W, 392–409
Tierney WM, 503–507
Tiitinen A, 323–337
Tikkiwal M, 205–211
Tilson D, 71–81
Timmreck L, 55
Timms N, 309–318
Timor-Tritsch, I, 301–304, 449–457
Tindle HA, 197–208
Tjeltveit AC, 63–79
Todorova I, 418–426
Toedter LJ, 292–303, 304
Tolor A, 40–57
Tomaer R, 101–113
Tomlinson L, 119–127, 158–167, 190–194, 246
Tompkins JR, 292–303
Toren P, 102–114
Toreson RW, 93–96
Totusek J, 204–210
Toubia N, 41–57
Tourelot E, 84–95
Tourgeman DE, 51–59, 333–338
Tournaye H, 239–256, 269–287, 431–438
Tourtelot E, 98–112
Tourtelot Z, 152–155
Townsend J, 205–210
Trabman T, 525–541
Trant AS, 204–210
Traub AI, 430–438
Tremaglio Coyle, A, 132–141
Trevarthen C, 482–492
Triandis HC, 68–70, 78, 80
Trimble JE, 62–79
Trimbos-Kemper TCM, 430–438, 461–474
Triseliotis J, 309–318
Tronstad SE, 52–59
Trounson A, 3–18, 478–491, 510–519
Trouson A, 320–337, 342–354
Truong KY, 190–193
Tsai C, 99–112
Tsai YY, 336–338
Tschann JM, 10–19, 58, 172–192, 266–286, 308–317, 469–476
Tschuggel W, 184–194, 203–210
Tse CK, 190–193
Tseng YF, 294–304
Tsuchiya K, 101–113
Tsukayama H, 198–209
Tucker J, 129–141
Tudelope DI, 292–303
Tugrul KG, 106–115
Tuil W, 182–194
Tulandi T, 98–112, 114, 119, 124, 145–154, 155, 173–193, 419–426
Tully LA, 467–475
Tummon IS, 359–369
Tunks E, 175–193
Tureck R, 39–56, 430–438
Turek PJ, 205–211
Turner A, 308–317
Turner C, 276
Turton P, 292–303
Tuschen-Caffier B, 40–57, 58, 119–128, 131–141, 144–154, 185–194
Tweed RG, 71–81
Tyler EM, 412–425
Ulbrich PM, 132–141
Ulman KH, 162–168
Umapathy E, 216–233
Unfer V, 204–210
Ungerer JA, 442–456, 462–475, 482–492
United States Census Bureau, 62–79
Unruh AM, 9, 248–257
Unterberg H, 307–316
Untergasser G, 50–59
Upchurch DM, 197–208
Upton RL, 71–81
Urdin C, 105–115
Ursano RJ, 133–141
Uskul AK, 70–81
Usuki S, 202–209
Usuki Y, 202–209
Vacc NA, 8–19, 117–127, 128, 186–194
Valabussa P, 241–256
Valentine P, 310–318
van Akker OV, 344–355
Van Assche E, 272–287
Van Balen F, 2–18, 19, 71–81, 123, 219–234, 411–425, 430–438, 461–474
van Berkel R, 308–317
van de Wiel HBM, 170–192
van den Akker OBA, 173–193, 194, 361–369, 389–408
Van den Bergh M, 510–519
van den Hout MA, 297–304
Van der Elst J, 241
van der Ende J, 392–409
van der Kolk BA, 108–116
van der Spuy ZM, 40–57, 70–71, 172–192, 194, 219–234
van der Veen F, 216–233
van der Veen L, 308–317
van der Ven H, 239–256
van der Ven K, 239–256
van Dijkum C, 392–409
van Dulman M, 390–409
Van Hall E, 307–317
Van Hartesveldt C, 100–113
van Ijzendoorn MH, 392–409
van Keppel M, 388–408
van Leeuwen E, 216–233
van Leeuwenhoek A, 3, 22, 341
van Minnen A, 53–54, 59, 106–115, 117–127, 173–193
Van Rompay MI, 197–208
Van Royen P, 214–233
Van Steirteghem A, 22–35, 239–256, 276–288, 431–438, 449–458, 481–491
Van Voorhis BJ, 359–369
van Weert JM, 216–233
Vandereycken W, 99–113
Vanderhoof V, 42–53, 58–59
Vanderschueren D, 144–154, 158–168
Vandervorst M, 431–438
Vanfraussen K, 309–317
van-Rooij FB, 123
Vanscoy SE, 158–168
Varney NR, 102–114
Vatev I, 463–475
Vayena E, 2–10, 17, 38–56, 63
Vazquez-Nutall E, 65–80
Veal L, 198–209
Veatch RM, 508–518
Vega M, 22–35
Venkat G, 51–59
Venn A, 242–256
Ventruba P, 204–210
Venturoli S, 204–210
Verburg C, 100–113
Vercollone CF, 488–492
Verhaak CM, 53–54, 59, 106–115, 117–127, 169–192, 193, 430–438
Verheyen G, 239–256
Verhulst F, 392–409
Verlinsky Y, 276–287, 288
Vermeiden J, 479–491
Verp MS, 283–289
Verres R, 5–18, 50–58, 93–95, 119–128, 144–154, 548–556
Versluis-den Bieman H, 392–409
Vervaeke M, 144–154, 158–168
Vesalius, 21
Vestergaard M, 271–287
Vidaver J, 450–458
Viguera AC, 104–114, 115
Vilimova S, 264–286
Villani F, 241–256
Villeponteaux VA, 445–457
Vine MF, 190–193
Vingerhoets AJJM, 171–192, 194
Vinnerljung B, 392–409
Viorst J, 420–426
Visnova H, 204–210
Visser AP, 184–194
Visser G, 479–491
Vitalli G, 205–210
Viviani S, 239–256
Vlaeyen JW, 297–304
Vogel W, 100–113
Vogelzang NJ, 256
Voigt RG, 107–115
Vollman JH, 292–303
Vollmer AM, 493–506
Volpe A, 158, 168, 173–193, 194, 204–210
von Baer, K, 3
von Kolliker, A, 3
Von Schoultz B, 132–141
von Schoultz B, 53–59
Vutyavanich T, 447–457
Vytiska-Binstroger E, 42
Wada I, 481–491
Wadden TA, 190–194
Wadhaw PD, 442–456
Wadsby M, 463–475
Wagner F, 151–155
Wagner KD, 102–114
Wagner M, 4–18
Wainwright JL, 514–519
Wald NJ, 279–288
Waldenstrom U, 202–209
Waletzky J, 206–211
Walker AP, 259–285
Walker BG, 3–18, 215–233
Walker HE, 7–19, 212–233
Walker I, 172–192
Walker ME, 495–507
Walker SM, 75–82, 86–95, 435–439
Walker SW, 310–318
Wall S, 486–492
Wallace KM, 147–155
Wallbott HG, 77–82
Waller L, 544–556
Walter JL, 135–142
Walters L, 478–491, 508–518
Walther VN, 292–303, 304, 448–457
Wampold BE, 65–80, 121
Wang HJ, 245–257
Wang SM, 48–58, 336–338
Wang W, 197–209
Wang X, 119–127
Warburton D, 282–289
Ward S, 182–194
Wardell H, 421–427
Wardle PG, 204–210
Warner J, 309–317
Warnock JK, 101–113, 114
Warnock M, 5–18
Watanabe O, 197–209
Watanabe S, 106–115
Watchman M, 107–116
Waters E, 486–492
Watkins C, 266–286
Watkins KJ, 495–507
Watson J, 258, 260
Watson L, 242–256
Watters WJ, 319–337
de Watteville H, 7–19
Weaver SM, 462–475
Webb S, 269–286, 480–491
Weber B, 106–115
Webster A, 184–194
Weeks GR, 225–234
Weijenborg P, 158–167
Weinberg H, 166–168
Weiner-Davis M, 152–155
Weingartner PJ, 6–19, 38–56, 150–155, 419–426, 430–438
Weinman J, 435–439, 441
Weinshel M, 144–154, 155
Weir RF, 359–369
Weiss NS, 191–195, 242–256
Weiss SM, 169–192
Weissman A, 182–194
Weitaman A, 105–115
Weitz B, 269–287
Weizman ES, 102–114
Wellisch DK, 245–257
Wells BG, 101–113
Wells RA, 134–141, 142
Wendland CL, 307–316
Wennerholm UB, 441, 456, 479–491
Wenqian Y, 202–209
Wertz DC, 263–286, 288, 510–519
Westergaard H, 479–491
Western Australia Reproductive Technology Council, 554–557
Westphal LM, 204–210
Westrom L, 28
Wheeler SM, 104–114
Whiston SC, 121, 125
Whitaker A, 446–457
White A, 197, 203–210
White R, 45–58
Whiteford LM, 39–56, 414–426
Whitehead G, 64–80
Whitehead MB, 371
Wick K, 481–491
Wiemann I, 309–317
Wiggins JG, 503–507
Wikland M, 202–209, 479–491
Wilcox L, 479–491
Wild T, 307–316
Wiley FM, 245–257
Wilholm BE, 104–114
Wilkey SA, 197–208
Will JC, 190
Wille MC, 269–287
Williams KE, 97–112, 113, 116
Willmott J, 57
Willouby DF, 242–256
Willson JB, 494–506
Wilmut I, 478–491
Wilson AF, 203–210
Wilson AL, 292–303
Wilson JF, 6–19, 38–56, 145–154, 155, 172–192, 193, 217–234, 246–257, 419–426, 430–438, 477–491
Wilson L, 37
Wilton L, 276–288
Windridge KC, 451–458
Wingfield MB, 158–167, 246–257
Winkler R, 388–408
Wirtz M, 122, 136–142, 144–154
Wischmann TH, 5–18, 19, 50–58, 93–95, 119–128, 138–142, 144–154, 170–192, 434–439, 527–541, 548–556
Wise MJ, 451–458, 467–475
Wisner KL, 104–114, 115, 116
Wlowlsky Y, 281–288
Wohlreich MM, 447–457
Wolf M, 412–425
Wolfe HG, 170
Wolff CF, 3
Wolff ES, 108–116
Wolfson V, 203–210
Wolitsky DL, 417–426
Wolpin J, 105–115
Wong WY, 189–194, 205–211
Wood C, 3–18, 158–167, 246–257, 342–354
Wood RM, 158–167, 199–209, 246–257
Woodcock K, 216–233
Woodside JV, 205–210
Woodward v. Commissioner of Social Security, 522–540, 543
Woody S, 118–127
Woolridge A, 259–286
Worden JW, 11
World Health Organization, 5, 22–35, 190–195, 196–208, 216–233
Wortman CB, 144–154
Wouters I, 184–194
Wozny M, 39–56, 84–95, 132–141, 149–151, 155, 217–234, 434–438
Wright, 536–542
Wright EJ, 103–107, 114
Wright J, 53–54, 59, 143–154, 155, 172–192, 430–438, 470–476
Wrobel G, 401–410
Wu LS, 202–209
Wu X, 336–338
Wurn BF, 206–211, 224–234
Wurn LJ, 206–211, 224–234
Xi G, 202–209
Yager A, 206–211
Yalom ID, 66–80, 157–167
Yalom M, 213–233, 411–425
Yamashita H, 198–209
Yamaura Y, 203–210
Yang DT, 48–58
Yang L, 41–57
Yang YS, 336–338
Yap C, 359–369
Yaryura-Tobias JA, 457
Yates RW, 205–211
Yee B, 190–195
Yen P, 28–36
Yen SSC, 100–113
Yeung CH, 205–211
Yingling S, 84–95, 98–112
Yoder JD, 418–426
Yokoyama Y, 468–476
Yong PC, 173–193
Yonkers KA, 106–115
York v. Jones, 536–542
Young KS, 77–82
Young MA, 261–286
Yovel I, 217–234
Yovitch J, 482–492
Yuksel E, 72–82
Yuzpe AA, 84–95, 98–112, 114, 145–154, 184–193, 419–426, 431–438, 461–474
Zabludovsky N, 203–210
Zahid MA, 42–57, 70, 74, 419–426
Zaki ZM, 205–211
Zalmstra H, 184–194
Zander KM, 106–115
Zappert LN, 97–112
Zaslow MJ, 291–303
Zboyan H, 107–115
Zeanan CH, 281–288, 291–303
Zeeb M, 84–95, 130–141
Zegers-Hochschild F, 73–82, 324–337, 526–541
Zekoski EM, 103–107, 114, 445
Zelizer V, 460–474
Zellman GL, 359–369
Zeskind PS, 104–114
Zhai Y, 202–209
Zhang M, 22–35, 197–209, 210
Zhang SH, 467
Zhang X, 105–115, 336–338
Zhang Z, 419–426
Zheng Z, 203–210
Zhou M, 105–115
Zhoujun S, 202–209
Zhu JL, 271–287
Ziebe S, 276–287
Zielhuis GA, 53–54, 59, 106–115, 117–127, 205–211
Zierler S, 105–115
Zilbergeld B, 226–235
Zilberstein M, 283–289
Zimon AE, 449–458
Zitzmann M, 190–195
Zolbrod AP, 37, 39–56, 58, 305–316, 338
Zuber C, 104–114
Zucali R, 241–256
Zukerman Z, 205–211
Zuttermeister PC, 41–54, 57, 59, 98–112, 114, 158–167, 178–193, 194, 245–257
Zuzkar D, 280–288
Zweifel J, 345
AAMFT. See American Association of Marriage and Family Therapy
ACMG. See American College of Medical Genetics
ACOG. See American College of Obstetricians and Gynecologists
acupuncture, 202–203
electroacupuncture, 202
β endorphin levels after, 202–209
GnRH normalization from, 202
IVF and, 202
male infertility and, 203, 211
ovulation and, 202
pregnancy and, 202–203
ADA. See Americans with Disabilities Act
Adjustment Disorder, 99, 103
adolescence, as parenthood stage, 472
adopted children. See children, adopted
adoption, 15, 33, 406–407
See also adoption agencies; complex adoption theory; domestic adoption; independent adoption; international adoption; transracial adoption
aboriginal, in Australia, 388
Adoption and Safe Families Act, 396
attachment and loss theory and, 393
birth parent relationships, 402–403
in China, 388
complex adoption theory, 11, 395
DI v., 306–307, 314
domestic, 389, 395–397
embryo v. ED, 358
enforced Native-American, in United States, 388
EuroAdopt program, 400
family systems theory and, 394–395
as family-building, 8, 9, 10, 12, 403–405
fears about, 401
grief therapy during, 405
home studies for, 400–401
identity formation and, 393–394
after infertility, 387
infertility counseling and, 390, 401–402, 407
information disclosure as part of, 391
information sources about, 405–406
intercountry, 389
international, 388, 389, 391–393, 398–399
Islam and, 74
migration’s influence on, 388
parent education of, 395–401
prenatal, 526
Protection of Children and Co-Operation in Respect of Intercountry Adoption, 389, 398
psychological issues as part of, 401
psychosocial adjustment to, 390–391
as relationship realignment, 387
in Romania, 388
social stigma of, 388, 389
social transitions towards, 407
transnational policies for, 388
transracial, 392–393, 399–400
adoption agencies
domestic, 395–397
Welcome Home, 388
Adoption and Safe Families Act, 396
adrenal hormones, 241
advanced maternal age, 270–271, 450, 466–467
American Society for Reproductive Medicine on, 513
Canadian Fertility and Andrology Society on, 513
Down syndrome from, 271
European Society of Human Reproduction and Embryology on, 513
infertility counseling for, 513–514
OD and, 332–333, 513
post-infertility pregnancy during, 450–451
pregnancy risks for, 450
prenatal testing for, 451
advocacy organizations. See organizations, advocacy
affective disorders, 98–99, 103
Adjustment Disorder, 99, 103
bipolar disorders, 99
depression, 98–99
pathological grief, 98
Africa. See also Egypt; Mozambique; Nigeria
childlessness in, 415
DI in, 306
female circumcision in, 214, 413
female sexual expression in, 214–215
fertility rites in, female, 3, 74
male infertility in, 40, 413
reproduction in, social importance of, 413
sub-Saharan, female infertility in, 42, 71
age
advanced maternal, 270–271, 466–467
ART and, as factor for, 173
childlessness and, for females, 415
female infertility and, 50–51
fertility and, for males, 271
infertility treatment withdrawal and, 430
male infertility and, 47
miscarriages and, 300
OD and, 332–333
parental, surrogacy and, 385
preconception counseling and, 270–271
pregnancy rates by, Spain,
pregnancy rates by, United States, 50
semen analysis and, 246
AHR. See Assisted Human Reproduction Act
AHRA. See Assisted Human Reproduction Agency
alarm reactions, 170
alcohol/drug usage, 190–191
male reproductive hormones and, 191
sperm production after, 188
Alcoholics Anonymous, 49
alexithymia, from male infertility, 40
allocentrism, 69
alternative medicine. See complementary and alternative medicine
altruism
empathy hypothesis for, 346
exchange reinforcement theory and, 346
in group counseling, 160
OD and, 321, 340
organ donation and, 346
psychoanalysis of, 373
surrogacy and, 373, 380
American Association of Marriage and Family Therapy (AAMFT), 527
American Board of Genetic Counseling, 261
American College of Medical Genetics (ACMG), 271
American College of Obstetricians and Gynecologists (ACOG), 271
American Psychiatric Association, 527
American Psychiatric Nurses’ Association
American Psychiatric Nurses’ Association (APNA), 527
American Psychological Association (APA), 75, 118, 527
ethics code for, 528
on informed consent, 87–95
American Public Health Service, 188
American Society for Reproductive Medicine (ASRM), 85, 129, 146, 261, 339, 485, 522, 544–546
on advanced maternal age, 513
Child-rearing ability and the provision of fertility services, 85
cryopreservation for, 249
DI recommendations, 306, 313
ED guidelines, 357
Ethics Committee of, 509
gamete donation guidelines, 347, 514
genetic testing guidelines, 352
infertility program guidelines, 85–92, 527
on infertility treatment withdrawal, 434
Mental Health Professional Group of, 86, 166, 340, 523, 544–546
OD guidelines, 321, 322, 340, 536
on PGD, 277
on post-infertility parenting, 459
surrogacy guidelines, 377
treatment denial guidelines, 311
Americans with Disabilities Act (ADA), 531
HIV under, 243
γ-aminobutyric acid. See GABA
amniocentesis, 280, 451
pregnancy adaptation from, 453
androgens, PCOS and, 52
aneuploidy, 276
anorexia nervosa, 99
See also eating disorders
anorgasmia, 105
in females, 216, 223
primary, 223
secondary, 223
Antenatal Questionnaire, 454
Antepartum Questionnaire, 454
antiandrogens, 30
anticipatory mourning, 132
antiestrogens, 30
clomiphene citrate, 30, 100–101
tamoxifen citrate, 30
anxiety disorders, 99, 107
See also phobias
Adjustment Disorder, 99, 103
estrogen’s influence on, 100
OCD, 99, 107
phobias, 99
during post-infertility pregnancy, 442, 444
during pregnancy, 445
reduction techniques for, 228
in Taiwan, 99
ANZICA. See Australia & New Zealand Infertility Counsellors Association
APA. See American Psychological Association
APNA. See American Psychiatric Nurses’ Association
ART (assisted reproductive technology), 4, 15, 32–33, 38
See also DI; donations; donors, embryo; donors, oocytes; ED; ICSI; IVF; MESA; OD; reproductive tourism; sperm donors; TESE
advances in, 441, 456
age demographics for, 173
in Asia, 67
Beckwith-Weideman syndrome from, 481
bereavement theory and, 295
bioethics for, 509–510
birth defects from, 482
Catholic Church and, 526
chemical pregnancies from, 290
children from, 16–17, 363
Christianity and, 73–74
family systems theory and, 486
genetic-assisted, 268, 269
in Germany, cultural attitudes towards, 72
gestational carriers, 15
in Greece, 73
HIV and, 240
ICSI, 22, 47, 48, 272, 420, 477
infertility counseling and, influence on, 494
infertility counseling for, 129, 486
information disclosure about, to children, 483–485, 487
Islam and, 74
in Italy, 340
IUI, 31, 48, 51
IVF, 4, 22, 23–35, 48, 51, 55, 143, 274, 477
Judaism and, 72, 73
MESA, 22, 47, 272
morality of, 306
MPR from, 290
in The Netherlands, 48
in Nigeria, 415
parenthood after, 462–463
perfect babies from, 441
PESA, 48
PGD as part of, 22, 35
PHSP, 514–515
pregnancy loss and, 290
pregnancy risks from, 441–442
psychological responses to, 173
psychosocial health after, for children, 482–483
PVSA, 48
sexual dysfunction and, 217–218
sperm donation, 15, 16, 272
stress from, 53–54, 59
in Sweden, 340
TESE, 22, 32, 47, 272
in Turkey, religion’s influence on, 67
in United States, 415
Artificial Conception Act, 525
artificial insemination by donor (AID). See DI
artificial insemination, history of, 341
Asia. See also Bangladesh; China; India; Taiwan; Turkey; Vietnam
reproduction in, social importance of, 412–413
sexual expression in, 214
ASRM. See American Society for Reproductive Medicine
assisted hatching, 33
age as factor for, 33
Assisted Human Reproduction Act (AHR), 524, 528, 551
ED guidelines under, 537
Assisted Human Reproduction Agency (AHRA), 339, 340
ED under, 358
OD under, 321
assisted reproductive technology. See ART
atheism, 63
attachment and loss theory
adoption and, 393
claiming under, 393
entitlement as part of, 393
full attachment parameters in, 393
grief counseling for, 137
infertility and, 132
OD and, 326
Australia
Artificial Conception Act in, 525
Australia & New Zealand Infertility Counsellors Association, 130, 321, 357, 528, 540, 546–547
children from ART in, psychosocial health of, 482–483
Commonwealth Family Law Act in, 525
complementary and alternative medicine in, 197, 199, 209
counselor accreditation in, 528–529
cystic fibrosis study, 246
DI in, 306
Donor Registry in, 321, 357, 468
ED in, 357–358
endometriosis study, 246
enforced adoption in, 388
eugenics in, 259
Federal Privacy Act in, 533–542
Fertility Society of Australia, 340
genetic counseling programs in, 261
healthcare privacy in, 533
Human Genetics Society of Australia, 261
Human Reproductive Technology Act, 480
Infertility Act in, 524
Infertility Treatment Act in, 321, 340
Ingarda tribes in, 3
IVF studies in, 462–463, 479–481
OD in, 340, 342
reproductive laws in, 524–525, 547
Reproductive Technology Accreditation Committee in, 321, 339, 340, 357
Reproductive Technology Register, 480
surrogacy in, 525
Western Australia Birth Defects Registry, 480
Australia & New Zealand Infertility Counsellors Association (ANZICA), 130, 321, 357, 528, 540, 546–547
Austria
information disclosure in, for gamete/embryo donations, 485
PCOS studies in, 42
autogenic therapy, 203
avoidance, 186
Avoidant/Dependent Personality Disorder, 109
azoospermia
in Klinefelter’s syndrome, 237
male infertility and, 28, 39, 47, 48
from Y-microdeletions, 273–287
Baby M., 522
BAI. See Beck Anxiety Inventory
Bangladesh, infertility treatment options in, 74
barren females, 3
basal body temperature. See BBT
Batak tribe, 3
BBT (basal body temperature)
menstruation and, 21
ovulation and, 26
BDI. See Beck Depression Inventory
Beck Anxiety Inventory (BAI), 454
Beck Depression Inventory (BDI), 92, 98, 178
in group counseling, 159
for OD, 324
Beckwith-Wiedeman syndrome (BWS), from ART, 481
behavioral medicine. See also biopsychosocial model
biopsychosocial model for, 174
cognition in, 175
focus areas for, 169
health-based, 187–191
Internet resources for, 593–594
Belgium, OD in, 324
Beratungsnetzwerk Kinderwunsch Deutschland (BKiD), 548
bereavement theory, 293–294
See also grief
ART and, 295
medical history and, 295
pregnancy loss history and, 295
psychological assessment under, 295
BFS (British Fertility Society), 528, 546
BICA. See British Infertility Counseling Association
biochemical/nuchal translucency screen, 278
bioethics, 509
American Society for Reproductive Medicine and, 509
for ART, 509–510
autonomy as part of, 512–517, 518
beneficence as part of, 512
committees, 511–512
European Society of Human Reproduction and Embryology guidelines, 509
future applications of, 518
IRBs and, 511
justice under, 512
literature on, 510–511
non-maleficence as part of, 512
for PHSP, 514–515
principles of, 512
biologically-based therapies, 201, 203–205
ephedra, 203
for female infertility, 204–205
Isoflavones, 205
for male infertility, 205
phytoestrogens, 204
Pychnogenol, 205
St. John’s Wort, 205
vitamin supplements, 204
Vitex, 204
biopsychosocial medicine, genetic counseling and, 264
biopsychosocial model (of infertility), 174, 175, 177–178
complementary and alternative medicine as part of, 199
crisis in, 175
DI and, 309
biotechnology, reproductive laws for, 522–523
bipolar disorders
clomiphene citrate and, in females, 101
from infertility, 99
in postpartum period, 106
valproic acid for, 106
birth control
in China, 215
depression symptoms, 102
development of, 215
under Islam, 215
oral, 102, 109–114
birth defects, from ART, 482
birth parents, during adoption, 402–403
BKiD. See Beratungsnetzwerk Kinderwunsch Deutschland
BMI (body mass index), 189
underweight, 189
WHO measurements for, 189
Borderline Personality Disorder, 107–108
boundary issues as part of, 108
sexual abuse as factor in, 108–116
Boulder model, of infertility counseling, 120
breast cancer
chemotherapy for, 241
female infertility from, 241–242
hormonal therapies for, 242
infertility counseling after, 251
IVF and, 241
oocyte cryopreservation and, 241
oopherectomy and, 241
pregnancy after, 241
British Association for Counselling and Psychotherapy Professionals, 528
British Infertility Counseling Association (BICA), 130, 505, 528, 546
under Human Fertilization and Embryo Authority, 546
bromocriptine mesylate, 101, 110
hyperprolactinemia and, 101, 105
Buddhism, 63
bulimia, 99.
See also eating disorders
burnout, compassion fatigue v., 498
BWS. See Beckwith-Wiedeman syndrome
CAH (congenital adrenal hyperplasia), 275
PCOS and, 275
CAM. See complementary and alternative medicine
Canada
Assisted Human Reproduction Act in, 524, 528, 551
Assisted Human Reproduction Agency in, 321, 339, 340, 358
Canadian Counselling Association in, 528
Canadian Infertility Counselling Association in, 551
Canadian Infertility Counsellor’s Association in, 528
complementary and alternative medicine in, 197
counselling regulation in, 528
cultural diversity in, 62
DI in, 310
ED in, 358, 359
Health Act, 524–540
healthcare privacy in, 533
infertility legislation in, 85
infertility rates in, 20
legal parentage in, 524–540
OD in, 321, 340
Personal Information Protection and Electronic Documents Act in, 533–542
Regulated Health Professionals Act in, 528
reproductive laws in, 524
Canada Health Act, 524–540
Canadian Counselling Association, 528
Canadian Fertility and Andrology Society (CFAS)
on advanced maternal age, 513
on lesbian couple counseling, 514
Canadian Infertility Counselling Association (CICA), 551
Canadian Infertility Counsellor’s Association, 528
cancers, 38, 245–246.
See also cancers, breast; cervical cancer; Hodgkin’s disease; testicular cancer
breast, 241–242
cervical, 242
crisis-intervention counseling for, 276–287
endometrial, 242
female infertility from, 50, 241–242
of female reproductive tract, 53–54, 242, 249
Hodgkin’s disease, 246, 250, 257
infertility counseling for, 54–59
male infertility from, 239
ovarian, 242
testicular, 48, 239
treatment decisions for, 276–287
urological, 245
carbamazepine, 109
Carib tribes, 9
Cartesian dualism, 170
catharsis, 160
CBAVD (congenital absence of the vas deferens), 27, 28, 47, 48, 273.
See also cystic fibrosis
CFTR and, 27, 273
sperm donation for, 273
CBT (Cognitive Behavioral Therapy), 49, 52, 107, 131, 159, 188
goals of, 134
in group counseling, 158, 164–165, 168
interactionist perspective in, 134
reciprocal determinism as part of, 134
Relaxation Response as part of, 165
CCP. See Certified Clinical Psychologist
CDC. See Center for Disease Control and Prevention
CEGRM. See Colored Ecological and Genetic Relational Map
Center for Disease Control and Prevention (CDC), 197, 523
Center for Epidemiological Studies Depression Scale. See CES-D
Center for Surrogate Parenting, 371
Certified Clinical Psychologist (CCP), 549
cervical cancer, 242
HPV and, 242
surgery for, 242
cervix, 29
CES-D (Center for Epidemiological Studies Depression Scale), 98
CFTR (cystic fibrosis transmembrane conductance regulator), 27, 273.
See also cystic fibrosis
chemotherapy, 249
for breast cancers, 241
Child Project Questionnaire, 566
childfree, 421
childless couples. See also counseling, couples; counseling, infertility; infertility, in females; infertility, in males
boundary issues for, 416
as childfree, 421
decision-making for, 421–422
emotional denial by, 421
exercises for, 421
familial relationships for, 416, 424
feminist theory and, 417–418
in object relations theory, 417
polygamy as response to, 419
pronatalism and, 422–423
psychological transitions for, 417
childlessness
across cultures, 411
aging and, for females, 415
in China, 412, 415
under Christianity, 412
cultural comparisons of, 66
distinctions within, 11
in Egypt, 415
emotional concerns about, in females, 415
family systems theory and, 416–417
grief from, 420–421
HIV/AIDS as cause of, 415
incidence rates for, 414
involuntary, 2, 61, 414–416
in Israel, 414
medical responses to, 66
National Center for Health Statistics, 414
in Nigeria, 415
paths to, 419–420
psychoanalytic theory and, 417
reproductive tourism and, 419
social psychology of, 418–419
social realignments as result of, 66
spirituality as response to, 66
stigma theory and, 418–419
throughout Africa, 415
for traditional females, 419
for transitional females, 419
Child-rearing ability and the provision of fertility services (American Society for Reproductive Medicine), 85
children, adopted
Adoption and Safe Families Act, 396
family compatibility for, 391
in The Netherlands, 392
psychosocial adjustment of, 390–391
PTSD for, 392, 409
special needs, 396–397
children, genetic, 459–460
from ART, 16–17, 363
from DI, 315
economic utility of, 460
eugenics and, 460
female investment in, 460
immortality desires and, 411, 460
as labor source, 460
last-chance-children, 467
normalcy desires for, 411
quality of life desires for, 411
religious reasons for,
social value of, 411
children, via third-party reproduction
from ART, 16–17, 363
from ED, 16, 359
from OD, 15, 16, 33, 51, 73, 84, 274, 319
parenting issues, 462–463, 464
psychosocial health of, 482–483
from S/GCs, 15, 16, 33, 34, 51, 370–371, 449–450
from sperm donors, 15, 16, 272, 341, 349–350
China
adoption in, 388
birth control in, 215
childlessness in, 412, 415
collective culture in, 69
Cultural Revolution in, 413
female infertility in, 41
international adoption from, 398
male infertility in, 40
personhood in, 291
traditional medicine in, 202
Chlamydia, 28
serology for, 53
chlamydiosis, 216–233
Christianity. See also Roman Catholic Church
ART and, 73–74
childlessness under, 412
reproduction under, 412
chromopertubation, 53
chromosomes, 260–261
female designations, 260
male designations, 260
Y-microdeletions in, 273
chronic illness
acute illness v., 247
couples counseling for, 254
development of, 247
psychosocial support for, 254
spirituality and, 254
stress management for, 254–255
support groups for, 254
chronic illness theory, 247–248
chronic stressors, 176–193
infertility as, 178
Chukchi shamans, 3
CICA. See Canadian Infertility Counselling Association
cimetidine, 240
CISS. See Coping Inventory for Stressful Situations
Civil Rights Act, 531–542
civil rights, in United States, 64
classical conditioning, 200
clinical practices, counseling, 502–503, 505–507
alternative services as part of, 503
Beck Anxiety Inventory for, 454
Beck Depression Inventory for, 504
collaboration within, 503
consultants in, 500
CPT for, 502, 507
ethics committees in, 515–517
expertise in, 504
Fertility Problem Inventory for, 147–148, 504, 565
independent, 499–500
management of, 502–503
multidisciplinary approach to, 504
patient assessment as part of, 503
PRIME-MD Brief PHQ for, 504
referrals as part of, 505
screening instruments for, 504
clinical practices, medical, infertility counselors as part of, 500–501
clomiphene citrate
bipolar disorder and, in females, 101
FSH and, 100
Gn-RH and, 100–101
LH and, 100
menopausal symptoms from, 100
PDD and, 100
premenstrual syndrome and, 100
psychosis as side effect, 101
cognitions, 175, 178
cognitive therapy, 184–185
cognitive-phenomenological stress theory, 176
infertility, 185
Social Cognition Theory, 199
Cognitive Adaptation Model, for infertility treatments, 434
Cognitive Behavioral Therapy. See CBT
cognitive therapy, 184–185
principles of, 184–185
cognitive-behavioral treatments, 15
cognitive-phenomenological stress theory, 176
Collaborative Reproductive Healthcare Model, 495–497
Six Phase of Infertility Treatment Model as part of, 496–497
Ten-step Circular Process Model as part of, 495–496
collective therapy, 157
collectivism
in Chinese culture, 69
cultures and, 68
emotional expression and, 78
in Indian culture, 69
infertility-specific distress from, 70
marriage under, 71
Colored Ecological and Genetic Relational Map (CEGRM), 262
commercial surrogacy, 373
Commonwealth Family Law Act, 525
COMPI (Copenhagen Multicentre Psychosocial Infertility), 179
complementary and alternative medicine (CAM), 15, 174, 175, 177–178, 196, 202–203
in Australia, 197, 199, 209
biologically-based therapies, 201, 203–205
in biopsychosocial theory, 199
in Canada, 197
caregiver communication as part of, 207–208
Clear Passage Therapies, 206
culture as factor for, 206
energy/biofield therapies, 201, 206
Expectancy Theory and, 199
5 categories of, 201–202
in Germany, 197
in Great Britain, 196, 197
homeopathy, 203
in Iceland, 198
infertility counselors and, 208
in integrated medicine, 196
Internet resources for, 594
in Japan, 197–198
manipulative/body-based methods, 201
mind-body programs, 201, 203
mind-body programs as part of, 201, 203
National Center for Complimentary and Alternative Medicine, 196
in Pakistan, 198
patient motivation’s towards, 206–207
placebo effects and, 199, 200
sexual counseling as part of, 15
traditional Chinese medicine, 202
treatment efficacy for, 207
in United States, 196, 197, 198–199
complex adoption theory, 11, 395
ED and, 360–361
ethnographic theory as part of, 395
Comprehensive Psychosocial History for Infertility. See CPHI
confidentiality forms, in contractual surrogacy, 374
conflict management
acceptance promotion as part of, 149–150
communication in, 150–151
in couples counseling, 149–151
for females, 150
for males, 151
resolution as part of, 151–152
conflict-of-interest waivers, 374
congenital absence of the vas deferens. See CBAVD
congenital adrenal hyperplasia. See CAH
contractual surrogacy, 370, 374
confidentiality forms as part of, 374
conflict-of-interest waivers as part of, 374
documents for, 374
informed consent for, 374
retainers, 374
Copenhagen Multicentre Psychosocial Infertility. See COMPI
Coping Inventory for Stressful Situations (CISS), 179
Coping Scale for Infertile Couples, 567
coping strategies, 185–187, 188
adaptive, 176
appraisal-focused, 176, 186–193
avoidance as, 186
COMPI, 179
Coping Inventory for Stressful Situations, 179
by culture, 71–73
emotion-focused, 176, 186
group counseling and, 164
hypervigilant, 453
for infertile females, 172
for infertile males, 172
in infertility counseling, 119
maladaptive, 176, 186–187
for post-infertility pregnancy, 452–454
problem-focused, 176, 186
in stress and coping theory, 174, 176, 179–180
Ways of Coping Checklist, 178, 179
cortisol secretions, 184
counseling. See clinical practices, counseling; counseling, couples; counseling, genetic; counseling, grief; counseling, group; counseling, infertility; counseling, multicultural; counseling, sexual
counseling, couples, 15, 148–149.
See also conflict management; psychological evaluations; psychological tests
for chronic illness sufferers, 254
conflict management as part of, 149–151
Coping Scale for Infertile Couples in, 567
deconstruction in, 152
Dyadic Adjustment Scale for, 147
effectiveness of, 145–146
Fertility Problem Inventory in, 147–148
gender differences in, 149
goals of, 148
history of, 143–144
infertility treatment parameters in, 23, 26
after infertility treatment withdrawal, 435–437
interventions for, 45–46
legal history as factor in, 89
Marital Adjustment Scale and, 147
MSI for, 147
participant assessment in, 146, 147
PGD in, 276–277
psychological evaluations as part of, 83–85, 88
psychological services as part of, 84
reasonable welfare principle in, 147
reconstruction in, 152–153
relationship history in, 89
ritual development from, 153
social support outside of, 89
spoiled identity in, 152
stage theories and, 144
welfare of the child as goal of, 147
counseling, genetic, 13, 261–262, 264, 265–267.
See also counseling, preconception; counselors, genetic
ART and, 268, 269
biopsychosocial medicine approach to, 264
client-centered, 263
collaborative treatment approach to, 264
communication approach to, 263
family pedigree assessment for, 262
family systems theory and, 264
gender responses to, 266
Internet resources for, 594
non-directive, 263
preconception, 269–272
psychological aspects of, 265, 269
psychotherapy v., 263
reproductive, 272–277
requirements for, 261
counseling, grief, 137
counseling, group, 15, 156
altruism as part of, 160
Beck Depression Inventory in, 159
behaviorally oriented, 103
catharsis in, 160
CBT in, 158, 164–165, 168
cognitive restructuring from, 157
collective therapy as, 157
confidentiality as part of, 162
coping strategies and, 164
curative factors of, 159
decision-making as part of, 164
diagnostic conditions and, 157–158
emotive-interactional, 165
encounter groups and, 157
gender differences within, 163–164
grief therapies under, 163
history of, 156–157
imitative behaviors within, 160
for infertility, 405
Internet groups, 166
interpersonal learning from, 160
loss of control in, 163
for medical staff, 166
membership in, 162
pregnancy during, 159, 164
psycho-educational, 165
social cohesion within, 160
socialization development in, 160, 164
stages of, 162–163
structure of, 161–162
support groups v., 161
technology-mediated, 166
themes within, 163
Transcendental Meditation as, 157
treatment teams in, 164
universality of, 160
weight loss under, 158
counseling, infertility, 2, 5, 55, 493, 527.
See also Collaborative Reproductive Healthcare Model; counseling, couples; counseling, group; counseling, multicultural; counselors, infertility; psychological evaluations
abnormality issues as part of, 252–253
access to, 554
adoption as part of, 390, 401–402, 407
for advanced maternal age, 513–514
American Society for Reproductive Medicine guidelines, 527
for ART, 129, 486
ART’s influence on, 494
behavioral medicines in, 15
Boulder model for, 120
after breast cancer, 251
British Infertility Counseling Association guidelines, 505
Canadian regulation of, 528
for cancer, 54–59
children’s welfare as factor in, 553
clinical issues within, 126
cognitive-behavioral treatments for, 15
Collaborative Reproductive Healthcare Model for, 495–497
common factors within, 121
compassion fatigue v. burnout in, 498
competency in, 14
complementary and alternative medical approaches to, 15
coping strategies as part of, 119
counter-transference in, 253–254, 497
for couples, 15, 23, 26
CPHI, 88, 125, 178, 563
crisis intervention therapy in, 15
cultural resistance to, 75
culturally-sensitive, 12
denial of treatment, 405
for DI, 310–312
after diabetes diagnosis, 251
for endometriosis, 52
ethics literature for, 511
European Society of Human Reproduction and Embryology guidelines, 24
family therapies in, 15
fear as factor in, 405
for gamete donations, 341
for gay males, 506, 514
genetic counseling as part of, 13
goals of, 13, 119
grief and, 15
gynecologists as part of, 23
history of, 129, 493–494
after HIV diagnosis, 251
hostility in, 180–181
Human Fertilization and Embryo Authority guidelines, 15
after hypertension diagnosis, 251
implication/decision-making therapies as part of, 15
independent clinical practice for, 499–500
for individuals, 15
Infertility Counseling Award, 505, 528
initial visits for, 24, 25
integrationist approach to, 121
International Infertility Counseling Organization, 14
intervention-focused, 120–121
legislation for, 5
with limited life expectancy, 252
literature about, 494
medical examinations as part of, 25
medical issues for, 12–13, 252
medical organizations and, 5
medical staff collaboration with, 498
mind-body programs for, 120
models for, 11, 12
mortality issues as part of, 252
multicultural, 63, 65, 66, 67, 77–78
multi-modal approach to, 123
National Association of Social Workers guidelines, 527
for OD, 333
patient collaboration as part of, 497–498
PGD during, 22, 35
for physicians, 436, 441
for post-infertility pregnancy, 16, 17, 451–452, 454–455
post-treatment, 435, 441
practice issues for, 13–14
with pre-existing illnesses, 513
pregnancy loss and, 13
psychodynamic therapy in, 15, 133–134
psycho-education in, 181–183
in psychological consequences theory, 7
Psychological Special Interest Group guidelines, 322
psychometric testing as part of, 552–553
psychosocial assessment during, 14
psychotherapy v., 132–133
RCTs and, 120, 123
relaxation training as part of, 119
religion as factor in, 78
reproductive health psychology as, 169
sexual counseling as part of, 15, 119, 230
for S/GCs, 449
shame and, 405
S-P model for, 120, 122–123
standards of care for, 505–506
strategic/solution-focused brief therapies in, 15
stratification of services, 2, 8, 18, 215
study parameters for, 118
tasks as part of, 501, 502
teams for, 23–24
testicular cancer and, 48, 249
transference in, 497
treatment options from, 14
urologists as part of, 23–24, 27
counseling, multicultural, 77–78
dimensions of, 65
for reproductive tourism, 63
sensitivity as part of, 66, 67
in United States, 65
counseling, preconception, 269–272
age as factor in, 270–271
family history assessment during, 270
counseling, sexual, 15
anxiety-reduction techniques in, 228
complementary and alternative medicine and, 15
directed masturbation in, 228
imagery techniques in, 228
within infertility counseling, 15, 119, 230
Internet resources for, 594
orgasmic reconditioning in, 228
P-LI-SS-IT model of, 228
sensate-focus techniques in, 229
counselors, genetic, 258
American Board of Genetic Counseling, 261
American Society for Reproductive Medicine, 85, 129, 146, 261
in Australia, 261
education programs for, 261
European Society of Human Reproduction and Embryology, 85, 130, 146, 261
Genetic Counseling Special Interest Groups, 261
Human Genetics Society of Australia, 261
International Society of Nurses in Genetics, 261
National Board of Medical Genetics, 261
PGD by, 259
counselors, infertility, 2, 4, 5, 67, 75–76, 83
advocacy organizations for, 499
in Australia, accreditation for, 528–529, 554–555
Canadian Infertility Counsellor’s Association, 528
client identification for, 530
colleague collaboration during, 498–499, 506
compassion fatigue for, 498
competency guidelines for, 529–530
complementary and alternative medicine and, 208
confidentiality and, 532–533
conflicts of interest for, 530–532
counter-transference/transference for, 137–138
cross-cultural competency among, 66, 67
electronic tools for, 122
ethics for, 13
European Society of Human Reproduction and Embryology guidelines, 527
during gamete donation, 347–348, 355
in Great Britain, accreditation for, 528, 554–555
as independent consultants, 500
on information disclosure, 487–488
informed consent guidelines for, 530
international guidelines for, 528, 552
lawsuit avoidance by, 533–534
legal issues, 13
as medical practice employee, 500–501
Mental Health Professional Group qualification guidelines for, 559
outcome assessment by, 124, 552
patient education by, 254
during post-infertility parenthood, 470–473
practice evaluation by, 123–124
qualification guidelines for, 527
Regulated Health Professionals Act for, 528
research collaboration by, 124–125
self-disclosure for, 138
sexual dysfunction and, 231–232
study research for, 122, 506
3 types of, 66–67
training of, 554
treatment modalities for, 14–15
counter-transference, 137–138
counselor self-disclosure and, 138
in infertility counseling, 253–254, 497
couples counseling. See counseling, couples
couvade experience, 440
CPHI (Comprehensive Psychosocial History for Infertility), 88, 125, 178, 563
for OD, 334
sexual dysfunction and, 219
surrogacy and, 381
CPT (Current Procedural Terminology), 502, 507
crisis intervention therapy, 15, 136–137
for cancer, 248
crises within the crisis in, 136
goals of, 136
phases of, 136
cryopreservation
for American Society for Reproductive Medicine, 249
of embryos, 356, 385
hepatitis and, 341
HIV and, 341
Hodgkin’s disease and, 245
of oocytes, 22, 53–54, 59, 241–256, 336, 342, 353
of ovarian tissue, 249
of sperm, 239, 341
testicular cancer and, 239, 245
cultures. See also multiculturalism
allocentric, 69
childlessness across, 411
collectivist, 68
coping strategies by, 71–73
definition of, 61–62
diversity of, immigration’s effect on, 62, 79
emic, 68
etic, 68
family roles within, 70–71
genograms for, 77
as identity, in Canada, 62
as identity, in United States, 62
idiocentric, 69
individualist, 68
infertility counseling within, 75
infertility response within, 1, 70
international adoption issues between, 399
personhood within, 291
psychology and, 68–70
stress factors as part of, 172
surrogacy and, differences between, 382
Current Procedural Terminology. See CPT
CVS (chorionic villi sampling), 279–280, 293, 451
cystic fibrosis
Australian study on, 246
genital, 273
male infertility from, 239–240
psychosocial issues from, 246
Scotland study on, 246
Wolffian duct derivatives in, 239
cystic fibrosis transmembrane conductance regulator. See CFTR
cysts, ovarian, from hyperstimulation syndrome, 30
DAS. See Dyadic Adjustment Scale
Data Protection Act, 533
D&C (dilatation and curettage), 32
deconstruction, in couples counseling, 152
denial of treatment, 311, 335, 501–502
Ethics Committee of the American Society for Reproductive Medicine guidelines, 311
factors for, 146, 459
medical ethics for, 517
Denmark, infertility rates in, 20
deoxyribonucleic acid. See DNA
depression
CES-D, 98
Gn-RH influence on, 101
HPA role in, 106
from infertility, 98–99
from IVF, 38
from LH, 106
from oral birth control, 102
during post-infertility pregnancy, 445, 454
postpartum, sources of, 106
PPD, 445
from pregnancy loss, 299–300
rapid relapse, 103
DES (diethylstilbestrol)
male infertility from, 39
uterine effects from, 29, 32
Dhammapada, 73
DI (donor insemination), 47, 49
adoption v., 306–307, 314
in Africa, 306
American Society for Reproductive Medicine recommendations for, 306, 313
in Australia, 306
biopsychosocial model for, 309
in Canada, 310
children from, 315
counseling for, 310–312
donor choice as part of, 311–318
European Study of Assisted Reproduction Families, 307
European Union documentation for, 306
family systems theory and, 309
future applications for, 315
in Germany, 306, 308
in Great Britain, 305–308, 316, 484
ICSI v., 315
identity theory and, 309–310
information disclosure for, 307–309
international legislation for, 305
for lesbian couples, 307
masturbation and, 306
morality of, 306
in New Zealand, 306, 310
pregnancy from, 314–315
psycho-educational group counseling for, 165
psychological evaluations for, 84, 85
psychological indications for, 313
reproductive tourism and, 314
research on, 306–307
stigma from, for males, 47
stigma theory and, 310
in Sweden, 306, 342
in Switzerland, 306
treatment termination of, 314
in United States, 305
diabetes
female infertility and, impact on, 243
infertility counseling after, 251
male infertility and, impact on, 240
obesity and, 243
pregnancy and, 243
retrograde ejaculation and, 240
diethylstilbestrol. See DES
dilatation and curettage, 32
discipline, for post-infertility parents, 471–472
diseases. See cancers; chronic illness; Hodgkin’s disease; Klinefelter’s syndrome; PCOS; PID; POF; Rokitansky-Küster-Hauser syndrome; STIs; tubal diseases; Turner’s syndrome
DNA (deoxyribonucleic acid), in genetics, 260
domestic adoption, 389, 395–397
identified, 398
independent, 397–398
placement rules for, 396
special needs children in, 396–397
donations (gamete/embryo). See also DI; donors, embryo; donors, gamete; ED; OD; sperm donors
American Society for Reproductive Medicine guidelines, 347, 514
anonymous v. known, 339, 344, 468
in Austria, 485
backups for, 48
donor-linking, 342
emotional consequences of, 16
exchange reinforcement theory and, 346
future applications for, 353
gender differences and, 347
genetic screening for, 283–284
HGC on, 283
Human Fertilization and Embryo Authority guidelines, 357
in Iceland, 485
infertility counseling for, 341
infertility counselors during, 347–348, 355
International Federation of Fertility Societies on, 340
international guidelines for, 283–284, 514
limits for, in Great Britain, 343
organ donations v., 346
Psychological Special Interest Group guidelines, 340
registry for, in Australia, 321, 357, 468
secrecy of, 450
sperm, 15, 16, 272
in Sweden, 485
third-party reproduction from, 449, 450
UNESCO on, 283
in United States, 485
WHO on, 283
donor backups, 48
donor insemination. See DI
Donor Registry (Australia), 321, 357, 468
donors, embryo, 351, 356–357, 365, 366
anonymous v. known, 362, 363
consent forms for, 586
legal issues for, 366–369
preparation for, 361–362
psychological guidelines for, 572–573
donors, gamete. See also OD; sperm donors
anonymity for, 319, 323–324, 330–331, 344, 348
commercial recruitment of, 319–320, 343
compensation for, 343
counseling for, 344–345, 352–353
genetic testing for, 352
interviews for, 351–352
known v. anonymous, 339, 344
medical follow-up for, 345–346
motivations for, 352
oocyte, 350
partners of, 350–351
protections for, 348
psychological interviews for, 348–351, 352
psychosocial assessment for, 347
psychosocial status of, 343
recipient matches with, 348
sperm, 15, 16, 272, 341, 349–350
tracking for, 351
donors, oocytes, 350
anonymous, guidelines for, 569–570
clinical interviews for, 350
known, guidelines for, 559, 569, 570
Down syndrome, 278, 279
prenatal genetic testing for, 278, 279–288
risks of, by maternal age, 271
drugs. See infertility medications; psychomedications
Dyadic Adjustment Scale (DAS), 147
dyspareunia, 224
treatments for, 224
Eating Attitudes Test, 99
eating disorders, 99
anorexia nervosa, 99
bulimia, 99
Eating Attitudes Test, 99
physical effects of, 99
during post-infertility pregnancy, 446
EBM (evidence-based medicine), in S-P model, 122–123
ectopic pregnancy, 290
ED (embryo donation), 16, 359.
See also donors, embryo; embryos
American Society for Reproductive Medicine guidelines, 357
under Assisted Human Reproduction Act, 537
Assisted Human Reproduction Agency guidelines, 358
in Australia, 357–358
in Canada, 358, 359
complex adoption theory and, 360–361
counselor bias during, 364–365
donor preparation, 361–362
embryo adoption v., 358
European Society of Human Reproduction and Embryology guidelines, 340, 357–369
extra embryos from, 356
in Finland, 359
future applications for, 367–368
in Great Britain, 359–360
grief and loss theories and, 362
information disclosure issues for, 363–364, 367
international regulation of, 356, 357, 358
Internet resources for, 595
for lesbian couples, 357, 368
medical reasons for, 357, 368
Mental Health Professional Group guidelines, 358
in New Zealand, 358, 363
pregnancies from, 356
prenatal genetic screening for, 284
psychological evaluations for, 84, 85
psychosocial evaluations as part, 362–363, 366–367
recipient consent forms for, 589
recipient counseling during, 365–366, 572, 573
reproductive laws for, 536–537
reproductive tourism and, 357
RESOLVE and, 360, 366
social-exchange theory and, 360
therapeutic interventions for, 365
United States agencies, 364
WHO guidelines, 363
Edinburgh Postpartum Depression Scale, 454–458
Egypt
childlessness in, 415
infertile women in, 70–71
elderly gravida. See advanced maternal age
elective abortion, 290.
See also MPR; pregnancy termination
electroacupuncture, 202
embryo donation. See ED
embryo donors. See donors, embryo
embryo transfer, blastocyst transfers, 33
embryologists, in infertility counseling, 24
embryos
cryopreservation of, 356, 385
ED, 16, 84
extra, 356
lost, 537–538
transfers of, in IVF, 33, 74
EMDR (eye movement desensitization and reprocessing), 54
Emic cultures, 68
encounter groups, 157
endometrial cancer, 242
endometrial polyps, 28
endometriosis, 46, 52, 246–247
Australian study, 246
counseling, for infertile women, 52
Endometriosis Association, 158
female infertility from, 31, 50, 242–243
Great Britain study, 247
infertility medications and, 31
male partner response to, 46
medical treatments for, 31, 243, 250
psychological effects of, 42
surgery for, 243
therapy for, 243
Endometriosis Association, 158
Endometriosis Health Profile-30, 567
endometrium
endometriosis, 46, 52
during ovulation, 26
β endorphins, 202–209
energy/biofield therapies, 201, 206
reflexology, 206
ephedra, 203
erectile dysfunction, 219, 225–226
male infertility and, 46, 225
medical treatments for, 226
primary, 225
psychological treatments for, 226
secondary, 225
ESHRE. See European Society of Human Reproduction and Embryology
estrogens, 100.
See also antiestrogens
anxiety increase from, 100
mood improvement from, 100
phytoestrogens, 204
serotonin availability increase from, 100
ethics. See also bioethics; medical ethics
in medicine, 508
ethics committees
for American Society for Reproductive Medicine, 509
components of, 516
in infertility counseling practices, 515–517
IRBs v., 511–512
ethnic cleansing, 260
ethnicity
genetic disorders by, 271, 272
OD and, 329
ethnographic theory, 395
Etic cultures, 68
eugenics, 259
in Australia, 259
children and, 460
Eugenics Society of Great Britain, 259
in Germany, 259
negative, 259–260
positive, 260
in United States, 259
Eugenics Society of Great Britain, 259
EuroAdopt program, 400
European Society of Human Reproduction and Embryology (ESHRE), 85, 130, 146, 261, 339, 547–548
on advance maternal age, 513
bioethics guidelines, 509
ED guidelines, 357–369
genetic testing guidelines, 351–355
on lesbian couples, 514
OD guidelines, 322, 340–341
PCSG of, 527
PCSIG of, 340, 358
on PGD, 277
Psychological Special Interest Group of, 322
surrogacy guidelines, 377
Task Force on Law and Ethics, 510
Ten-step Circular Process Model and, 496
European Study of Assisted Reproduction Families, 307
European Union (EU). See also Austria; Belgium; Denmark; Finland; France; Germany; Great Britain; Greece; Italy; The Netherlands; Scotland; Sweden; Switzerland
DI documentation within, 306
European Society of Human Reproduction and Embryology, 85, 130
European Union Tissue ands Cells Directive, 321, 339
immigration to (2001), 62
IVF studies in, 463
obesity rates in, 189
third-party reproduction studies, 463–464
European Union Tissue ands Cells Directive, 321, 339
OD guidelines, 357
evidence-based medicine. See EBM
examinations, medical. See also gynecology
infertility counseling and, 25
exchange reinforcement theory
altruism and, 346
gamete donations and, 346
Expectancy theory, 200–201
complementary and alternative medicine and, 199
placebo effects and, 200–201
eye movement desensitization and reprocessing. See EMDR
Eysenck Personality Inventory, 99
failure, female infertility as, 41
faith. See spirituality
faith-healing, for infertility, 74
fallopian tubes
evaluation of, 21, 28–29
HSG for, 21, 28
surgical procedures for, 30
false positives, for pregnancies, 278
family systems theory, 10–11, 43, 552
adoption and, 394–395
ART and, 486
boundary issues, 11, 326–327
childlessness and, 416–417
complex adoption as part of, 11
couples developmental stages in, 12
DI and, 309
genetic counseling and, 264
genograms in, 327
insistence of difference under, 394–409
life stage model in, 10, 416
OD and, 326–327
family therapies, in infertility counseling, 15
fatherhood, 38, 132
infertility theories and, by gender, 43
Internet resources on, 596
as secondary focus, 45
Federal Privacy Act, 533–542
female circumcision, in Africa, 214, 413
female sexual dysfunction. See sexual dysfunction, in females
females. See also infertility, in females; motherhood; sexual dysfunction, in females
advanced maternal age for, 270–271
in Africa, sexual expression of, 214–215
ambitious, 7
in ancient Greece, 213
anorgasmia in, 216
barren, 3
childlessness fears in, 415
children as investment for, 460
circumcision of, in Africa, 214
conflict management for, 150
fallopian tube evaluation for, 21, 28–29
fertility rites for, African, 3
Freudian infertility theories for, 43–44
human sexual response in, 218
identity formation for, under object relations theory, 417
infertility and, social treatment of, 3
marianismo, 412
medical consultation parameters for, 23
MRKH in, 158
penis envy for, 417
premature ovarian failure in, 26
in psychogenic infertility theory, 7
sexual dysfunction in, 222–224
sexual expression for, 215
support groups for, 119
tobacco usage by, 190–195
traditional, 419
umazume, 3
uterus evaluation in, 28–29
zina for, 214
feminist theory
childless couples and, 417–418
motherhood in, 325, 414
object-relations theory and, 325
OD and, 324–325
FertiForum, 549–550
under Swiss Society for Reproductive Health, 550
fertility
advance paternal age and, 271
African rites, female, 3, 74
dietary modification for, 204–205
Fertility Problem Inventory, 147–148
FSH testing for, in females, 26, 50
FSH testing for, in males, 28
historical overview for, 3–4
subfertility, 106
symbols for, 1–2
WHO definition of, 414
Fertility Adjustment Scale, 566
Fertility Clinic Success Rate and Certification Act, 522
Fertility Problem Inventory (FPI), 147–148, 504, 565
Fertility Problem Stress Inventory, 565
fertility rites, in Africa, 3, 74
Fertility Society of Australia, 340
FertiQol, 567
fetoscopy, 451
fight or flight, 171
fimbrioplasty, 53
Finland, ED in, 359
FISH (flourescent in situ hybridization), 276
FLASEF. See Latin American Federation of Fertility and Sterility Services
flourescent in situ hybridization. See FISH
Fluoxetine, 104, 105
follicle-stimulating hormone. See FSH
Food and Drug Administration (FDA), 523
GGTP-HCT/P under, 523
forgotten mourners, 8
FPI. See Fertility Problem Inventory
Fragile X syndrome, 42
female infertility from, 275
France
IVF in, 479
National Institute for Health and Medical Research in, 479
OD in, 321, 340
freezing. See cryopreservation
Freudian theories, 43–44, 324–325
female factor, 43–44
infertility and, 43
male factor, 43
OD and, 324–325
FSH (follicle-stimulating hormone)
clomiphene citrate and, 100
in female fertility testing, 26, 50
male infertility and, 28, 32
GABA (γ-aminobutyric acid), 100
galactorrhea, 105
Gamblers Anonymous, 49
gamete donors. See donors, gamete
gay male couples
cultural beliefs about, 376
infertility counseling for, 506, 514
Internet resources for, 596
parenthood for, 469–470
surrogacy for, 375–376, 478
gender. See also females; males
conflict management by, 150
couples counseling and, 149
gamete donations and, 347
genetic counseling by, 266
grief and, 9, 292
in group counseling, 163–164
infertility theories by, 43
infertility treatment withdrawal by, 430
infertility-specific diagnoses by, 12, 46, 55
information disclosure by, 488
general adaptation syndrome, 170
genes, 259, 260
genetic children. See children, genetic
genetic counseling. See counseling, genetic
Genetic Counseling Special Interest Groups, 261
genetic counselors. See counselors, genetic
genetic disorders
from advanced maternal age, 270–271
advanced paternal age and, 271
CAH, 275
CBAVD, 27, 28, 47, 48, 273
Down syndrome, 271, 278, 279
emotional responses to, 267–268
by ethnicity, 271, 272
family issues and, 267
female chromosomal abnormalities, 274–275
female infertility from, 273–275
female syndromes, 275
Fragile X syndrome, 42, 275
Kartagener syndrome, 273
Klinefelter’s syndrome, 272
male chromosomal abnormalities, 272–273
male infertility from, 272, 273
PGD for, 22, 35, 275–276
PGS for, 276
Rokitansky-Küster-Hauser syndrome, 23, 50, 51, 238, 275
syndromes, 273
Turner’s syndrome, 42, 50, 51, 274–275
XYY, in males, 281–288
Y-microdeletions, 273
genetic testing, 260, 282
American College of Medical Genetics and, 271
American College of Obstetricians and Gynecologists, 271
American Society for Reproductive Medicine guidelines, 352
CVS, 279–280, 293
European Society of Human Reproduction and Embryology guidelines, 351–355
for gamete donors, 352
HGP and, 260
international perspectives on, 262–263
for male infertility, 28
PGD as part of, 22, 35, 275–276
prenatal, 277–283
genetics, 259.
See also counseling, genetic; counselors, genetic; genetic disorders; genetic testing
chromosomes, 260–261
DNA in, 260
genes, 259, 260
genotypes, 259
HGP and, 260
Law of Dominance in, 259
Law of Independent Assortment in, 259
Law of Segregation in, 259
modern, 259–260
negative eugenics, 259–260
positive eugenics, 260
genital herpes, 216
genograms
cultural, 77
in family systems theory, 327
genotypes, 259
Germany
ART in, cultural attitudes towards, 72
BKiD in, 548
complementary and alternative medicine in, 197
DI in, 306, 308
eugenics in, 259
idiopathic infertility in, 131
male infertility study in, 40
solution-focused psychotherapy in, 136
gestational carriers. See S/GCs
GGTP-HCT/P (Current Good Tissue Practice for Human Cells, Tissues, and Cellular and Tissue-Based Products), 523
GLASMI. See Grupo Latinoamericano de Interes en Salud Mental en Infertilidad
Glutathione, 205
Gn-RH (gonadotropin-releasing hormone), 31, 32, 101–102
acupuncture’s influence on, 202
clomiphene citrate and, 100–101
cognitive changes from, 102
depression symptoms from, 101
hypoestrogenism from, 101
IVF and, 101
Lupron, 101
Triptorelin, 101, 102
gonadotropins, 30
Gn-Rh, 31
hGC, 31
human menopausal, 101, 102
neurotropic effects of, 100
gonorrhea, 216
Great Britain
BFS in, 528, 546
British Association for Counselling and Psychotherapy Professionals in, 528
British Infertility Counseling Association, 130, 505, 528, 546
complementary and alternative medicine in, 196, 197, 198
counselor accreditation in, 528
Data Protection Act in, 533
DI in, 305–308, 316, 484
donation limits in, 343
ED in, 359–360
endometriosis study, 247
Eugenics Society of Great Britain, 259
healthcare privacy in, 533
Human Fertilization and Embryo Authority in, 85–95, 339–340, 350, 485, 509, 522, 523, 528
Human Rights Act in, 533
IVF in, 258, 478–479
IVF in, female attitudes towards, 67
male infertility in, 39
Medical Research Council in, 478
OD in, 323–324, 357
Project Group on Assisted Reproduction in, 546
reproductive laws in, 523–524
Voluntary Licensing Authority in, 478
Greece
ART in, 73
children from ART in, psychosocial health of, 482
female infertility in, 42
homosexuality in, 213
male infertility in, 40
motherhood as cultural symbol in, 72–73
reproduction in, historical female role in, 213
reproduction’s role in (ancient Greece), 411–413
grief. See also attachment and loss theory; grief therapy; pathological grief; perinatal grief
anticipatory mourning and, 132
from childlessness, 420–421
chronic infertility-specific models of, 9
definition of, 293
disenfranchised, 9, 420
forgotten mourners, 8
gender differences in, 9, 292
gestational age of pregnancy and, 292
in infertile females, 41
infertility theories and, 8–9
keening syndrome and, 8
normal, 98–112
pathological, 98, 292
perinatal, 294–296
from pregnancy loss, 291–292
in psychopathology, 98
shadow, 295
stages of, in psychological consequences theory, 7
grief and loss theory, 45.
See also attachment and loss theory
ED and, 362
grief counseling. See counseling, grief
grief therapy, 15
during adoption, 405
anger resolution as part of, 405
goals of, 299–300
in group counseling, 163
guilt resolution as part of, 405
in infertility counseling, 15
memory boxes in, 299
patient assessment during, 297–298
for pregnancy loss, 291, 296, 297–299, 300
group counseling. See counseling, group
Grupo Latinoamericano de Interes en Salud Mental en Infertilidad (GLASMI), 550–551
goals of, 550–551
Latin American Federation of Fertility and Sterility Services and, 550
Guatemala, international adoption from, 398
Guizhi-Fuling-Wan, 202
Guyin decoction, 202
gynecologists. See also reproductive endocrinologists
in infertility counseling, 23
gynecology. See also cervix; fallopian tubes; ovulation; uterus
HSG, 21
hysterosalpingography in, 21–35
laparoscopy, 21
Hachimijiogan, 202
hCG (human chorionic gonadotropin), 31
health behavioral interventions, 187–191
self-efficacy beliefs and, 188
weight management, 189–190
health care, WHO on, 424
Health Council of the Netherlands, ART and, 48
Health Insurance Portability and Accountability Act (HIPAA), 532–533
medical records under, 532
Heart Rate Variability. See HRV
Heidelberg model in, 8
hepatitis, cryopreservation and, 341
heredity. See also genetics
concept of, 260, 282
HGC (Human Genetics Commission)
on gamete donations, 283
on PGD, 277
HGP (Human Genome Project), 260
genetic testing and, 260
Hinduism
fertility symbols in, 3
lingam in, 3
yoni in, 3
Hippocratic Oath, 508.
See also ethics
Histrionic Personality Disorder, 108.
See also psychopathology
HIV/AIDS (human immunodeficiency virus/Acquired Immune Deficiency Syndrome), 216, 237
under Americans with Disabilities Act, 243
ART and, 240
childlessness from, 415
cryopreservation and, 341
female infertility from, 243
infertility counseling and, 251
male infertility from, 240
during pregnancy, 243
in sperm banks, 342
Hoccheukkito, 202
Hodgkin’s disease, 246, 250, 257
CABVD treatment for, 239, 241
female infertility from, 241
male infertility from, 48, 239
MOPP treatment for, 239, 241
oocyte cryopreservation and, 241–256
sperm cryopreservation and, 245
Holocaust, as negative eugenics, 259
homeopathy, 203
homosexuality. See also gay male couples; lesbian couples
in ancient Greece, 213
hormones. See also estrogens; progesterone
adrenal, 241
estrogens, 100
female sexual dysfunction from, 222
FSH, 26, 28, 32, 50
Gn-RH, 31, 32, 101–102
Gn-Rh, 31, 32
hCG, 31
LH, 32
male infertility and, 38
male reproductive, alcohol’s effect on, 191
progesterone, 26, 100
therapies, for infertile males, 32
thyroid, 241
hot flashes, 241
HPA (hypothalmic adrenal system), 106
HPV (human papilloma virus), 216
cervical cancer and, 242
HRV (Heart Rate Variability), 104
HSG (hysterosalpingogram), 21, 28
human chorionic gonadotropin. See hCG
Human Fertilization and Embryo Authority (HFEA), 11, 85–95, 339–340, 350, 485, 509, 522, 528
British Infertility Counseling Association under, 546
Code of Practice, 118
gamete donation guidelines, 357
on lesbian couples, 514–519
OD guidelines, 321, 357–369
on PGD, 277
reproductive laws under, 523
Human Fertilization and Embryo Authority Code of Practice, 118
Human Fertilization and Embryology Act, 509
Human Genetics Commission. See HGC
Human Genetics Society of Australia, 261
Human Genome Project. See HGP
human immunodeficiency virus/Acquired Immune Deficiency Syndrome. See HIV/AIDS
human papilloma virus. See HPV
Human Reproductive Technology Act, 480
Human Rights Act, 533
human sexual response. See also sexual dysfunction; sexual expression
desire as part of, 220
infertility and,
orgasm as part of, 218
sexual expression and, 218
3 phases of, 218
in women, 218
hyperemesis gravidarum
management of, 446
during post-infertility pregnancy, 446
hyperprolactinemia, 101, 105
ovulation dysfunctions from, 101
hyperstimulation syndrome, 30
ovarian cyst formation from, 30
hypertension
calcium channel blockers and, 239
infertility counseling after, 251
treatment of, in males, 238–239
hypnosis, 203
hypoactive sexual desire disorder, 220
primary, 220
hypoestrogenism, 101
hypothalmic adrenal system. See HPA
hysterosalpingogram. See HSG
hysterosalpingography, 21–35, 53
hysteroscopy, 29, 32
ICD-9, multiculturalism under, 65
Iceland
complementary and alternative medicine in, 198
information disclosure in, for gamete/embryo donations, 485
ICSI (intracytoplasmic sperm injection), 22, 47, 48, 272, 420, 477
DI v., 315
in IVF, 32
in Sweden, for males, 39
identified adoption, 398
identity theory
adoption and, 393–394
DI and, 309–310
language acquisition as part of, 418
maternal identity in, post-infertility, 461
under object relations theory, for females, 417
idiocentrism, 69
idiopathic infertility, in Germany, 131
IFFS. See International Federation of Fertility Societies
IFIPA. See International Federation of Infertility Patient Associations
IICO. See International Infertility Counseling Organization
immigration
cultural diversity from, 62, 79
to European Union (2001), 62
to United States, (1995–2000), 62
immortality desires, reproduction as form of, 131, 411, 460
implication/decision-making therapy, 15
impotence, in males, 39
as sexual dysfunction, 219
in vitro fertilization. See IVF
independent adoption, 397–398
costs for, 397
disadvantages of, 397–398
networking for, 397
independent consultants
advantages/disadvantages for, 500
infertility counselors as, 500
India, collective culture in, 69
individual identity theory, 9
individualism
cultures and, 68
emotional expression and, 78
in United States, 69
Industrial Revolution, motherhood after, 413
infabulation. See female circumcision
infant mortality
neonatal death, 290
personhood and, 291
SIDS, 290
infertility, 20, 238.
See also childlessness; counseling, infertility; counselors, infertility; infertility theories; research, infertility; secondary infertility; stage theory; third-party reproduction
adoption after, 387
advocacy organizations for, 5
anticipatory mourning from, 132
attachment/loss and, 132
biblical references to, 37
biopsychosocial model of, 174, 175, 177–178
bipolar disorders from, 99
in Canada, 20
cancers and, 38
causes of, medical, 20, 21, 34
as chronic stressor, 178
cognitions, 185
counseling for, 2, 4, 5, 55
as crisis, 9–10
cultural responses to, 3, 70
definition of, 34
in Denmark, 20
depression from, 98–99
distress from, psychological, 4, 145
from erectile dysfunction, 219
exercise and, excessive, 25
Fertility Problem Stress Inventory for, 565
Freudian theories and, 43
gender-specific diagnoses for, 12, 46, 55
genetic causes of, 237–238
grief and, 9
group counseling for, 405
historical overview of, 20–22
holistic views on, 4–6
idiopathic, 131
Infertility Cognitions Questionnaire for, 565
Infertility Distress Scale for, 566
Infertility Problem Inventory for, 179, 565
Infertility Reaction Scale, 565
as intergenerational family developmental crisis, 10
internalization of, 9
legislation, in Canada, 85
maternal identity after, 461
in media, 37–38
medical solutions to, 4, 7–19
medicalization of, 2, 145
medications for, 99–102
multidimensional questionnaires about, 565
in Nigeria, 20, 415
obesity as risk factor for, 189, 243–244
parenthood after, 459, 461–462, 465–466, 474
PCOS and, 38
personality disorders and, 99, 107–109, 111
personality tests and, 93
personality types and, 109, 140
POF and, 38
polygamy as solution to, 1, 42
pre-existing psychiatric disorders and, 84
primary, 2, 20
psychogenic, 6–7, 130, 170, 171, 216
psychological reactions to, 171–172, 471
psychopathology and, 98–99
psychosocial interventions for, 5, 6, 173–174
rates, worldwide, 37, 415
religion and, 67–68, 73–75
research on, 5
rituals, 442
Rokitansky-Küster-Hauser syndrome and, 23, 50, 51
in Scotland, 20
secondary, 2, 20
self models and, integration of, 9
sexual dysfunction and, in couples, 213–217, 233, 235
sexual dysfunction as cause of, 219–220
STDs as cause of, 216
as stigma, 10, 39
stress and coping theory and, 179–180
in Sweden, 20
theories, by gender, 43
third-party reproduction and, 15–16
tobacco usage and, 25
as transformational process, 10
treatment goals, 83
unidimensional questionnaires about, 565–566
in United States, 20
from vaginismus, 219
worldwide rates for, 1
Infertility (Medical Procedures) Act, 524
infertility belt, 2–17
Infertility Cognitions Questionnaire, 565
infertility counseling. See counseling, infertility
Infertility Counseling Award, 505, 528
infertility counselors. See counselors, infertility
Infertility Distress Scale, 566
infertility, in females, 50–55, 240–244
in Africa, sub-Saharan, 42, 71
age as factor in, 50–51
anorexia nervosa as risk factor for, 99
biologically-based therapies for, 204–205
from CAH, 275
from cancers, 50, 241–242
cervical evaluation for, 29
in China, 41
from chromosomal abnormalities, 274–275
congenital uterine anomalies as factor for, 50
coping strategies for, 172
cortisol secretions in, 184
from diabetes, 243
in Egypt, 70–71
emotional effects from, 53–54, 55, 84
from endometriosis, 31, 50, 242–243
endometriosis as factor in, 31, 50
as failure, 41
fallopian tubal factors for, 21, 28–29, 52–53
fallopian tubal surgery and, 30
from Fragile X syndrome, 275
FSH as factor in, 26, 50
future research for, 56
genetic causes of, 273–275
in Greece, 42
grief from, 41
from HIV, 243
from Hodgkin’s disease, 241
from inflammatory bowel diseases, 244
intrusive ideation from, 53–54
in Israel, 42
IUI and, 31
in Japan, 4
in Kuwait, 42
L-arginine for, 204
in matrilineal societies, 71, 82
nitric oxide for, 204
obesity as risk factor for, 189, 246
OD and, 319
ovulation and, 26–27
PCOS and, 50
from PID, 50
from POF, 26, 38, 45, 50, 52, 240–241
psychological responses to, 41–43, 172
religion’s impact on, 67
from Rokitansky-Küster-Hauser syndrome, 238, 275
self-esteem in, 41
shame from, 46, 54
social treatment of, 3
stigma theory and, 44
stress in, 53–54, 172
tubal ligations and, 30
from Turner’s syndrome, 238, 240
uterine evaluation and, 28–29
uterine surgery and, 30–32
in Vietnam, cultural attitudes towards, 72
Vitex for, 204
infertility, in males, 22, 46–49, 50, 132
acupuncture and, 203, 211
in Africa, 40, 413
age as factor for, 47
alexithymia from, 40
azoospermia and, 28, 39, 47, 48
behavioral changes for, 47
biologically-based therapies for, 205
from cancer, 239
CBAVD, 27, 28, 47, 48, 273
CBT for, 49
CFTR and, 27
in China, 40
from chromosomal abnormalities, 48, 272–273
coping strategies for, 172
from cystic fibrosis, 239–240
from DES, 39
DI as result of, 47
from diabetes, 240
emotional response implications for, 49–50
erectile dysfunction as factor in, 46, 225
FSH as factor in, 28, 32
future research for, 55–56
genetic causes of, 272, 273
genetic testing for, 28
in Germany, 40
Glutathione for, 205
in Great Britain, 39
in Greece, 40
Guizhi-Fuling-Wan for, 202
from HIV, 240
Hoccheukkito for, 202
from Hodgkin’s disease, 48, 239
hormonal causes for, 28, 38
hormonal therapies for, 32
hypertension treatment as factor in, 238–239
ICSI for, 22, 47, 48, 272
impulse control issues and, 49
in Iran, 40
Isoflavones for, 205
IUI and, 39
Ju Jing powder for, 202
from Kartagener syndrome, 273
from Klinefelter’s syndrome, 23, 38, 47, 237–238, 272
L-carnitine for, 205
LH as factor in, 32
medical treatments for, 32
MESA for, 22, 47, 272
oligospermia and, 39, 48
from pharmaceutical use, 240
psychogenic, 7, 216
psychological responses to, 38–41, 172
Pychnogenol for, 205
quality-of-Life assessments for, 568
Selenium for, 205
semen analysis as part of, 22, 27
shame from, 49
social views on, 38
St. John’s Wort for, 205
stress from, 172, 173
in Sweden, 39–40
TESE for, 22, 32, 47, 272
testicular cancer, 48, 239
traditional Chinese medicine for, 202
varicoceles and, 28, 38
vasectomies and, 32, 39, 47–58
vitamin supplements for, 205
from Y-microdeletions, 273
Zinc for, 205
infertility medications, 99–102.
See also bromocriptine mesylate; clomiphene citrate; estrogens; Gn-RH; progesterone; psychopharmacology
antiandrogens, 30
antiestrogens, 30
bromocriptine mesylate, 101, 110
for endometriosis, 31
Gn-RH, 31, 32, 101–102
gonadotropins, 30, 100
hyperstimulation syndrome from, 30
for ovulation induction, 30
progesterone, 26, 100, 102
psychiatric effects from, 100
sperm production and, effect on, 27
USDA approval for, 30
Infertility Problem Inventory, 179, 565
Infertility Reaction Scale, 565
infertility research. See research, infertility
infertility theories, 6–8.
See also family systems theory; stigma theory
chronic grief models, 9
family systems, 10–11, 43, 552
grief, 8–9
individual identity, 9
psychogenic, 6–7, 130, 170, 171, 216
psychological consequences, 7, 171
psychological cyclical model, 7
psychological outcome approach, 7–8, 171
psychosocial context approach, 8
self-discrepancy, 9
stage, 11
stigma, 10, 43, 44, 58, 248
stress/coping, 9–10, 174, 176, 179–180
Infertility Treatment Act, 321
IVF guidelines, 357
infertility treatment providers. See counselors, infertility
infertility treatments. See also infertility medications
American Society for Reproductive Medicine on, 434
Cognitive Adaptation Model for, 434
costs as factor for, 430–431
couples counseling after, 435–437
disengagement from, 433
emotional factors in, 431–432
faith-healing as, 74
fear as factor in, 432
gender-based responses to, 430
goals of, 83
interpersonal factors in, 431
mandatory counseling after, 435, 441
maternal age as factor for, 430
optimism as factor in, 431
parity as predictor for, 430, 431–438
physician counseling after, 436, 441
physician-recommended withdrawal from, 434–435
psychological distress from, 432
sociodemographic factors for, 430, 431–438
staff-patient communications during, 435
stage theories for, 433–434
information disclosure
for adoption, 391
about ART, to children, 483–485, 487
in Austria, for gamete/embryo donations, 485
for DI, 307–309
for ED, 363–364, 367
gender as factor in, 488
in Iceland, for gamete/embryo donations, 485
from infertility counselors, 138
infertility counselors on, 487–488
international perspectives on, 485
for OD, 334
parenthood and, 488–489
in Sweden, for gamete/embryo donations, 485
about third-party reproduction, to children, 469, 472, 489, 490, 553–554
informed consent, 87, 584
for American Psychological Association, 87–95
for contractual surrogacy, 374
infertility counselors and, 530
under reproductive laws, 539–540
from S/GCs, 377
Ingarda tribe, 3
INSERM. See National Institute for Health and Medical Research
international adoption, 388, 389, 391–393, 398–399
from China, 398
costs of, 398
cultural issues for, 399
from Guatemala, 398
from Kazakhstan, 398
political instability and, 399
Protection of Children and Co-Operation in Respect of Intercountry Adoption, 389, 398
from Russia, 398
from South Korea, 398
International Federation of Fertility Societies (IFFS), 340
Fertility Society of Australia, 340
International Federation of Fertility Societies’ Surveillance Report, 339
International Federation of Infertility Patient Associations (IFIPA), 499
International Infertility Counseling Organization (IICO), 14, 130, 544, 548–549
International Premature Ovarian Failure Association (IPOFA), 250
international review boards. See IRBs
International Society of Nurses in Genetics, 261
Internet resources, 593–596
for behavioral medicine, 593–594
for children, 596
for complementary and alternative medicine, 594
for ED, 595
on fatherhood, 596
for gay couples, 596
for genetic counseling, 594
for group counseling, 166
for medical information, 593–594
for medical organizations, 593–595
on parenthood, 596
for patient organizations, 593
for post-infertility pregnancy, 596
for pregnancy loss, 594–595
for psychological organizations, 593
for sexual counseling, 594
for surrogacy, 593–595
for third-party reproduction, 595
intracytoplasmic sperm injection. See ICSI
intrauterine insemination. See IUI
intrusive ideation, from female infertility, 53–54
involuntary childlessness, 1, 61
iontophoresis, 202
IPOFA. See International Premature Ovarian Failure Association
Iran
IVF in, female attitudes towards, 67
male infertility in, 40
IRBs (international review boards)
for bioethics, 511
ethics committees v., 511–512
Irrational Parenthood Adjustment Scale for, 566
Isla de las Mujeres, 1
Islam
adoption and, 74
ART and, 74
birth control under, 215
embryo transfers and, 74
infertility as God’s will under, 72
IUI and, 74
Koran, 73, 214
male infertility under, 40
marriage under, 214
reproduction under, 412
sexual expression within, 214
third-party reproduction and, 74
Isoflavones, 205
Israel
female infertility in, 42
involuntary childlessness in, 414
National Insurance Law in, 525
OD in, 525
Public Health (In Vitro Fertilisation) Regulation, 72
Public Health (Semen Banks) Regulation, 72
reproductive laws in, 72, 525–526
Surrogacy Arrangement Act in, 525
Italy, ART in, 340
IUI (intrauterine insemination), 31, 48, 51
embryo transfers and, 74
hCG and, 31
Islam and, 74
for male infertility, 39
IVF (in vitro fertilization), 4, 22, 23–35, 48, 51, 55, 143, 274, 477.
See also DI; ED; OD
acupuncture and, 202
assisted hatching, 33
Australian studies, 462–463, 479–481
blastocyst transfers in, 33
breast cancer and, 241
depression from, 38
embryo transfers in, 33
European Union studies, 463
female attitudes towards, 67
in France, 479
Gn-RH and, 101
in Great Britain, 258, 478–479
history of, 358–359
ICSI in, 32
increase in, 20
infant outcome studies from, 480
under Infertility Treatment Act, 357
in Iran, female attitudes towards, 67
MMPI for, 93
ovarian stimulation in, 32
pregnancy rates from, 479
psychological testing for, 92–93
psychosocial consultations for, 84
SSRIs and, 105
in Sweden, 39, 479
in United States, 481
Zung depression scores and, 106
Japan
complementary and alternative medicine in, 197–198
female infertility in, 4
Japan Association of Psychological Counseling for Reproductive Health in, 549
reproductive tourism and, 530
umazume in, 3
Japan Association of Psychological Counseling for Reproductive Health (JAPCRM), 549
Certified Clinical Psychologist guidelines under, 549
Ju Jing powder, 202
Judaism
ART under, 72, 73
OD under, 73
personhood under, 291
reproduction under, 412
sexual expression within, 213–214
surrogacy under, 73
Torah, 213
Kahoun papyrus, 20–35
Kartagener syndrome, 273
Kazakhstan, international adoption from, 398
keening syndrome, 8
Klinefelter’s syndrome, 23
azoospermia in, 237
as genetic disorder, 272
male infertility from, 23, 38, 47, 237–238, 272
pregnancy termination rates for, 281
Koran, 73, 214
Kuwait, female infertility in, 42
laparoscopic ovarian drilling. See LOD
laparoscopy
LOD, 52
pelvic cavity evaluation, 21, 29
L-arginine, for female infertility, 204
last-chance-children, 467.
Latin America. See also Mexico
Grupo Latinoamericano de Interes en Salud Mental en Infertilidad in, 550–551
Latin American Federation of Fertility and Sterility Services in, 526
machismo in, 412
marianismo in, 412
reproduction in (colonial), 412
reproductive laws in, 526
Latin American Federation of Fertility and Sterility Services (FLASEF), 526
Grupo Latinoamericano de Interes en Salud Mental en Infertilidad and, 550
Latin American Network of Assisted Reproduction, 73
Law of Dominance, 259
Law of Independent Assortment, 259
Law of Segregation, 259
L-carnitine, 205
legal rights. See also reproductive laws
DI and, 305
for ED, 366–369
infertility counselors and, 13
surrogacy and, 33, 371–372, 382
lesbian couples
Canadian Fertility and Andrology Society guidelines for, 514
DI for, 307
ED as option for, 357, 368
European Society of Human Reproduction and Embryology guidelines for, 514
Human Fertilization and Embryo Authority on, 514–519
Internet resources for, 596
parenthood for, 469–470
levonorgestrel subdermal implants, 102
LH (luteinizing hormone), 32
clomiphene citrate and, 100
depression from, 106
life stage model, in family systems theory, 10, 416
lingam (penis), 3
lithium, 106
LOD (laparoscopic ovarian drilling), for PCOS, 52
low libido, 220
Lupron, 101
luteinizing hormone. See LH
Macau culture, 71
fertility rites within, 74
machismo, 412
male sexual dysfunction. See sexual dysfunction, in males
males. See also fatherhood; gay male couples; infertility, in males; sexual dysfunction, in males
advanced paternal age for, 271
on antidepressants, 105
azoospermia in, 28, 39, 47, 48
CBAVD in, 27, 28, 47, 48
CFTR in, 27
chromosomal abnormalities in, 272–273
conflict management for, 151
endometriosis, response to diagnosis in partner, 46
erectile dysfunction in, 219
as forgotten mourners, 8
Freudian infertility theories for, 43
gay, 375–376
immortality desires for, 460
machismo for, 412
medical consultation parameters for, 23
oligospermia in, 39, 48
in psychogenic infertility theory, 7
reproductive hormones for, 191
retrograde ejaculation for, 38, 227
sexual dysfunction in, 224–228
sexual functioning myths, 224
sexual functioning treatments for, 217
tobacco usage by, 190
urological history for, 24
XYY, 281–288
manipulative/body-based methods, 201, 205–206
massage, 205–206
Yoga, 205
marianismo, 412
Marital Adjustment Scale (MAS), 147
Marital Satisfaction Inventory (MSI), 147
marital therapy. See counseling, couples
marriage
under collectivism, 71
under Islam, 214
perinatal grief’s influence on, 298, 303
in Renaissance Europe, 215
MAS. See Marital Adjustment Scale
massage, 205–206
maternal identification, pregnancy and, 293
maternal mortality, 440–441
maternal serum screen, 278
MDI (mental development index), 104
media, infertility in, 37–38
medical economics, 22
medical ethics, 508.
See also bioethics
denial of infertility treatment and, 517
Nuremberg Code, 508
in Tuskegee Study, 508
World Medical Association and, 508
medical organizations. See organizations, medical
Medical Research Council, 478
medicine. See also behavioral medicine; complementary and alternative medicine; Western medicine
behavioral, 169
biopsychosocial, 264
Chinese traditional, 202
complementary and alternative, 174, 175, 177–178, 196
ethics in, 508
Hippocratic Oath in, 508
historical overview of, 197
integrated, 196
psychosomatic, 170
traditional, 196
Western, 64
meditation, mindfulness, 66
memory boxes, 299
men. See males
menopause
gonadotropins and, 101, 102
hot flashes during, 241
symptoms, from clomiphene citrate, 100
menstruation. See also ovulation
BBT influence on, 21
history of, 26
influences on, 3
ovulation detection during, 26–27
traditional Chinese medicine for, 202
mental development index. See MDI
Mental Health Professional Group (MHPG). See also American Society for Reproductive Medicine 86, 129, 166, 340, 523, 544–546
activities of, 540, 545–546
committees of, 545
ED guidelines, 358
goals of, 545
qualification guidelines of, 559
task forces under, 545
mental health professionals. See counselors, genetic; counselors, infertility
MEPA. See Multiethnic Placement Act
MESA (microsurgical epididymal sperm aspiration), 22, 32–36, 47
Mexico
Grupo Latinoamericano de Interes en Salud Mental en Infertilidad, 550–551
Latin American Federation of Fertility and Sterility Services, 526
National Board of Medical Genetics, 261
MHPG. See Mental Health Professional Group
microsurgery
development of, 47–58
MESA, 22, 32–36
TESE, 22, 32
tubal reanastomosis, 30
vasectomies, 32
microsurgical epididymal sperm aspiration. See MESA
microsurgical tubal reanastomosis, 30
Middle East. See Egypt; Iran; Israel; Pakistan
Mind/Body model, 429–438
mind-body programs, 203, 551
autogenic therapy, 203
in complementary and alternative medicine, 201
hypnosis, 203
for infertility counseling, 120
Transcendental Meditation, 157, 203–210
mindfulness meditation, 66
Minnesota Multiphasic Personality Inventory. See MMPI
miscarriages, 290
age as factor for, 300
chemical pregnancies, 290
multiple, 300
preimplantation, 290
recurrent pregnancy loss, 300
MMPI (Minnesota Multiphasic Personality Inventory), 92, 93, 94, 178
for IVF, 93
MMPI-2, 92, 93, 94
for oocyte donors, 345
personality disorders and, 99
for S/GCs, 378
T-scores for, 94
mood stabilizers, 106
carbamazepine, 109
lithium, 106
mortality. See also infant mortality
infertility counseling and, 252
maternal, 440–441
motherhood, 38, 460.
See also reproduction
age demographics for, 50
biological clock for, 51
cultural pressures for, 51
as defining role, 45, 131–132, 141, 418
in feminist theory, 325, 414
Greek cultural attitudes of, 72–73
after Industrial Revolution, 413
infertility theories and, by gender, 43
legal definitions of, 468–469
medicalization of, 460
myths of, 320
OD and, 325
as reparative, 131
in retirement, 319
solo, 469–470
in Vietnamese culture, 70
mourning, 294.
See also grief
Moxibustion, 202
Mozambique, Macau culture in, 71, 74
MPR (multifetal pregnancy reduction), 290, 301, 448–449
MSI. See Marital Satisfaction Inventory
multiculturalism, 68
emic approach to, 68
etic approach to, 68
ICD-9 and, 65
infertility counseling and, 63, 65, 66, 67
Multiethnic Placement Act (MEPA), 399
multifetal pregnancy reduction. See MPR
multiple birth/pregnancy, 448–449
after infertility treatment, 448–449
miscarriages during, 300–301
MPR for, 290, 301, 448–449
parenting issues from, 467–468
pregnancy termination, 301–302
vanishing twin syndrome, 301
mycoplasmosis, 216
narcissism, pregnancy and, 293
Narcissistic Personality Disorder, 108
NASW. See National Association of Social Workers
National Association of Black Social Workers, 399
National Association of Social Workers (NASW), 527
counselling guidelines of, 527
National Board for Certified Counselors, 527
National Board of Medical Genetics, 261
National Center for Complimentary and Alternative Medicine (NCCAM), 196
National Center for Health Statistics (NCHS), 197, 414
National Health Service, 118, 198
National Institute for Clinical Excellence (NICE), 118–127
National Institute for Health and Medical Research (INSERM), 479
National Insurance Law, 525
natural-killer cells. See NK
NCHS. See National Center for Health Statistics
needle phobia, 99, 107
negative eugenics, 259–260
ethnic cleansing as, 260
Holocaust as, 259
positive v., 260
Neisseria gonorrhoeae, 28
neonatal death, 290.
See also perinatal grief
The Netherlands
adopted children in, 392
ART in, 48
children from ART in, psychosocial health of, 483
neural tube defects, prenatal genetic testing for, 278
New Testament, 73
New Zealand
Australia & New Zealand Infertility Counsellors Association, 130, 321
DI in, 306, 310
ED in, 358, 363
NICE. See National Institute for Clinical Excellence
Nigeria
ART cycles in, 415
childlessness in, 415
divorce factors in, 42
infertility rates in, 20, 415
polygamy in, 71
nitric oxide, for female infertility, 204
nitrofurantoin, 240
NK (natural-killer) cells, during pregnancy, 159
North America. See Canada; Mexico; United States
nuclear conflict theory, 170
Nuremberg Code, 508
obesity. See also weight loss
BMI and, 189
diabetes and, 243
in European Union, 189
female-factor infertility and, 189, 243–244, 246
health behavioral interventions for, 189–190
PCOS and, 189
object relations theory, 325
female identity formation under, 417
generative tasks under, 417
in psychoanalytic theory, 417
stages of, 417
obsessive compulsive disorder. See OCD
OCD (obsessive compulsive disorder), 99, 107, 109
pharmaceutical treatment for, 109
during pregnancy, 107
OD (oocyte donation), 15, 16, 33, 51, 73, 84, 274, 319.
See also donors, oocytes; oocytes
advanced maternal age and, 332–333, 513
age and, 332
altruistic, 321, 340
American Society for Reproductive Medicine guidelines, 321, 322, 340, 536
anonymous, 319, 323–324, 330–331, 569–570
Assisted Human Reproduction Agency, 321
Assisted Human Reproduction Agency guidelines, 321
attachment and loss theory and, 326
in Australia, 321, 340, 342
Australia & New Zealand Infertility Counsellors Association guidelines, 321
in Belgium, 324
in Canada, 321, 340
commercial recruitment of, 319–320
counseling for, 333
CPHI for, 334
disclosure issues with, 334
donor characteristics, 322–323
educational materials for, 3–18
egg-sharing, 319
ethnicity as factor in, 329
European Society of Human Reproduction and Embryology guidelines, 322
European Union Tissue ands Cells Directive guidelines, 321, 357
family systems theory and, 326–327
female infertility and, 319
feminism and, 324–325
financial reimbursements for, 331
in France, 321, 340
future applications of, 336
in Great Britain, 323–324, 357
Human Fertilization and Embryo Authority guidelines, 321, 357–369
indications/contraindications for, 335
Infertility Treatment Act and, 321
intergenerational, 319
intrafamilial, 319, 323, 324, 331
in Israel, 525
known, 319, 323–324, 331–332, 559, 569, 570
legislation for, 320–321, 331
medical compliance during, 347
medical rejection rates for, 331
medical risks of, 342
Mental Health Professional Group of American Society of Reproductive Medicine guidelines, 321, 322
MMPI tests for, 345
motherhood from, 325
ovarian reimplantation and, 336
personalized anonymity for, 340
after POF, 320, 332
psychoanalytic theory and, 324–325
psychological evaluations for, 84, 85
psychosocial response to, 327–328
recipient characteristics, 324
recipient interviews for, 332, 333–334
recipient motivation for, 322
rejection criteria for, 335
relaxation training for, 182
reproductive laws for, 536
Reproductive Technology Accreditation Committee on, 321
reproductive tourism and, 319, 330
after secondary infertility, 333
selection issues for, 323–324, 328–332
split-egg, 319
stigma theory and, 325–326
stratified reproduction from, 319
transvaginal ultrasound retrieval for, 342
in United States, 484–485
oligospermia, 39, 48
from Y-microdeletions, 273
onohysterosalpingography, 53
oocytes
aging of, 51
cryopreservation of, 22, 53–54, 59, 241–256, 336, 342, 353
donors, 350
OD, 15, 16, 33, 51, 73, 84, 274
oopherectomy, 53–54
breast cancer and, 241
organ donations
altruism and, 346
gamete donations v., 346
surrogacy v., 373
organizations, advocacy
American Association of Marriage and Family Therapy, 527
American Psychiatric Association, 527
American Psychological Association, 75, 118, 527
American Society for Reproductive Medicine, 85, 129, 146, 261, 339, 485, 522
APNA, 527
Australia & New Zealand Infertility Counsellors Association, 130, 321, 357, 528, 540, 546–547
BFS, 528, 546
BKiD, 548
British Association for Counselling and Psychotherapy Professionals, 528
British Infertility Counseling Association, 130, 505, 528, 546
Canadian Counselling Association, 528
Canadian Infertility Counselling Association, 551
Canadian Infertility Counsellor’s Association, 528
development of, 7
Endometriosis Association, 158
European Society of Human Reproduction and Embryology, 85, 130, 146, 261, 339, 547–548
FertiForum, 549–550
Grupo Latinoamericano de Interes en Salud Mental en Infertilidad, 550–551
IFIPA, 499
for infertility, 5
for infertility counselors, 499
International Infertility Counseling Organization, 14, 130, 544, 548–549
Internet resources for, 593–596
IPOFA, 250
Japan Association of Psychological Counseling for Reproductive Health, 549
Latin American Federation of Fertility and Sterility Services, 526
Mental Health Professional Group, 86, 129, 166, 340, 523, 544–546
National Association of Black Social Workers, 399
National Association of Social Workers, 527
RESOLVE, 129, 156, 351, 499
World Medical Association, 508
organizations, medical, infertility counseling and, 5
orgasm phase disorders, 223
anorgasmia, 223
treatments for, 228
orgasms, in human sexual response, 218
ovarian cancer, 242
ovarian cysts. See cysts, ovarian
ovulation, 26–27
acupuncture and, 202
antiandrogens and, 30
BBT and, 26
endometrium during, 26
gonadotropins and, 30
hyperprolactinemia and, 101
induction of, 30
predictor kits, 26
progesterone value during, 26
serial ultrasound exams during, 26
PAI. See Personality Assessment Inventory
Pakistan, complementary and alternative medicine in, 198.
parenthood. See also fatherhood; motherhood
adaptation to, 471–473
adolescence as stage of, 472
alternative forms of, 469–470
American Society for Reproductive Medicine on, 459
after ART, 462–463
ART v. genetic, psychosocial studies of, 464
in Canada, legal definition of, 524–540
caregiver collaboration during, 473
Child Project Questionnaire for, 566
counseling for, 574, 577
discipline issues as part of, 471–472
expectations of, 466
Fertility Adjustment Scale for, 566
after infertility, 459, 461–462, 465–466, 474
information disclosure as part of, 488–489
Internet resources on, 596
Irrational Parenthood Adjustment Scale for, 566
last-chance-children and, 467
life expectancies after, 466
mental health assessment for, 473
motivations for, 461
after multiple birth/pregnancy, 467–468
normalization of, 470–471
older, 270–271, 466–467
only children and, 467
Parenting after Infertility Survey for, 462
after secondary infertility, 467
six stages of, 465
tasks of, 464–466
after third-party reproduction, 463–464, 468–469
Wikman Reproduction Scale for, 566
Parenting after Infertility Survey, 462
pastoral psychology, 66
pathological grief, 98, 292
predictors of, 292, 295
payak (reproductive spirits), 213
PCOS (Polycystic Ovarian syndrome), 38, 45
androgen levels and, 52
CAH and, 275
diagnosis-specific studies of, 42
female infertility from, 50
LOD for, 52
medical treatments for, 52
obesity and, 189
psychological effects of, 52
Quality-of-Life assessment for, 567
PCR (polymerase chain reaction), 276
PDD (premenstrual dysphoric disorder), 100
PDI. See Psychomotor Development Index
Pediatric Advisory Committee, 104
pedigree assessment
CEGRM, 262
for genetic counseling, 262
pedunculated submucosal fibroids, 28
pelvic cavity, 29
adhesions in, 29
laparoscopy for, 21, 29
pelvic inflammatory disease. See PID
penis envy, 417
percutaneous epididymal sperm aspiration. See PESA
percutaneous umbilical blood sampling, 451
percutaneous vasal sperm aspiration. See PVSA
perinatal grief, 294–296
marital relationships after, 298, 303
patterns of, 294–296
physical manifestations of, 294–295
primary, 297
psychotropic medications for, 297–298
PTSD from, 297–298
secondary, 297
shadow grief as part of, 295
Personal Information Protection and Electronic Documents Act (PIPEDA), 533–542
Personality Assessment Inventory (PAI)
for S/GCs, 378
personality disorders, 99, 107–109, 111.
See also Borderline Personality Disorder
Avoidant/Dependent Personality Disorder, 109
Borderline Personality Disorder, 107–108
Eysenck Personality Inventory, 99
Histrionic Personality Disorder, 108
MMPI, 99
Narcissistic Personality Disorder, 108
during post-infertility pregnancy, 445–446
personalized anonymity, 340
personhood
in China, 291
by culture, 291
under Judaism, 291
PESA (percutaneous epididymal sperm aspiration), 48
PGD (preimplantation diagnosis), 22, 35, 275–276
American Society for Reproductive Medicine on, 277
counseling issues for, 277
for couples, 276–277
European Society of Human Reproduction and Embryology on, 277
FISH in, 276
by genetic counselors, 259
HGC on, 277
Human Fertilization and Embryo Authority on, 277
international use of, 277
limitations of, 277
patient attitudes towards,
PCR in, 276
pregnancy termination after, 302
UNESCO on, 277
WHO on, 277
for Y-microdeletions, 273
PGS (preimplantation genetic screening), 276
for aneuploidy, 276
pharmaceuticals. See psychomedications
phobias, 99
blood-injury, 99
needle, 99, 107
PHSP (posthumous sperm procurement)
bioethics for, 514–515
international ban on, 515
reproductive laws for, 539
physical exercise
excessive, infertility from, 25
uterus and, effects on, 31
physicians
culturally sensitive, 67, 75–76
culturally unaware, 66
infertility counseling collaboration with, 498
infertility counseling for, 436, 441
infertility treatment withdrawal from, 434–435
phytoestrogens, 204
PID (pelvic inflammatory disease), 50
Pilaga tribe, 213
the pill. See birth control, oral
PIPEDA. See Personal Information Protection and Electronic Documents Act
placebo effects, 200–201
classical conditioning and, 200
in complementary and alternative medicine, 199, 200
conditioned, 201
expectancy theory and, 200–201
P-LI-SS-IT model, for sexual counseling, 228
PMR (progressive muscle relaxation), 183
POF (premature ovarian failure)
adrenal hormone deficiency from, 241
affliction rates, 42
causes of, 42–43
diagnostic communication issues for, 435
female infertility from, 26, 38, 45, 50, 52, 240–241
Fragile X syndrome and, 42
hot flashes and, 241
idiopathic, 42
IPOFA, 250
negative body image from, 43
OD after, 320, 332
pregnancy and, 42–57
secondary, 240
thyroid deficiency from, 241
treatment of, 250
Turner’s syndrome and, 42, 50, 51
Polycystic Ovarian syndrome. See PCOS
Polycystic ovarian Syndrome, 34
polygamy
for childless couples, 419
infertility and, 1, 42
polymerase chain reaction. See PCR
Post Traumatic Stress Disorder. See PTSD
posthumous sperm procurement. See PHSP
postpartum depression. See PPD
PPD (postpartum depression), 106
Antenatal Questionnaire for, 454
Antepartum Questionnaire for, 454
Beck Anxiety Inventory for, 454
Edinburgh Postpartum Depression Scale for, 454–458
incidence rates for, 473
after pregnancy, 445
risk factors for, 473
pregnancy. See also counseling, preconception; multiple birth/pregnancy; pregnancy loss; pregnancy, post-infertility; pregnancy termination; prenatal genetic testing
acupuncture and, 202–203
advanced maternal age and, 270–271
amniocentesis during, 453
anxiety disorders during, 445
ART risks, 441–442
bipolar disorders after, 106
bonding during, 293
after breast cancer, 241
chemical, 290
couvade experience during, 440
developmental tasks of, 444, 456
from DI, 314–315
diabetes and, 243
ectopic, 290
false positives for, 278
folic acid supplementation during, 270
during group counseling, 159, 164
HIV during, 243
as instinctual, 293
Internet resources for, 596
from IVF, 479
loss during, 13
maternal identification as part of, 293
as narcissistic condition, 293
NK cell study during, 159
as object-seeking, 293
OCD symptoms during, 107
payak and, 213
POF and, 42–57
PPD after, 445
preconception counseling before, 269–272
as psychological concept, 293, 304, 443
rubella immunity during, 270
after secondary infertility, 451
spontaneous loss during, 13
SSRIs during, 104, 105
termination of, 13, 280–282
after transcervical balloon tuboplasty, 30
trial, 276
trophoblastic disease and, 290.
pregnancy loss. See also miscarriages
ART as factor in, 290
bereavement theory and, 295
depression from, 299–300
genetically-affected, 282–283
grief from, 291–292
Internet resources for, 594–595
medical care after, 296–297
miscarriage, 290
psychotherapeutic approach to, 291, 296, 297–299, 300
recurrent pregnancy loss, 300
resolution of, 295
stillbirth, 290
support groups for, 300
timeline for, 291
pregnancy, post-infertility
advanced maternal age during, 450–451
ambiguity during, 444–456
anxiety during, 442, 444
bedrest for, 447–448
complicated, 446–448
coping strategies for, 452–454
decision making during, 452
denial of, 446
depression during, 445, 454
distress from, 454
eating disorders during, 446
entitlement issues during, 442
external stress factors on, 442
hospitalizations during, psychiatric, 444
hyperemesis gravidarum during, 446
infertility counseling for, 16, 17, 451–452, 454–455
infertility rituals during, 442
isolation during, 444–457
loss during, 444
nausea/vomiting during, 447
normalization of, 443–456
personality disorders during, 445–446
physical vulnerability during, 442
as premium, 440
pseudocyesis during, 446
psychological tasks of, 443–444
psychopathology during, 444–446
resources for, 454
selflessness during, 442
support groups for, 452, 454
by third-party reproduction, 449–450
pregnancy termination, 13, 522–540
elective abortion, 290
Klinefelter’s syndrome and, 281
for mosaic cases, 281
MPR, 290, 301
during multiple pregnancy, 301–302
after PGD, 302
from prenatal genetic testing, 280–282, 302
psychological responses to, 281
Turner’s syndrome and, 281
XYY males and, 281–288
preimplantation diagnosis. See PGD
preimplantation genetic screening. See PGS
preimplantation miscarriages, 290
premature ejaculation, 226–227
treatments for, 226–227
premature ovarian failure. See POF
premenstrual dysphoric disorder. See PDD
premenstrual syndrome, 100
premium pregnancy, 440
prenatal adoption, 526
prenatal genetic testing, 277–283.
See also PGD
abnormalities during, 279
for advanced maternal age, 451
amniocentesis, 280, 451, 453
biochemical/nuchal translucency screen, 278
CVS, 279–280, 451
for Down syndrome, 278, 279–288
for ED, 284
fetoscopy, 451
first-trimester screening in, 279
maternal serum screen, 278
for neural tube defects, 278
percutaneous umbilical blood sampling, 451
pregnancy termination as result of, 280–282, 302
with serum alpha-fetoproteins, 451
ultrasound, 278, 279
Primary Care Evaluation of Mental Disorders Brief Patient Health Questionnaire. See PRIME-MD Brief PHQ
primary infertility, 2, 20
PRIME-MD Brief PHQ (Primary Care Evaluation of Mental Disorders Brief Patient Health Questionnaire), 504
private adoption. See independent adoption
privatization of happiness, 460
PROGAR. See Project Group on Assisted Reproduction
progesterone, 26, 100, 102
GABA modulation from, 100
levonorgestrel subdermal implants, 102
in oral birth control, 102
during ovulation, 26
serotonin decreases from, 100
progressive muscle relaxation. See PMR
Project Group on Assisted Reproduction (PROGAR), 546
pronatalism, 413
childless couples and, 422–423
Protection of Children and Co-Operation in Respect of Intercountry Adoption (Hague Convention), 389, 398
pseudocyesis, 446
PSIG. See Psychological Special Interest Group
psychoanalytic theory. See also Freudian theories
childlessness in, 417
ego psychology as part of, 417
object relations theory, 417
OD and, 324–325
penis envy as part of, 417
self-psychology as part of, 417
psychodynamic therapy, 15, 133–134, 159
brief, 133, 134, 138–139
features of, 138
long-term, 133, 134
shared values of, 138
psycho-education, 181–183
information sources for, 183
psycho-educational group counseling, 165
for DI recipients, 165
psychogenic infertility theory, 6–7, 130, 170, 171, 216
females and, 7
males and, 7, 216
psychological consequences theory, 7, 171
infertility counseling in, 7
stages of grief as part of, 7
psychological cyclical model, 7
psychological disorders. See psychopathology
psychological evaluations, 86, 87–91
assessment factors within, 86–87
content of, 88
in couples counseling, 83–85, 88
CPHI, 88, 125, 178, 563
for DI, 84, 85
for ED, 84, 85
expectation management as part of, 89–90
fertility treatment contraindications from, 90
information gathering for, 88–89
informed consent as part of, 87–95
interview preparations for, 87–88
legal history as factor in, 89
for OD, 84, 85
psychological testing and, 91
recommendations after, 90–91, 95
record storage and, 87
relationship history as part of, 89
social support outside of, 89
psychological outcome approach, 7–8, 171
Heidelberg model in, 8
Psychological Special Interest Group (PSIG). See also European Society of Human Reproduction and Embryology; Mental Health Professional Group
of European Society of Human Reproduction and Embryology, 322
gamete donation guidelines, 340
infertility counseling guidelines, 322
psychological tests. See also psychometric testing
Antenatal Questionnaire, 454
Antepartum Questionnaire, 454
Beck Anxiety Inventory, 454
Beck Depression Inventory, 92, 98, 178
characteristics of, 92
Coping Inventory for Stressful Situations, 179
Coping Scale for Infertile Couples, 567
development of, 91
Dyadic Adjustment Scale, 147
Eating Attitudes Test, 99
Edinburgh Postpartum Depression Scale, 454–458
Eysenck Personality Inventory, 99
Fertility Adjustment Scale, 566
Fertility Problem Inventory, 147–148, 565
future applications for, 93–94
Infertility Cognitions Questionnaire, 565
Infertility Distress Scale, 566
Infertility Reaction Scale, 565
Irrational Parenthood Adjustment Scale, 566
for IVF, 92–93
literature review on, 92–93
Marital Adjustment Scale, 147
MMPI, 92, 178
MMPI-2, 92, 93, 94
MSI, 147
Personality Assessment Inventory, for S/GCs, 378
personality tests, 91, 93
PRIME-MD Brief PHQ, 504
psychological evaluations and, 91
psychometric, 93
Psychomotor Development Index, 104
reliability in, 92
of S/GCs, 376, 378, 381
State-Trait Anxiety Inventory, 92, 178
Symptom Checklist, 92, 178
validity in, 92
Ways of Coping Checklist, 178, 179
psychology
of altruism, 373
culture and, 68–70
in genetic counseling, 265, 269
pastoral, 66
of pregnancy, 293, 304
religion v., 65–66
social, 418–419
psychomedications. See also mood stabilizers; SSRIs; tricyclic antidepressants
cimetidine, 240
infertility treatments interactions, 109–110
mood stabilizers, 106
nitrofurantoin, 240
for perinatal grief, 297–298
spironolactone, 240
SSRIs, 104–105
sulfasalazine, 240
tricyclic antidepressants, 104, 112
psychometric testing, 93, 552–553.
See also MMPI; psychological tests
Psychomotor Development Index (PDI), 104
psychopathology, 94, 97, 103–107.
See also affective disorders; anxiety disorders; bipolar disorders; eating disorders; sexual dysfunction
Adjustment Disorder, 99, 103
affective disorders, 98–99, 103
anxiety disorders, 99, 107
bipolar disorders, 99
eating disorders, 99
grief reactions, 98
infertility and, 98–99
OCD, 99, 107, 109
personality disorders, 99
psychopharmacology, 97
psychosis, from clomiphene citrate, 101
psychosocial context approach, 8
psychosocial support services. See also counseling, infertility; support groups
for infertility, 5, 6
pregnancy rates influenced by, 5
psychotherapy. See also CBT (Cognitive Behavioral Therapy); counseling, couples; counseling, sexual
crisis intervention, 15, 136–137
genetic counseling v., 263
grief counseling and, 137
infertility counseling v., 132–133
psychodynamic, 15, 133, 134
solution-focused, 135, 136
strategic, 135–136
PTSD (Post Traumatic Stress Disorder)
for adopted children, 392, 409
from perinatal grief, 297–298
psychological videotapes as part of, 297
for S/GCs, 380
Public Health (In Vitro Fertilisation) Regulation (Israel), 72
Public Health (Semen Banks) Regulation (Israel), 72
PVSA (percutaneous vasal sperm aspiration), 48
Pychnogenol, 205
quality-of-Life assessments
Endometriosis Health Profile-30, 567
FertiQol, 567
in infertile men, 568
for PCOS, 567
Qu’an. See Koran
RCT (Relational Cultural Theory), 43–44
components of, 44
connectedness as part of, 44
RCT (randomized control trial), in infertility counseling, 120
reasonable welfare principle, 147
recipients
characteristics, for OD, 324
counseling, for DI, 165
counseling, for ED, 365–366, 572, 573
ED consent forms for, 589
gamete donor, 348
interview process, for OD, 332, 333–334
motivations for OD, 322
screening of, for S/GCs, 380–382
reciprocal determinism, 134, 199
triadic reciprocality from, 199
reconstruction, in couples counseling, 152–153
reflexology, 206
Regulated Health Professionals Act, 528
Rehabilitation Act, 531–542
Relational Cultural Theory. See RCT
relaxation
PMR, 183
response, to stress, 171
techniques, 183–184, 192
reliability, psychological testing, 92
internal consistency and, 92
test-retest, 92
religion. See also Buddhism; Christianity; Islam; Judaism
children in, as symbols,
infertile female distress levels and, 67
infertility counseling and, 78
infertility treatment influenced by, 67–68, 73–75
major world religions, by population, 63
monotheistic, 62–63
polytheistic, 62–63
psychology v., 65–66
S/GCs and, 378
spirituality v., 62–63
reproduction, 131–132.
See also birth control; fatherhood; motherhood; parenthood; pregnancy
in Africa, social importance of, 413
in ancient Greece, female role in, 213, 411–413
in Asia, social importance of, 412–413
birth control development and, 215
under Christianity, 412
in colonial Latin America, 412
as form of immortality, 131, 411, 460
generativity and, 131
happiness from, 413
under Islam, 412
under Judaism, 412
privatization of happiness and, 460
sexual expression and, 213
stratified, 319, 415
theories of, 320
in Vietnam, social importance of, 413
reproductive endocrinologists, 23, 51
reproductive health psychology, 169
reproductive laws, 521–522, 524, 540.
See also Human Fertilization and Embryo Authority; legal rights
Artificial Conception Act, 525
Assisted Human Reproduction Act, 524, 528
in Australia, 524–525, 547
Baby M., 522
for biotechnology, 522–523
in Canada, 524
Canada Health Act, 524–540
Commonwealth Family Law Act, 525
for donor sperm, 535–536
for ED, 536–537
under Human Fertilization and Embryo Authority, 523
Infertility Act, 524
informed consent under, 539–540
in Israel, 72, 525–526
in Latin America, 526
for lost embryos, 537–538
National Insurance Law, 525
for OD, 536
for PHSP, 539
Public Health (In Vitro Fertilisation) Regulation, 72
Public Health (Semen Banks) Regulation, 72
for S/GCs, 538–539
Surrogacy Arrangement Act, 525
in United States, 523
Reproductive Technology Accreditation Committee, 321
Reproductive Technology Accreditation Committee (RTAC), 321, 339, 340, 357
Reproductive Technology Register, 480
reproductive tourism, 2–18, 63–64, 341, 512, 529, 555
childlessness and, 419
DI and, 314
ED and, 357
multicultural counseling for, 63
OD and, 319, 330
S/GCs and, 379
stratification of services for, 63–64, 512
reproductive tract, female, cancers of, 53–54, 242, 249
research, infertility
demographic issues in, 5
ethnographic case studies, 5
RESOLVE (National Infertility Association), 129, 156, 351, 499
ED education by, 360, 366
retainers, for contractual surrogacy, 374
retirement motherhood, 319
retrograde ejaculation, 38, 227
diabetes and, 240
treatments for, 227
rituals, development of, 153
Rokitansky-Küster-Hauser syndrome, 23, 50, 51, 158
female infertility from, 238, 275
Roman Catholic Church, ART and, 526
Romania, adoption in, 388
RPL (recurrent pregnancy loss), 300
habitual aborters and, 300
rubella, during pregnancy, immunity from, 270
Russia, international adoption from, 398
salpingoscopy, 52–53, 59
salpingostomy, 53
SCL-90. See Symptom Checklist
Scotland
cystic fibrosis study, 246
infertility rates in, 20
secondary infertility, 2, 20
OD after, 333
parenthood after, 467
pregnancy after, 451
Selenium, 205
self
discrepancy theory of, 9
idiocentrism and, 69
models, infertility and, 9
psychology of, 417
self-blame. See also shame; stigma theory
by gender, 46
self-efficacy beliefs, 188
emotional reactions influenced by, 200
self-regulation from, 200
in Social Cognition Theory, 199–200
self-esteem
body image issues and, 43
female infertility and, 41
male infertility and, 49
self-psychology theory, 43, 44–45
semen analysis, 22, 27.
See also sperm production
age as factor in, 246
parameters for, 27
stress as factor for, 217–218
sensate-focus techniques in, 229
serotonin
brain effects from, 105
estrogen effects on, 100
progesterone effect on, 100
SSRIs, 104–105
sertraline, 105
serum alpha-fetoproteins, 451
sex therapy. See counseling, sexual
sexual arousal phase disorders, 222–223
treatments for, 223
sexual counseling. See counseling, sexual
sexual dysfunction, 212, 213–233.
See also sexual dysfunction, in females; sexual dysfunction, in males
ART and, 217–218
assessment of, 219
clinical histories of, 219
CPHI and, 219
diagnostic grid for, 221
ethical issues regarding, 231
in females, 222–224
generalized, 212
hypoactive sexual desire disorder, 220
impotence as, 219
in infertile couples, 213–217, 233, 235
infertility counselors and, 231–232
infertility from, 219–220
low libido, 220
prevention of, 229–231
primary, 212
secondary, 212
situational, 212
treatments for, 227, 228–229, 231
sexual dysfunction, in females, 222–224
dyspareunia, 224
hormonal changes as cause of, 222
orgasm phase disorders, 223
sexual arousal phase disorders, 222–223
vaginismus, 219, 223–224
sexual dysfunction, in males, 224–228
erectile dysfunction, 219, 225–226
premature ejaculation, 226–227
retrograde ejaculation, 38, 227
sexual pain disorders, 227–228
sexual expression, 212
in Africa, for females, 214–215
in Asia, 214
for females, 215
human sexual response and, 218
in Islam, 214
in Judaism, 213–214
for males, myths about, 224
in medieval Europe, 214
reproduction and, 213
zina as, 214
sexual health, 212, 218
sexual pain disorders, for males, 227–228
sexuality, 218.
See also homosexuality
cultural influence on, 219
sexually transmitted infections. See STIs
S/GCs (surrogacy/gestational carriers), 15, 16, 33, 34, 51, 370–371, 449–450.
See also contractual surrogacy
adoptive parents and, 370
age as factor in, for parents, 385
altruistic, 373, 380
American Society for Reproductive Medicine guidelines, 377
assessment of, 377–380
in Australia, 525
Baby M. and, 522
commercial, 373
common problems within, 374–375
compensation for, 577
contractual, 370, 374
CPHI and, 381
cultural sensitivity during, 382
demographics for, 372
ethical arguments of, 371
European Society of Human Reproduction and Embryology guidelines, 377
evaluation guidelines for, 574–577
future of, 385–386
for gay male couples, 375–376, 478
infertility counseling for, 449
informed consent from, 377
Internet resources for, 593–595
intrafamilial, 380
IVF surrogates, 370
joint session interviews as part of, 382–385
under Judaism, 73
legal rights for, 33, 371–372, 382
MMPI-2 testing for, 378
organ donation v., 373
Personality Assessment Inventory for, 378
psychological risks in, 33
psychological testing of, 376, 378, 381
PTSD from, 380
public curiosity about, 371
recipient screening for, 380–382
reference checks for, 379
religion and, 378
reproductive laws for, 538–539
reproductive tourism and, 379
social support for, 378
traditional, 370
United States agencies for, 371
United States guidelines for, 371
shadow grief, 295
shame, 44
as clinical issue, 46
EMDR for, 54
from female infertility, 54
infertility counseling and, 405
for infertility females, 46
from male infertility, 49
in stigma theory, 44
Short Form Health Survey Questionnaire, 41
SIDS (sudden infant death syndrome), 290
situation-stress-symptom, 171
Six Phase of Infertility Treatment Model, 496–497
smoking. See tobacco usage
Social Cognition Theory, 199
reciprocal determinism in, 199
self-efficacy beliefs in, 199–200
social-exchange theory, ED and, 360
solution-focused psychotherapy, 135
coping strategies in, 135
in Germany, 136
sonohysterogram, 29
South Korea, international adoption from, 398
S-P (scientist-practitioner) model
EBM as part of, 122–123
of infertility counseling, 120, 122–123
sperm banks, 33
HIV’s effect on, 342
sperm donors, 15, 16, 272, 341, 349–350
for CBAVD, 273
reproductive laws for, 535–536
sperm production
alcohol/drug use and, 188
cryopreservation and, 239, 341
ICSI, 22, 47, 48
identification of, 3
IUI, 31, 48
medication’s effects on, 27
MESA, 22
PESA, 48
pharmaceutical’s effect on, 27
production/delivery evaluation, 27–28, 31
PVSA, 48
semen analysis, 22, 27
TESE, 22
tobacco use and, 27
Spina bifida, 106
spirituality
chronic illness and, 254
non-religious, 63
religion v., 62–63
spironolactone, 240
spoiled identity, 152
SSRIs (serotonin reuptake inhibitors), 104–105
brain activity effected by, 105
Fluoxetine, 104, 105
galactorrhea and, 105
IVF and, 105
during pregnancy, 104, 105
sertraline, 105
Venlafaxine, 104, 105, 110
SSRM. See Swiss Society for Reproductive Health
St. John’s Wort, 205
stage theory (of infertility), 11
couples counseling and, 144
dawning in, 11
immersion in, 11
for infertility treatment, 433–434
legacy as part of, 11
mobilization in, 11
resolution in, 11
State-Trait Anxiety Inventory (STAI), 92, 178
stigma theory, 10, 43, 44, 58, 248
adoption under, 388, 389
childlessness and, 418–419
DI and, 47, 310
for infertile women, 44
infertility as, 10, 39
OD and, 325–326
physical deformity types and, 44
shame as part of, 44
stillbirth, 290
STIs (sexually transmitted infections)
Chlamydia, 28
chlamydiosis, 216–233
genital herpes, 216
gonorrhea, 216
HIV, 216
HPV, 216
infertility from, 216
mycoplasmosis, 216
Neisseria gonorrhoeae, 28
syphilis, 216
trichomoniasis, 216
strategic/solution-focused brief therapy, 15
stratification of services
human rights and, 424
for infertility counseling, 2, 8, 18, 215
for reproductive tourism, 63–64, 512
stratified reproduction, 319, 415
stress
adaptation as result of, 171, 183
alarm reaction from, 170
from ART, 53–54, 59
baseline, 174
chronic stressors, 176–193
cognitive-phenomenological stress theory, 176
cognitive-phenomenological theory of, 176
coping strategies for, 174, 176, 179–180
cultural influences on, 172
exhaustion from, 171
females and, 172
fight or flight and, 171
general adaptation syndrome from, 170
as health factor, 170–171
in infertile females, 172
in infertile males, 172, 173
Fertility Problem Inventory, 179
from infertility treatments, 432
infertility-specific, 178–179
interactional approach to, 178
management programs for, 131
from post-infertility pregnancy, 454
pregnancy and, 442
relaxation response to, 171
response-oriented, 178
semen quality and, 217–218
situation-stress-symptom, 171
stimulus-oriented, 178
theories, for infertile individuals, 9–10, 53–54
stress and coping theory, 174, 176.
See also coping strategies
distress in, 176
infertility and, 179–180
subfertility, 106
sudden infant death syndrome. See SIDS
sulfasalazine, 240
support groups
for chronic illness sufferers, 254
female, 119
group counseling v., 161
for post-infertility pregnancy, 452, 454
for pregnancy loss, 300
surgery. See also microsurgery; surgery, fallopian tube
for cervical cancer, 242
for endometriosis, 243
fallopian tube, 30
uterine, 30–32
surgery, fallopian tube, 30
microsurgical tubal reanastomosis, 30
transcervical balloon tuboplasty, 30
tubal ligations and, 30
surgery, uterine, 30–32
IUI, 31
Surrogacy Arrangement Act, 525
surrogacy/gestational carriers. See S/GCs
Sweden
ART in, 340
DI in, 306, 342
ICSI in, for males, 39
infertility rates in, 20
information disclosure in, for gamete/embryo donations, 485
IVF in, 39, 479
male infertility study in, 39–40
Swiss Society for Reproductive Health (SSRM)
FertiForum under, 550
Switzerland
DI in, 306
FertiForum in, 549–550
SSRM, 550
Symptom Checklist (SCL-90), 92, 178
syphilis, 216
Taiwan
anxiety disorders in, 99
children from ART in, psychosocial health of, 483
Talmud, 73
tamoxifen citrate, 30
Tao Te Ching, 73
TCM. See traditional Chinese medicine
Ten-step Circular Process Model, 495–496
European Society of Human Reproduction and Embryology and, 496
TESE (testicular sperm extraction), 22, 32, 47
testicular cancer, 48, 239
counseling for, 48, 249
sperm cryopreservation and, 239, 245
testicular sperm extraction. See TESE
therapies. See also biologically-based therapies; CBT; counseling, couples; counseling, infertility; counseling, multicultural; counseling, sexual; counselors, infertility; crisis intervention therapy; grief therapy; psychodynamic therapy; psychopharmacology; psychotherapy
biologically-based, 201, 203–205
for breast cancer, 242
CBT, 49, 52, 107, 131, 134–135, 159, 188
chemotherapy, 241, 249
Clear Passage, 206
collective, 157
crisis intervention, 15
for endometriosis, 243
energy/biofield, 201
family, 15
grief, 15
Group-Rational-Emotive, 159
hormonal, for infertile males, 32
implication/decision-making, 15
marital, 143–144
psychodynamic, 15, 133–134
psychodynamic therapy, 15, 133, 134, 159
strategic/solution-focused brief, 15
third-party reproduction, 33–34, 35.
See also children, via third-party reproduction; S/GCs; surrogacy
disclosure about, to children, 469, 472, 489, 490, 553–554
European Union studies, 463–464
family-building from, 15–16
from gamete donation, 449, 450
internet resources for, 595
Islam and, 74
OD as part of, 15, 16, 33
parenthood after, 463–464, 468–469
post-infertility pregnancy from, 449–450
sperm donation as part of, 15
thyroid hormones, POF’s effect on, 241
tobacco usage, 190
American Public Health Service on, 188
by females, 190–195
infertility and, 25
by males, 190
sperm production and, effect on, 27
Tobrian Islanders, 3
Torah, 73, 213
traditional Chinese medicine (TCM), 202.
See also acupuncture
acupuncture, 202–203
Guizhi-Fuling-Wan, 202
Guyin decoction, 202
Hachimijiogan, 202
Hoccheukkito, 202
iontophoresis, 202
Ju Jing powder, 202
for male infertility, 202
for menstrual irregularity, 202
Moxibustion, 202
Transcendental Meditation, 157, 203–210
transcervical balloon tuboplasty, 30
pregnancy rates after, 30
transcervical tubal cannulation, 53
transference, 137–138
in infertility counseling, 497
transracial adoption, 392–393, 399–400
arguments against, 400
EuroAdopt program for, 400
under Multiethnic Placement Act, 399
National Association of Black Social Workers on, 399
transvaginal ultrasound retrieval, 342
trial pregnancies, 276
trichomoniasis, 216
tricyclic antidepressants, 104, 112
fetal malformations from, 104
male sexual function and, 105
Triptorelin, 101, 102
trophoblastic disease, 290
tubal diseases
behavioral interventions for, 53
female infertility from, 53
PID, 50
therapeutic approaches to, distal, 53, 59
therapeutic approaches to, proximal, 52–53
tubal ligations, 30
tubocornual anastomosis, 53
Turkey, ART in, religious attitudes towards, 67
Turner’s syndrome, 42, 50, 51, 274–275
female infertility from, 238, 240
pregnancy termination rates for, 281
Tuskegee Study, 508
Twelve Item General Health Questionnaire, 41
ultrasound, 278, 279
transvaginal retrieval, 342
ultrasound exams, serial, during ovulation, 26
umazume (infertile women), 3
UNICEF (United Nations Childrens Fund), 389
United Nations Educational, Scientific, and Cultural Organisation (UNESCO)
on gamete donations, 283
on PGD, 277
United States (U.S.)
American Board of Genetic Counseling, 261
American Society for Reproductive Medicine in, 85, 129, 146, 261, 339, 485, 522, 544–546
Americans with Disabilities Act in, 243, 531
ART cycles in, 415
census demographics (2000), 62
Center for Disease Control and Prevention in, 197, 523
Center for Surrogate Parenting in, 371
Civil Rights Act in, 531–542
civil rights movement in, 64
complementary and alternative medicine in, 196, 197, 198–199
cultural identification in, 62
DI in, 305
ED agencies in, 364
enforced adoption in, 388
eugenics in, 259
family life cycles in, 416
Fertility Clinic Success Rate and Certification Act, 522
Food and Drug Administration, 30, 523
gamete/oocyte donation disclosure in, 485
Health Insurance Portability and Accountability Act in, 532–533
immigration to (1995–2000), 62
individualism in, 69
infertility rates in, 20
IVF studies in, 481
Mental Health Professional Group in, 86
multicultural infertility counseling in, 65
National Center for Complimentary and Alternative Medicine in, 196
National Center for Health Statistics in, 197, 414
OD in, 484–485
Rehabilitation Act in, 531–542
reproductive laws in, 523
S/GC agencies in, 371
surrogacy guidelines in, 371
USDA in, 30
urologists, in infertility counseling, 23–24, 27
uterine septae, 29
uterus, 28–29
bicornate, 29–36
D&C on, 32
DES effects on, 29, 32
endometrial polyps in, 28
exercise’s effect on, 31
hysteroscopy for, 29, 32
pedunculated submucosal fibroids in, 28
sonohysterogram for, 29
surgical procedures for, 30–32
uterine septae in, 29
vaginismus, 219, 223–224
causes of, 224
treatments for, 224
validity, psychological testing, 92
construct, 92
content, 92
criterion-related, 92
valproic acid, 106
spina bifida from, 106
vanishing twin syndrome, 301
varicoceles
in infertile males, 28, 38
surgical procedures for, 32
vasectomies, 32, 47–58
psychological effects of, 39
reversals for, in United States,
VE, 48
VVS, 48–58
vasocongestion, 218
vasoepididymostomy. See VE
vasovasostomy. See VVS
VE (vasoepididymostomy), 48
Venlafaxine, 104, 105, 110
Vietnam
female infertility in, 72
motherhood as cultural symbol, 70
reproduction in, social importance of, 413
virtual group counseling, 166
vitamin supplements, 204
for male infertility, 205
during pregnancy, 270
Vitex, 204
Voluntary Licensing Authority, 478
VVS (vasovasostomy), 48–58
Ways of Coping Checklist (WCC), 178, 179
weight loss. See also obesity
under group counseling, 158
Welcome Home agency, 388
welfare of the child, 147
Western Australia Birth Defects Registry, 480
Western medicine, 64
mindfulness meditation in, 66
WHO. See World Health Organization
Wikman Reproduction Scale, 566
women. See females
World Health Organization (WHO)
BMI measurements by, 189
ED guidelines, 363
fertility definition by, 414
on gamete donations, 283
on PGD, 277
traditional medicine parameters for, 196, 207
on universal health care, 424
World Medical Association, 508
Y-microdeletions
azoospermia from, 273–287
male infertility from, 273
oligospermia from, 273
PGD for, 273
Yoga, 205
yoni (female genitalia), 3
zina (female sexual expression), 214
Zinc, 205
Zung depression scores, 106